ЖЕВАТЕЛЬНАЯ РЕЗИНКА

Использование: в пищевой промышленности, в частности в кондитерской для приготовления жевательной резинки с сохранением аромата и сладости длительное время. Сущность изобретения: жевательная резинка содержит покрытый оболочкой продукт, полученный путем нанесения покрытия (заключения в оболочку) плодов Curculigo latifolia, обработанных плодов Curculigo latifolia или компонента, содержащего куркулин, выделенного из этих плодов, с помощью покрывающего средства. 13 п. ф-лы, 2 табл.

CHEWING RUBBER.

Stable dry probiotic compositions for special dietary uses

A dry stable probiotic composition is provided. The composition comprises one or more viable probiotic microorganisms, one or more hydrolyzed proteins, one or more disaccharides, one or more oligosaccharides, and one or more polysaccharides, but not trehalose. The composition has viability of at least 1x10 ...

PRODUCTION OF ACORN FERMENTED JUICES USING ACORNS AND BYPRODUCTS OF ACORN

The present invention relates to a method for manufacturing acorn fermented juices using acorns and byproducts of acorns. According to the present invention, tannin components of acorns are decomposed by using vitamin C and it has a similar effect to fermentation in natural oak barrels by applying a re-fermentation method. COPYRIGHT KIPO 2017 (AA) Fermented acorn liquid (BB) Refermented acorn liquid ...

SYRUP COMPOSITION COMPRISING HIGH CONTENT OF FRUCTOOLIGOSACCHARIDE

The present invention relates to a syrup composition comprising a high content of fructooligosaccharide and having high electrical conductivity, and a production method thereof. According to the present invention, the content reduction of fructooligosaccharide, which is an effective component inside fructooligosaccharide syrup, since the decomposition can be minimized, and the syrup composition has excellent long-term storage stability by not having color change. COPYRIGHT KIPO 2018 ...

Method of Making Rice Cake by Mixing Jerusalem Artichoke

xarope de tagatose e galactose

NUTRITIONAL FORMULATIONS INCLUDING HUMAN MILK OLIGOSACCHARIDES AND LONG CHAIN POLYUNSATURATED POLYUNSATURATED FATTY ACIDS AND USES THEREOF

Disclosed are nutritional compositions including human milk oligosaccharides in combination with long chain polyunsaturated fatty acids and/or carotenoids that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases.

FORTIFIED MILK-BASED NUTRITIONAL COMPOSITIONS

COMPOSITIONS FOR USE IN THE REDUCTION OF PAIN AND/OR PERCEPTION OF PAIN IN INFANTS AND YOUNG CHILDREN

PROCEDURE FOR THE PRODUCTION OF ISO MARK TON OLIGOSACCHARID REALMS SYRUPS

METHOD FOR THE PRODUCTION OF ISOMALTO-OLIGOSACCHARIDE RICH SYRUPS

The present invention describes a method for the production of isomalto-oligosac charides syrups. The method comprises the use of enzymes immobilized on a reusable carrier. The carrier is preferably an anion exchanger. The enzymes used for the conversion of starch hydrolysates are transglucosidase and pullulanase preferabl y these enzymes are co-immobilized. The carrier/enzyme conjugate is further reinforced b y cross-linking.

다래의 삽미를 제거한 다래 잼 및 다래 양갱의 제조방법

... 본 발명의 다래 잼 및 다래 양갱의 제조방법에 관한 것으로, (A) 다래를 민서기로 분쇄하여 다래 분쇄물을 제조하는 단계; (B) 상기 다래 분쇄물과 프락토올리고당, 펙틴, 구연산, 트레할로스, 물, 아스파탐용액 및 아세설팜칼륨용액을 혼합하여 다래 잼 혼합물을 제조하는 단계; 및 (C) 상기 다래 잼 혼합물을 가열 및 교반하는 단계;를 포함하는 것을 특징으로 하는 다래 잼의 제조방법과; (a) 다래를 민서기로 분쇄하여 다래 분쇄물을 제조하는 단계; (b) 상기 다래 분쇄물과 콩앙금, 과당, 프락토올리고당, 물, 트레할로스, 한천, 잔탄검, 아스파탐용액 및 아세설팜칼륨용액을 혼합하여 다래 양갱 혼합물을 제조하는 단계; 및 (c) 상기 다래 양갱 혼합물을 가열 및 교반하는 단계;를 포함하는 것을 특징으로 하는 다래 양갱의 제조방법;을 제공한다. 본 발명에 의해 제조된 다래 잼 및 다래 양갱은 다래 고유의 색이 유지되고, 다래 특유의 삽미가 제거되어 기호도가 매우 우수하다.

METHOD FOR COATING SURFACE OF CEREAL WITH TURMERIC

The present invention relates to a method for coating the surface of a cereal with turmeric. More specifically, the method for coating the surface of a cereal with turmeric adds gum ghatti, Arabia gum, chitooligosaccharide, etc. to turmeric to make an aqueous solution to grind the aqueous solution into a nano size to improve a water-dispersible property to easily coat the surface of the cereal with the turmeric. Since the surface of the cereal is coated with the nano turmeric by undergoing a coating process in two steps, coating performance including a dispersion property and an adhesion property can be markedly improved. COPYRIGHT KIPO 2016 (S1) Step of preparing turmeric powder (S2) Step of preparing an aqueous solution containing the turmeric powder and gum ghatti (S3) Step of wet-grinding the turmeric solution to manufacture a nano turmeric solution (S4) Step of firstly coating a cereal with the nano turmeric solution (S5) Step of secondly coating the cereal with glycerin ...

멸치 분말을 함유한 캔디 및 그 제조방법

... 천연 칼슘을 이용하여 부작용이 없고 흡수 이용 효율을 높이며, 성장기 어린이에게 성장 촉진을 도모할 수 있도록 칼슘섭취를 자연스럽게 복용할 수 있는 멸치 분말을 함유한 캔디 및 그 제조방법에 관한 것으로, (a) 멸치 분말을 마련하는 단계, (b) 상기 단계 (a)에서 마련된 멸치 분말에서 멸치 냄새를 제거하는 단계, (c) 상기 단계 (b)에서 냄새가 제거된 멸치 분말에 비타민 D를 혼합하는 단계, (d) 상기 단계 (c)에서 마련된 멸치 분말과 비타민 D와 프락토올리고당(fructooligosaccharide)을 함유한 캔디를 성형하는 단계를 포함하고, 상기 캔디에는 멸치 분말, 비타민 D와 프락토올리고당이 중량비로서 700㎎ : 10㎍ : 3~8g의 비율로 함유되는 구성을 마련하여, 칼슘공급원으로 우수한 멸치 분말을 어린이에게 용이하게 섭취할게 할 수 있다.

기능성 식이섬유를 함유한 단무지의 제조방법 및 이에 의해 제조된 기능성 식이섬유를 함유한 단무지

... 본 발명은 기능성 식이섬유를 함유한 단무지의 제조방법 및 이에 의해 제조된 기능성 식이섬유를 함유한 단무지에 관한 것이다. 본 발명에 따른 기능성 식이섬유를 함유한 단무지의 제조방법은 재배된 무를 세척하고 소금물에 절인 후 절임 탱크에서 숙성시키는 절임 단계(S100); 상기 절여진 무를 절임 탱크에서 꺼낸 후 정제수로 채워진 탈염 탱크에 투입하여 상기 무의 염도를 줄이는 탈염 단계(S200); 상기 탈염된 무의 껍질 부분이나 잔털을 제거하고 정제수에서 세척하는 탈피 및 세척 단계(S300); 상기 탈피 및 세척된 무를 용도에 따라 필요한 크기 또는 형태로 자르는 절단 및 재단 단계(S400); 상기 재단된 절임무와 혼합되어 상기 절임무를 숙성시킬 조미액을 제조하는 조미액 제조 단계(S500); 상기 재단된 절임무를 조미액에 침지시켜 숙성시킨 후 포장용기에 투입하고 진공 포장하여 단무지를 제조하는 절임무 및 조미액 혼합 숙성 및 진공포장 단계(S600); 및 상기 진공 포장된 단무지에 존재하는 미생물을 제거함과 동시에 저장 및 유통하는 과정에서 단무지가 변질되는 것을 방지하기 위해 살균하는 살균 및 냉각 단계(S700)를 포함한다. 상기한 구성에 의해 본 발명은 식이섬유가 함유된 단무지를 제조함으로써, 단무지의 색도, 신맛, 단맛 등이 향상되어 상품성이 증대되며 장기간의 저장성을 만족시킴과 아울러 뛰어난 식감과 영양가를 높일 수 있고 소비자의 기호도가 증대될 수 있으며 웰빙 시대를 맞이하여 건강 지향적인 소비자의 수요에 부응하여 소비자의 취향과 기호에 맞게 즐길 수 있으며, 젊은 세대에게 친숙하게 다가갈 수 있다.

COMPOSITION FOR IMPROVING LIVER FUNCTION COMPRISING NATURAL EXTRACTS

The present invention relates to a composition for improving liver function comprising natural extracts. More specifically. The present invention relates to a composition for improving liver function which contains at least two of chitooligosaccharides, post-fermented tea extracts, and milk-syrup extracts, thereby improving fatty liver, relieving stress and alleviating heavy metal poisoning. By using the composition for improving liver function according to the present invention, heavy metal poisoning is alleviated as fatty liver is improved and deciphering function of liver is promoted, and stress and fatigue can be relieved as the liver function is improved. COPYRIGHT KIPO 2016 (AA) Negative control group (BB) Comparative example 1 (CC) Example 1 (DD) Example 2 (EE) Example 3 (FF) Example 4 (GG) Example 5 (HH) Comparative example 2 (II) Comparative example 3 (JJ) Comparative example 4 ...

produto e processo lácteo

Fortified milk-based nutritional compositions

A nutritional composition which includes up to about 5.5 g/100 kcal of a fat or lipid source; up to about 6 g/100 kcal of a protein source; and a source of carbohydrates such that the nutritional composition has up to about 18 g/100 kcal of total carbohydrates, wherein at least 60% of the total carbohydrates comprises fructose, lactose or combinations thereof.

Fortified milk-based nutritional compositions

A nutritional composition which includes up to about 5.5 g/100 kcal of a fat or lipid source; up to about 6 g/100 kcal of a protein source; and a source of carbohydrates such that the nutritional composition has up to about 18 g/100 kcal of total carbohydrates, wherein at least 60% of the total carbohydrates comprises fructose, lactose or combinations thereof.

Oligosaccharide mixture and food product comprising this mixture, especially infant formula

The invention discloses an oligosaccharide mixture comprising at least one N-acetyl-lactosamine, at least one sialylated oligosaccharide, and at least one fucosylated oligosaccharide. Food product, especially infant formula, comprising said oligosaccharide mixture.

Nutritional composition useful in the treatment of IBD patients

Compositions and methods are provided that are useful in the treatment of inflammatory bowel disease (IBD) patients. The Compositions and methods are suitable in the prevention or postponement of a relapse in inflammatory bowel disease patients.

NUTRITIONAL COMPOSITION USEFUL IN THE TREATMENT OF IBD PATIENTS

Compositions and methods are provided that are useful in the treatment of inflammatory bowel disease (IBD) patients. The Compositions and methods are suitable in the prevention or postponement of a relapse in inflammatory bowel disease patients.

NUTRITIONAL FORMULATIONS INCLUDING HUMAN MILK OLIGOSACCHARIDES AND ANTIOXIDANTS AND USES THEREOF

Disclosed are nutritional compositions including human milk oligosaccharides in combination with long chain polyunsaturated fatty acids and/or carotenoids that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases.

Fortified milk-based nutritional compositions

A nutritional composition which includes up to about 5.5 g/100 kcal of a fat or lipid source; up to about 6 g/100 kcal of a protein source; and a source of carbohydrates such that the nutritional composition has up to about 18 g/100 kcal of total carbohydrates, wherein at least 60% of the total carbohydrates comprises fructose, lactose or combinations thereof.

COMPLEX MACROMOLECULAR Of BACTERIAL ORIGIN AND MOLECULAR USE OF THE AFORESAID COMPLEX TO WARN AND TREAT INFLAMMATORY RHEUMATISMS

La présente invention porte sur un Complexe macromoléculaire bactérien produit par des bactéries appartenant à la souche Bifidobacterium longum I-3994, constitué de chaînes associant une lipoprotéine et un oligosaccharide caractérisé par le fait que : - la lipoprotéine présente une masse moléculaire de 30kDa à 60kDa ; - l'oligosaccharide présente une masse moléculaire inférieure à 15kDa, et de manière préférée inférieure à 10kDa ; - la partie lipoprotéique qui est constituée de l'ensemble des lipoprotéines de chacune des chaînes représente 75 à 99%, préférentiellement de 80 à 98%, plus préférentiellement de 85 à 95% en poids de la masse totale du complexe et la partie oligosaccharidique qui est constituée par l'ensemble des oligosaccharides liée à chacune des chaînes représente 1 à 25%, préférentiellement de 2 à 20%, et plus préférentiellement de 5 à 15% de la masse totale du complexe.

RED GINSENG AND GRAIN POWDER AND PREPARING METHOD THEREOF

The present invention relates to a red ginseng and grain powder product. A method for preparing the red ginseng and grain powder product includes: a step of preparing grain ingredients; a step of soaking and immersing the grain ingredients in a red ginseng extract liquid; a step of coating the mixture in functional oligosaccharides; a drying step; a roasting step; and a grinding step. The red ginseng and grain powder product includes powder prepared with one or more grains including brown rice, glutinous rice, corn, barley, black rice, nonglutinous rice, Sorghum bicolor, Setaria italica, white beans, black beans, Coix lacryma-jobi, whole wheat, etc. The powder also includes ginsenoside, polyacetylene-based compounds, and functional oligosaccharides. The red ginseng and grain powder has the original functions and effects of red ginseng and excellent flavors while being easily digested. Accordingly, the red ginseng and grain powder can be used as food for patients with poor and moderate masticatory ...

ALPHA WHOLE GRAIN SUBSTITUTE FOOD PRODUCT AND MANUFACTURING METHOD THEREOF

The present invention relates to an alpha whole grain substitute food product and a manufacturing method thereof, capable of enabling a user to feel satiated with the substitute food product by mixing alpha whole grains with grain mixture powder. The present invention is manufactured by mixing grain mixture powder with alpha whole grain brown rice, whole grain sorghum, sesame grains, and black sesame grains, and then, adding oligosaccharide powder and crystalized fructose. A material to be mixed with the substitute food product is manufactured by mixing 100 parts by weight of grain mixture powder with 20-40 parts by weight of whole grain brown rice, 10-20 parts by weight of whole grain sorghum, 5-15 parts by weight of sesame grains, and 5-15 parts by weight of black sesame grains. The grain mixture powder is manufactured by mixing 100 parts by weight of barley powder with 70-90 parts by weight of brown rice powder, 50-60 parts by weight of black bean powder, 40-55 parts by weight of brown ...

Kaugummi.

Immunomodulatory oligosaccharides

The disclosure provides for immunomodulatory oligosaccharides, and uses thereof.

PREBIOTIC GUMMY FOOD PRODUCTS

Disclosed herein are gelatin-free confectionery compositions comprising (i) a prebiotic composition comprising a first prebiotic ingredient and a second prebiotic ingredient different from the first prebiotic ingredient; and (ii) a third ingredient comprising a carrier and, optionally, additives.

METHODS OF PROMOTING HEALTHY CATCH-UP GROWTH

A method of promoting healthy catch-up growth in a moderately malnourished individual is provided. The method includes administering to the moderately malnourished individual a nutritional composition that contains a carbohydrate blend, wherein the carbohydrate blend comprises a source of at least one carbohydrate that provides rapidly available glucose, a source of at least one carbohydrate that provides slowly available glucose, and a source of at least one non-digestible carbohydrate or resistant starch.

NUTRITIONAL FORMULATIONS USING HUMAN MILK OLIGOSACCHARIDES FOR MODULATING INFLAMMATION

Disclosed is a nutritional composition for use in modulating or reducing inflammation in an adult or elderly individual in need thereof. In some aspects, the nutritional composition comprises a neutral human milk oligosaccharide.

Immunomodulatory oligosaccharides

watermelon jelly stick and manufacturing method thereof

... 본 발명은 수박 젤리스틱 및 이의 제조방법에 관한 것으로서, 수박 껍질 추출물을 풍부하게 함유함으로서 섭취시 몸속 노폐물을 배출할수 있을 뿐만 아니라, 향, 식감, 맛 및 전반적인 기호도를 상승시켜, 남녀노소 누구나 맛있고 건강하게 섭취할 수 있는 수박 젤리스틱 및 이의 제조방법에 관한 것이다.

MANUFACTURING METHOD OF ANCHOVY WITH IMPROVED CALCIUM ABSORPTANCE

The present invention relates to a manufacturing method of anchovy with improved calcium absorptance and, more specifically, to a manufacturing method of anchovy with improved calcium absorptance, promoting the absorption of calcium in body if taken, by comprising vitamin D in anchovy. Accordingly, vitamin D, fructooligosaccharide, and polygamma glutamate are included in anchovy to increase calcium absorptance so immunity is strengthened and an atopic dermatitis is alleviated. COPYRIGHT KIPO 2017 (AA) Comprising vitamin D in anchovy (BB) Comprising at least one of liquid fructooligosaccharide, and polygamma glutamate in the anchovy (CC) Removing salt through low-salt processing the anchovy ...

SAND CREAM FOR COOKIES

The present invention relates to: a composition for preparing sand cream for baked cookies containing allulose; sand cream prepared using the composition; a preparation method thereof; and the baked cookies to which the sand cream is applied. The sand cream for the baked cookies according to the present invention is excellent in stability in retention and emulsion stability, so when applied to the baked cookies, a fresh feeling is provided to the cream to improve the flavor, to make adhesion of a cookie base and the sand cream and to maintain the outer shape of a product for a long time during distribution. COPYRIGHT KIPO 2018 ...

COMPOSITION FOR TREATING OSTEOPOROSIS BY CHRONOLOGICAL AGING, CONTAINING UNSATURATED MANNURONIC ACID OLIGOSACCHARIDE (OligoM) WITH NON-REDUCING TERMINAL AS EFFECTIVE COMPONENT

The present invention provides a composition for alleviating, preventing or treating osteoporosis comprising alginate oligosaccharide as an effective component. According to the present invention, the composition is effective for osteoporosis due to natural aging and has an economical advantage because alginate oligosaccharide is easy to produce as an effective substance. COPYRIGHT KIPO 2018 ...

Oligosaccharide preparation and method for manufacturing same

The purpose of the present invention is to provide an oligosaccharide preparation, which sustains preferable physiological functions of oligosaccharides and has suppressed hygroscopicity and good storage stability, and a method for manufacturing the same. Provided is a method for producing an oligosaccharide preparation, said method comprising: (a) a step for dissolving oligosaccharides and acacia dietary fiber in a solvent to give a solution; and (b) a step for spray drying, vacuum drying or freeze drying the solution obtained by step (a); optionally followed by (c) a step for granulation. Also provided is the oligosaccharide preparation manufactured by the aforesaid method.

FOOD COMPOSITION AND COSMETIC COMPOSITION FOR IMPROVING SKIN BEAUTY, COMPRISING SUGAR SOLUTION WITH HIGH GALACTOOLIGOSACCHARIDE CONTENT

The present invention relates to a food composition and a cosmetic composition for improving skin beauty, which include galactooligosaccharide and have an ability to increase a skin water holding capacity, an ability to suppress transepidermal water loss, an ability to alleviate wrinkles, and an ability to alleviate erythema.

КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ПО МЕНЬШЕЙ МЕРЕ ОДИН N-АЦЕТИЛИРОВАННЫЙ И ПО МЕНЬШЕЙ МЕРЕ ОДИН ФУКОЗИЛИРОВАННЫЙ ОЛИГОСАХАРИД, ДЛЯ ПРИМЕНЕНИЯ В АКТИВАЦИИ ПЕРЕВАРИВАЮЩЕЙ СПОСОБНОСТИ У МЛАДЕНЦЕВ И ДЕТЕЙ МЛАДШЕГО ВОЗРАСТА

МАКРОМОЛЕКУЛЯРНЫЙ КОМПЛЕКС БАКТЕРИАЛЬНОГО ПРОИСХОЖДЕНИЯ И ЕГО ПРИМЕНЕНИЕ ДЛЯ ПРЕДОТВРАЩЕНИЯ И ЛЕЧЕНИЯ РЕВМАТОИДНОГО АРТРИТА

... 1. Бактериальный макромолекулярный комплекс, который может быть продуцирован бактериями, принадлежащими к штамму Bifidobacterium longum, депонированному в соответствии с Будапештским договором под номером CNCM 1-3994, 23 мая 2008 года, из Национальной Коллекции Культур Микроорганизмов, состоящий из цепей, объединяющих липопротеин и олигосахарид, отличающийся тем, что:- липопротеин имеет молекулярную массу от 30 кДа до 60 кДа;- олигосахарид имеет молекулярную массу меньше чем 15 кДа, и предпочтительно меньше чем 10 кДа;- липопротеиновая компонента, которая состоит из всех липопротеинов каждой цепи, составляет от 75 до 99%, предпочтительно от 80 до 98%, более предпочтительно от 85 до 95% по массе от общей массы комплекса, и олигосахаридная компонента, которая состоит из всех олигосахаридов, объединенных с каждой из цепей, составляет от 1 до 25%, предпочтительно от 2 до 20% и более предпочтительно от 5 до 15% от общей массы комплекса.2. Макромолекулярный комплекс по п.1, отличающийся тем, ...

Method for the production of isomalto-oligosaccharide rich syrups

Oligosaccharide mixture and food product comprising this mixture, especially infant formula

The invention discloses an oligosaccharide mixture comprising at least one N-acetyl-lactosamine, at least one sialylated oligosaccharide, and at least one fucosylated oligosaccharide. Food product, especially infant formula, comprising said oligosaccharide mixture.

COMPLEX MACROMOLECULAR Of BACTERIAL ORIGIN AND MOLECULAR USE OF THE AFORESAID COMPLEX TO WARN AND TREAT INFLAMMATORY RHEUMATISMS

RED GINSENG DRINK COMPRISING FRUIT AND HERB MEDICINE MIXED LIQUIDS, AND MANUFACTURING METHOD THEREOF

The present invention relates to a red ginseng drink comprising fruit and herb medicine mixed liquids, and a manufacturing method thereof. The red ginseng drink is manufactured by: mixing a red ginseng concentrate with a fruit mixed liquid of an apple, pomegranate, red grape, agave syrup, aronia berries, etc. and a herb medicine mixed liquid of wilfordi root, Korean angelica root, and Phlomis koraiensis Nakai; ripening the mixture with purified water at warm temperature; and sterilizing and filtering the mixture. Accordingly, the red ginseng drink has anti-aging effects without destroying effective components of ginseng and efficacy as a tonic, protects the liver and bowels, alleviates anemia, and alleviates menopause symptoms of women. COPYRIGHT KIPO 2016 ...

METHOD FOR MANUFACTURING TRADITIONAL FERMENTED SOYBEAN PASTE USING WATER-SOLUBLE DIETARY FIBERS, AND TRADITIONAL FERMENTED SOYBEAN PASTE MANUFACTURED BY SAME

The present invention relates to a method for manufacturing traditional fermented soybean paste using water-soluble dietary fibers, and traditional fermented soybean paste manufactured by the same. The method comprises the following steps: preparing fermented soybean lumps and immersing the same into salt water with constant salinity (S110); mixing water-soluble dietary fibers in the salt water in which the fermented soybean lumps are immersed (S120); mixing garlic and fast-fermented bean paste (S130); mixing the aged fermented soybean lumps with mixed powder of the garlic and fast-fermented bean paste (S140); and aging the aged fermented soybean lump powder with the mixed powder of the garlic and fast-fermented bean paste for a period of time (S150). According to the present invention, palatability of consumers with respect to traditional fermented soybean paste can be increased, and the appearance, smell, and flavors can be improved. COPYRIGHT KIPO 2017 (S110) Prepare fermented soybean ...

Allulose syrup and method of preparing the same

본 발명은 알룰로스 시럽 및 이의 제조방법에 관한 것으로서, 더욱 자세하게는 점도 조절제 및 분산제를 포함하는 적정 점도범위를 갖는 알룰로스 시럽 및 이의 제조방법에 관한 것이다. The present invention relates to an allulose syrup and a method for preparing the same, and more particularly, to an allulose syrup having a suitable viscosity range including a viscosity modifier and a dispersant and a method for producing the same.

METHOD FOR MANUFACTURING MINERAL PEPTIDE BY USING SILKWORM PROTEIN AND HEALTH DRINK MANUFACTURED BY USING SAME

The present invention relates to silkworm-based health drink manufacturing and, more particularly, to a method for manufacturing mineral peptide by using silkworm protein and a health drink manufactured by the same. According to the present invention, the silkworm protein is hydrolyzed by the use of a silkworm feeding on mulberry leaves and serrapeptase, which is a proteolytic enzyme in the body of the silkworm, fatty acid contained in the silkworm is emulsified with malt, and ion mineral addition is performed for effective intake of an active ingredient of the silkworm. The mineral peptide according to the present invention is realized by the method including: a first step of boiling a mixture of the silkworm and purified water for 1 to 2 hours at a temperature of 95 degrees Celsius to 100 degrees Celsius; a second step of making a suspension by grinding the mixture after the first step; a third step of obtaining a silkworm extract by pressing a fresh silkworm; a fourth step of obtaining ...

NUTRITIONAL FORMULATIONS INCLUDING HUMAN MILK OLIGOSACCHARIDES AND ANTIOXIDANTS AND USES THEREOF

Disclosed are nutritional compositions including human milk oligosaccharides in combination with long chain polyunsaturated fatty acids and/or carotenoids that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases.

Confectionery composition with high fibre

A confectionery composition comprising at least one fructan such as fructooligosaccharide, inulin, or levan; at least one isomaltose oligosaccharide (IMO); and at least one further soluble dietary fibre ingredient. The fructan is preferably 10-35 wt.%, the IMO is 25-35 wt.%, and the further dietary fibre is 10-45 wt.%. The composition may be caramel, fudge, nougat, marshmallow, jelly, or honeycomb. The composition may also be essentially free of sugar, glucose, sucrose, sugar alcohols, or low energy sugars. A chocolate shell may be provided as a separate layer, and may be applied by a method of depositing or coating.

Stable dry probiotic compositions for special dietary uses

A dry stable probiotic composition is provided. The composition comprises one or more viable probiotic microorganisms, one or more hydrolyzed proteins, one or more disaccharides, one or more oligosaccharides, and one or more polysaccharides, but not trehalose. The composition has viability of at least 1x10 ...

Method for preparing isomaltooligosaccharide composition

This invention provides an isomaltooligosaccharide (IMO) composite and the method to manufacture. According to this invention, isomaltooligosaccharide with a high level of sweetness can be provided without an additional process of adding fructose.

MACROMOLECULAR COMPLEX OF BACTERIAL ORIGIN AND USE OF SAID MACROMOLECULAR COMPLEX FOR PREVENTING AND TREATING INFLAMMATORY RHEUMATISM

La présente invention porte sur un complexe macromoléculaire bactérien produit par des bactéries appartenant à la souche Bifidobacterium longum déposée selon le traité de Budapest sous le numéro CNCM I-3994 auprès de la Collection Nationale de Cultures de Microorganismes (CNCM), constitué de chaînes associant une lipoprotéine et un oligosaccharide caractérisé par le fait que : la lipoprotéine présente une masse moléculaire de 30kDa à 60kDa; l'oligosaccharide présente une masse moléculaire inférieure à 15kDa, et de manière préférée inférieure à 10kDa; la partie lipoprotéique qui est constituée de l'ensemble des lipoprotéines de chacune des chaînes représente 75 à 99 %, préférentiellement de 80 à 98 %, plus préférentiellement de 85 à 95 % en poids de la masse totale du complexe et la partie oligosaccharidique qui est constituée par l'ensemble des oligosaccharides liée à chacune des chaînes représente 1 à 25 %, préférentiellement de 2 à 20 %, et plus préférentiellement de 5 à 15 % de la masse ...

TAGATOSE AND GALACTOSE SYRUP

The present invention describes a syrup of tagatose and galactose as main components together with other secondary products such as glycerol, oligosaccharides and other sugars in a minority amount.

DAIRY PRODUCT AND PROCESS

Heat-treated, shelf-stable liquid nutritional compositions comprising whey protein and non-whey protein, and methods of producing and using these compositions. The compositions have a pH of from about 6.0 to about 8.0, a total protein content of at least about 6 g per 100 mL of the composition. The whey protein comprises or is provided by an ingredient that comprises heat-denaturable protein of which at least about 55% is present in a denatured state, and the non-whey protein comprises or consists of casein, or one or more non-dairy proteins, or casein and one or more non-dairy proteins.

NUTRITIONAL FORMULATIONS USING HUMAN MILK OLIGOSACCHARIDES FOR MODULATING INFLAMMATION

Disclosed is a nutritional composition for use in modulating or reducing inflammation in an adult or elderly individual in need thereof. In some aspects, the nutritional composition comprises a neutral human milk oligosaccharide.

DRIED BURDOK COMPRISING CHLOROGENIC ACID AND CAFFEIC ACID AND THE MANUFACTURING METHOD THEREOF

백하수오 당귀 혼합추출물 및 산양삼 열매 농축액을 함유하는 음료 조성물

... 본 발명은 백하수오 당귀 혼합추출물, 산양삼 열매 농축액, 석류 농축액, 자색고구마 농축액, 구연산, 스테비아 및 프락토올리고당으로 조성되는 것을 특징으로 하는 백하수오 당귀 혼합추출물 및 산양삼 열매 농축액을 함유하는 음료 조성물에 관한 것으로, 본 발명의 음료 조성물은, 기능성 성분이 다량 함유되어 기능성이 우수하면서도 기호성이 좋아 남녀노소 모두 섭취가 용이하다.

PILL COMPOSITION FOR HAIR GROWTH PROMOTION USING MEDICINAL HERB AND MANUFACTURING METHOD THEREOF

The present invention relates to a pill composition aiding prevention of hair loss manufactured by processing a medicinal herb mixture including Rehmanniae Radix Preparata, Eclipta prostrata L., Lycium chinense Miller, Angelica gigas Nakai, ginseng, roots of Polygonum multiflorum Thunb., Perilla frutescens var. acuta, and dried ginger into powder, mixing the powdered mixture with water, kneading the paste, forming the paste into pills with a predetermined size, and drying the pills, and to a manufacturing method thereof. According to the present invention, the manufacturing method of a pill composition for hair growth promotion using medicinal herbs comprises the following steps of: preparing medicinal herb materials including 19 to 21 wt% of Rehmanniae Radix Preparata, 17 to 19 wt% of Eclipta prostrata L., 14 to 16 wt% of Lycium chinense Miller, 14 to 16 wt% of Angelica gigas Nakai, 11 to 13 wt% of ginseng, 11 to 13 wt% of roots of Polygonum multiflorum Thunb., 4 to 6 wt% of Perilla frutescens ...

LOW SUGAR SWEETENING AGENT AND FOOD COMPOSITION COMPRISING SAME

The present specification relates to a low sugar sweetening agent prepared by means of combining a saccharide mixture with a high-intensity sweetener, and to a food composition comprising the same. According to the present invention, sugars are combined with high-intensity sweeteners to produce a low sugar sweetening agent having sensory properties similar to table sugar and high fructose corn syrup, wherein the sugars comprise two or more selected from high fructose corn syrup, table sugar, starch syrup, and oligosaccharides; and the high-intensity sweeteners comprise two or more selected from sucralose, steviol glycoside, and enzymatically treated stevia. The low sugar sweetening agent of the present invention may be used as sweetening material in foods such as beverages, dairy products, liquid coffee, sauce, jams, and baked goods to thereby effectively reduce the sugar content in comparison with pre-existing products that use table sugar or high fructose corn syrup alone, without causing ...

PROBIOTIC COMPOSITIONS FOR SPECIAL DIETARY USES STABLE DRY

Se proporciona una composición probiótica estable seca. La composición comprende uno o más microorganismos probióticos viables, una o más proteínas hidrolizadas, uno o más disacáridos, uno o más oligosacáridos, y uno o más polisacáridos, pero no trehalosa. La composición tiene una viabilidad de al menos 1 x 10¹⁰ UFC/g, y una pérdida de viabilidad menor de 1 unidad log/g después de 3 meses a una temperatura de 40ºC y una humedad relativa de 33%. También se proporcionan métodos para preparar la composición probiótica estable seca.

Dairy product and process

Heat-treated, shelf-stable liquid nutritional compositions comprising whey protein and non-whey protein, and methods of producing and using these compositions. The compositions have a pH of from about 6.0 to about 8.0, a total protein content of at least about 6 g per 100 mL of the composition. The whey protein comprises or is provided by an ingredient that comprises heat-denaturable protein of which at least about 55% is present in a denatured state, and the non-whey protein comprises or consists of casein, or one or more non-dairy proteins, or casein and one or more non-dairy proteins.

Prebiotic gummy food products

Disclosed herein are gelatin-free confectionery compositions comprising (i) a prebiotic composition comprising a first prebiotic ingredient and a second prebiotic ingredient different from the first prebiotic ingredient; and (ii) a third ingredient comprising a carrier and, optionally, additives.

IMMUNOMODULATORY OLIGOSACCHARIDES

The disclosure provides for immunomodulatory oligosaccharides, and uses thereof.

CHEWING GUM

The chewing gum of the present invention contains a coated material prepared by coating Curculigo latifolia fruits, processed Curculigo latifolia fruits or a component containing curculin obtained therefrom with a coating agent.

Calcium complex comprising mussel shell and oligosaccharide and uses thereof

알룰로스 시럽 및 이의 제조 방법

... 본 발명은 알룰로스 시럽 및 이의 제조방법에 관한 것으로서, 더욱 자세하게는 점도 조절제 및 분산제를 포함하는 적정 점도범위를 갖는 알룰로스 시럽 및 이의 제조방법에 관한 것이다.

METHOD FOR PRODUCING SUGARED BLUEBERRIES

The present invention relates to a method for producing sugared blueberries. More specifically, the present invention relates to a method for producing sugared blueberries by adding oligosaccharides to blueberries during the production. The sugared blueberries produced by the production method excellently keeps taste and colors of blueberries intact, increases preference of consumers, and lowers sugar absorption rate when taken. COPYRIGHT KIPO 2018 (A) Production process of existing blueberry syrup (AA) Cooked rice (hard-boiled rice) (B) Production process of sugared blueberries of the present invention (BB) Water (CC) Saccharify for 8 hours (DD) Concentrate for 8 hours (120°C) (EE) Blueberry syrup (FF,PP) Packaging and shipping (GG) Malt and enzyme (HH) Add a blueberry extract (II) Extract blueberries (JJ) Concentrate for 6 hours (KK) Oligosaccharide (LL) Mixing (MM) Fresh blueberries (NN) Age for 15 days (OO) Sugared blueberries (=blueberry preserve) ...

CANDY CONTAINING ANCHOVY POWDER, AND PRODUCTION METHOD THEREOF

The present invention relates to a candy containing anchovy powder and a production method thereof. By using natural calcium, there is not a side effect, and absorbing efficiency is improved. Also, children in the growing period can naturally consume calcium, and thus the growth of the children can be promoted. The method comprises the steps of: (a) preparing anchovy powder; (b) removing anchovy smells from the anchovy powder prepared in step (a); (c) mixing vitamin D with the anchovy powder from which the smells are removed in step (b); and (d) molding a candy including the anchovy powder and vitamin D prepared in step (c) and fructooligosaccharide. The candy contains anchovy powder, vitamin D, and fructooligosaccharide at a weight ratio of 700 mg: 10 μg: 3-8 g. Thus, anchovy powder which is excellent as a calcium supply source can be easily consumed by children. COPYRIGHT KIPO 2018 (S10) Prepare anchovy powder (S20) Remove anchovy smells (S30) Mix vitamin D (S40) Mold a candy ...

올리고당 제제 및 그 제조 방법

... 본 발명은 올리고당의 바람직한 생리적 기능을 유지하는 것에 더하여, 흡습성이 억제된, 보존 안정성이 양호한 올리고당 제제 및 그 제조 방법을 제공하는 것을 목적으로 한다. 본 발명에 따르면, (a) 올리고당 및 아카시아 식이섬유를 용매로 용해해서 용액을 얻는 공정 및 (b) 상기 공정 (a)에 의해 얻어진 용액을 분무 건조, 진공 건조 또는 동결 건조하는 공정 및 경우에 따라서는 (c) 조립 공정을 포함하여 이루어지는, 올리고당 제제의 제조 방법, 및 해당 제조 방법에 의해 제조된 올리고당 제제가 제공된다.

CREAM FILLING FOR NON-FERMENTATIVE BAKERIES AND METHOD OF PREPARING SAME

The present invention relates to a composition for producing a cream filling for non-fermentative bakeries containing allulose, and a method of preparing the same, a cream filling produced by using the composition, a method for preparing the composition, and non-fermentative bakeries using the cream filling. The cream filling for non-fermentative bakeries according to the present invention is excellent in shape forming ability of emulsion stability and can be applied to various foods. COPYRIGHT KIPO 2018 ...

composição de confeitaria, e, método de preparação de uma composição de confeitaria isenta de gelatina.

Stable dry probiotic compositions for special dietary uses

A dry stable probiotic composition is provided. The composition comprises one or more viable probiotic microorganisms, one or more hydrolyzed proteins, one or more disaccharides, one or more oligosaccharides, and one or more polysaccharides, but not trehalose. The composition has viability of at least 1x10 ...

Compositions comprising at least on N-acetylated and at least one fucosylated oligosaccharide for use in the promotion of digestive capacity in infants and young children

This invention relates to compositions for use in the promotion of the development and/or of the growth of the surface area of the small intestine and in the associated improvement of the digestive capacity in an infant or in a young child.

COMPOSITION FOR PREPARING CANDY

The present invention relates to a composition for preparing candy, and a method for preparing candy using same, and provides candy having reduced stickiness and/or cold flow. The composition for preparing candy contains saccharides having a degree of polymerization of 2 or less, and saccharides having a degree of polymerization of 3 or more, wherein, on a dry-solids basis, the composition contains 29 parts by weight or more of the saccharides having a degree of polymerization of 3 or more with respect to 100 parts by weight of the saccharides having a degree of polymerization of 2 or less.

STABLE DRY PROBIOTIC COMPOSITIONS FOR SPECIAL DIETARY USES

A dry stable probiotic composition is provided. The composition comprises one or more viable probiotic microorganisms, one or more hydrolyzed proteins, one or more disaccharides, one or more oligosaccharides, and one or more polysaccharides, but not trehalose. The composition has viability of at least 1x1010 CFU/g, and a viability loss of less than 1 log unit/g after 3 months at a temperature of 40 °C and a relative humidity of 33%. Also provided are methods for preparing the dry stable probiotic composition.

호흡계통의 건강을 위한 기능성 식품의 제조방법

... 본 발명은 호흡계통의 건강을 위한 기능성 식품의 제조방법에 관한 것으로, 도라지, 수세미, 생강, 배, 호박 및 무를 손질하는 손질단계(S10); 상기 도라지, 상기 수세미, 상기 생강을 물에 담근 뒤 끓이는 1차 추출단계(S20) 및 상기 1차 추출단계 이후 배, 호박, 무를 추가한 뒤 끓이는 2차 추출단계(S30)를 포함하여 구성된다. 이에 따라, 사용되는 각 재료들이 서로 부족한 성분을 보완하면서 천식과 같은 호흡기 계통의 질환을 개선하는데 효과가 있고, 간, 신장과 같은 각종 장기의 회복을 도와 영양분 흡수율을 높여 면역력을 높임으로써 상기 질환 회복 속도를 높여준다. 또한, 한의학적으로도 각 재료들이 상생하는 효과가 있다.

CALCIUM COMPOSITE CONTAINING OLIGOSACCHARIDE AND MUSSEL SHELLS AS ACTIVE INGREDIENTS, AND USE THEREOF

The present invention relates to a water-soluble calcium composite containing a nanocomposite composed of oligosaccharide and mussel shells as an active ingredient. More specifically, the calcium composite containing oligosaccharide and mussel shells as the active ingredient exhibits excellent water solubility, increases absorption rate, and shows outstanding osteogenic effects and bone tissue regeneration effects by containing substances safe to human body. Therefore, the calcium composite containing oligosaccharide and mussel shells as the active ingredient can be used as a composition effective in preventing or treating bone or joint disease. COPYRIGHT KIPO 2018 (AA) Control group (BB) Mussel shell powder (CC) Mussel shell/fructooligosaccharide complex (DD) Mussel shell/fructooligosaccharide mixture ...

특수 식이 용도를 위한 안정한 프로바이오틱 건조 조성물

... 건조된 안정한 프로바이오틱 조성물이 제공된다. 조성물은 하나 이상의 생존가능 프로바이오틱 미생물, 하나 이상의 가수분해 단백질, 하나 이상의 이당류, 하나 이상의 올리고사카라이드, 및 하나 이상의 다당류를 포함하지만, 트레할로스는 포함하지 않는다. 조성물은 적어도 1x1010 CFU/g의 생존력, 및 40℃의 온도 및 33%의 상대 습도에서 3개월 후 1 log 단위/g 미만의 생존력 손실을 갖는다. 또한, 건조된 안정한 프로바이오틱 조성물을 제조하는 방법이 제공된다.

METHOD FOR PRODUCING RED PEPPER PASTE USING WATER-SOLUBLE DIETARY FIBER AND RED PEPPER PASTE PRODUCED THEREBY

The present invention relates to a method for producing red pepper paste using water-soluble dietary fiber, enhancing preference of consumers for red pepper paste. To this end, the method for producing the red pepper paste using water-soluble dietary fiber comprises the following steps: a step (S310) of preparing fermented soybean lump and soaking the same; a step (S320) of mixing water-soluble dietary fiber and aging fermented soybean lump; a step (S330) of separating aged fermented soybean lump and pulverizing the same; a step (S340) of mixing fermented soybean lump powder and dried red pepper powder; and a step (S350) of aging red pepper paste. COPYRIGHT KIPO 2017 (S110) Step of preparing fermented soybean lump and soaking the same (S120) Step of mixing water-soluble dietary fiber and aging the fermented soybean lump (S130) Step of separating the aged fermented soybean lump and pulverizing the same (S140) Step of mixing fermented soybean lump powder and dried red pepper power (S150) ...

METHOD FOR PRODUCING ALGINATE OLIGOSACCHARIDE, AND OBESITY TREATING OR PREVENTING COMPOSITION INCLUDING ALGINATE OLIGOSACCHARIDE AND PRODUCED THROUGH SAME

The present invention relates to a method for producing alginate oligosaccharide having an anti-obesity activity, and to an obesity treatment or prevention composition including alginate oligosaccharide produced through the method as an active ingredient. In particular, the method of the present invention comprises: a kelp extract producing step of producing a kelp solvent extract; a step of producing an alginate oligosaccharide by treating a Pseudoalteromonas sp. alginate isolate strain in the kelp extract; and a step of producing an alginate oligosaccharide fermented material by inoculating and fermenting a fermentation strain which is Lactobacillus brevis in the alginate oligosaccharide. COPYRIGHT KIPO 2017 ...

SYNBIOTIC COMBINATION OF PROBIOTIC AND HUMAN MILK OLIGOSACCHARIDES TO PROMOTE GROWTH OF BENEFICIAL MICROBIOTA

Disclosed are nutritional compositions including human milk oligosaccharides that can be administered to individuals including preterm infants, infants, toddlers, and children for improving gastrointestinal function and tolerance, as well as the growth of beneficial microbiota. Suitable additional methods of using the nutritional compositions including the human milk oligosaccharides are also disclosed.

SYNBIOTIC COMBINATION OF PROBIOTIC AND HUMAN MILK OLIGOSACCHARIDES TO PROMOTE GROWTH OF BENEFICIAL MICROBIOTA

Macromolecular complex of bacterial origin and use of said macromolecular complex for preventing and treating inflammatory rheumatism

The present invention relates to a bacterial macromolecular complex produced by bacteria belonging to the ...

METHOD FOR THE PRODUCTION OF ISOMALTO-OLIGOSACCHARIDE RICH SYRUPS

The present invention describes a method for the production of isomalto- oligosaccharides syrups. The method comprises the use of enzymes immobilized on a re-usable carrier. The carrier is preferably an anion exchanger. The enzymes used for the conversion of starch hydrolysates are transglucosidase and pullulanase preferably these enzymes are co-immobilized. The carrier/enzyme conjugate is further reinforc ed by cross-linking.

METHOD FOR PREPARING ISOMALTOOLIGOSACCHARIDE COMPOSITION

This invention provides an isomaltooligosaccharide (IMO) composite and the method to manufacture. According to this invention, isomaltooligosaccharide with a high level of sweetness can be provided without an additional process of adding fructose.

Sweetener composition with high color stability

스팀 처리를 이용한 알로에 다당체의 제조방법

... 본 발명은 알로에 잎을 고온ㆍ고압으로 스팀처리 한 후 효소 처리하여 높은 수율로 고순도의 알로에 다당체를 제조하는 방법에 관한 것이다. 본 발명에 따르면, 고온ㆍ고압의 스팀처리 및 효소 처리 단계를 순차적으로 처리하여 알로에 다당체를 제조하는 경우 높은 수율의 고순도 알로에 다당체를 제조할 수 있다.

수용성 식이섬유를 이용한 간장의 제조방법 및 이에 의해 제조된 간장

... 본 발명은 수용성 식이섬유를 이용한 간장의 제조방법 및 이에 의해 제조된 간장에 관한 것이다. 메주를 준비하여 일정한 염도의 소금물에 침지하는 메주 준비 및 침지 단계(S210); 상기 메주가 침지된 소금물에 수용성 식이섬유를 혼합하여 숙성시키는 수용성 식이섬유 혼합 및 메주 숙성 단계(S220); 및 상기 수용성 식이섬유 혼합 및 메주 숙성 단계(S220)에서 사용된 메주를 분리한 후 남은 숙성된 수용성 식이섬유 및 소금물의 혼합물을 이용하여 간장을 제조하는 메주 분리 및 간장 숙성 단계(S230)를 포함하고, 상기 수용성 식이섬유 혼합 및 메주 숙성 단계(S220)에서 수용성 식이섬유는 수용성 식이섬유 재료와 증점 다당류를 혼합하여 제조되되, 상기 수용성 식이섬유 재료는 난소화성 말토덱스트린 또는 폴리덱스트로스 중 어느 하나 이상이 사용되며, 50질량% 이상의 식이섬유를 함유하고, 20℃의 물 100㎖에 20g 이상 용해되며, 20℃에서 5질량% 수용액의 점도가 20mPas 미만의 점도를 나타내는 난소화성 당류이고, 상기 증점 다당류는 20℃에서 5질량% 수용액의 점도가 20mPas 이상의 점도를 나타내는 다당류로, 알긴산염, 알긴산 프로필렌글리콜에스테르, 카라기난, 구아검, 전분 또는 전분 유도체 중 어느 하나 이상이 사용되어 간장이 제조되는 것을 특징으로 하는 수용성 식이섬유를 이용한 간장의 제조방법이다. 본 발명에 따른 수용성 식이섬유를 이용한 간장의 제조방법 및 이에 의해 제조된 간장은 혈당치 상승 억제, 정장 작용, 지질 대사 개선 등의 생리 효과를 발현하거나 발암물질을 체외로 배출하여 고지혈증, 당뇨병, 대장암 등 성인병 예방에 우수한 효과를 발휘하는 수용성 식이섬유를 이용하여 간장을 제조함으로써, 간장에 대한 소비자의 기호성을 증진할 수 있으며 외관 및 냄새, 풍미를 개선할 수 있다. 또한, 본 발명에 따른 수용성 식이섬유를 이용한 간장의 제조방법 및 이에 의해 제조된 간장은 웰빙 시대를 맞이하여 건강 지향적인 소비자의 수요에 부응하여 소비자의 ...

ALLULOSE SYRUP AND METHOD OF PREPARING SAME

The present invention relates to allulose syrup and a method of preparing the same, and more specifically, to allulose syrup which contains a viscosity adjusting agent and a dispersing agent and has a proper viscosity range, and a method of preparing the same. The present invention provides a sugar syrup composition with a specific viscosity range and high dispersing ability of the viscosity adjusting agent, so that the composition can be applied to foods, food additives, beverages, or beverage additives. COPYRIGHT KIPO 2018 ...

FUNCTIONAL FERMENTED VEGETABLE COMPOSITION FOR REDUCING GLUCOSE ABSORPTION BY INCLUDING ISOMALTO-OLIGOSACCHARIDE

The present invention relates to a functional fermented vegetable composition for reducing glucose absorption by including isomalto-oligosaccharide. More specifically, the fermented vegetable composition for reducing glucose absorption is manufactured by mixing 20-30 wt% of isomalto-oligosaccharide, Brassicaceae vegetables, and purified water to grind a mixture, then inoculating Lactobacillus plantarum PMO 08, and fermenting the mixture at a temperature of 30-35°C for 72-120 hours. The fermented vegetable composition including isomalto-oligosaccharide inhibits decomposition of oligosaccharide by fermented microorganisms and organic acid to reduce absorption of monosaccharide. Therefore, the excellent and abrupt blood glucose elevation inhibition effect after consumption makes this an effective composition in the manufacture of functional food for blood glucose control. COPYRIGHT KIPO 2018 (AA) Add fructooligosaccharide (FO) (BB) Add isomalto-oligosaccharides (IMO) (C1,C2) Before fermentation ...

METHOD OF MANUFACTURING FUNCTIONAL DIETARY FIBER USING EXTRACT OF JAPANESE APRICOT AND JAPANESE APRICOT BEVERAGE MANUFACTURED THEREBY

The present invention relates to a method of manufacturing functional dietary fiber using an extract of Japanese apricot and Japanese apricot beverage using an extract of Japanese apricot manufactured thereby. According to the present invention, the method comprises: a Japanese apricot seed removing step (S100) of removing seeds from Japanese apricot to separate flesh; an enzyme decomposing step (S200) of using enzyme to decompose the separated flesh of Japanese apricot; an aging step (S300) of storing the enzyme-dissolved flesh of Japanese apricot to perform aging; a filtering step (S400) of using a filter to filter the aged flesh of Japanese apricot; a concentration step (S500) of vacuum-concentrating and sterilizing the filtered flesh of Japanese apricot to manufacture an extract of Japanese apricot; a starch syrup solution manufacturing step (S600) of manufacture a starch syrup solution containing dietary fiber mixed with the extract of Japanese apricot; and a Japanese apricot extract ...

Chocolate product with high fibre

Chocolate product comprising a chocolate shell containing a confectionery filling wherein the shell comprises at least 15 wt.% of the product and the filling comprises at least one soluble dietary fibre in an amount of at least 40 wt.% and wherein the filling comprises less than 5 wt.% sugar and less than 5 wt.% sugar alcohols. The dietary fibres preferentially comprise fructans such as fructooligosaccharide, inulin, and levan, and isomaltose oligosaccharide (IMO). The filling may be caramel, fudge, nougat, marshmallow, jelly, or honeycomb. The filling composition may also be essentially free of sugar, glucose, sucrose, sugar alcohols, or low energy sugars. The chocolate shell preferably covers most of the product, and methods for providing the shell by coating or depositing are disclosed.

Oligosaccharide mixture and food product comprising this mixture, especially infant formula

The invention discloses an oligosaccharide mixture comprising at least one N-acetyl-lactosamine, at least one sialylated oligosaccharide, and at least one fucosylated oligosaccharide. Food product, especially infant formula, comprising said oligosaccharide mixture.

과피 및 과육을 포함하는 과일청의 제조방법

... 본 발명은 과피 및 과육을 포함하는 과일청의 제조방법에 관한 것이다. 본 발명에 따른 제조방법에 따라 자몽청을 제조하게 되면, 단맛이 지나치게 발현됨으로 인해 과일청으로서 발휘되어야 할 음용감이 떨어지는 것을 방지하였으며, 일반적인 제조방법으로 제조된 자몽청에서 발현되는 쓴맛을 적절히 조절하는 것이 가능하여 소비자의 기호도를 보다 우수하게 충족시킬 수 있다.

METHOD FOR PRODUCING OLIGOSACCHARIDE-RICH SCHISANDRA BERRY, OLIGOSACCHARIDE-RICH SCHISANDRA BERRY PRODUCED BY THE SAME AND USE THEREOF

본 발명은 올리고당 고함유 오미자청의 제조방법, 이의 의하여 제조된 올리고당 고함유 오미자청 및 이의 용도에 관한 것이다. 본 발명에 따라 제조된 올리고당 고함유 오미자청은 저열량을 가지며, 기능성 및 관능성이 우수하다는 장점이 있다. The present invention relates to a method for producing a high oligosaccharide-containing Schisandra chinensis, a high oligosaccharide-containing Schisandra chinensis produced thereby. Oligosaccharide high content Omija blue prepared according to the present invention has a low calorific value, has the advantage of excellent functionality and functionality.

PREBIOTICS COMPOSITION FOR IMPROVING STABILITY OF LACTOBACILLUS STRAINS, AND STABILIZATION IMPROVEMENT METHOD USING THEREOF

The present invention relates to a probiotics composition for improving the stability of Lactobacillus strains. Specifically, the present invention relates to an additive contained into a culture medium, and when a predetermined amount of a maltodextrin single compound, a gentiooligosaccharide single compound, or a mixture thereof is contained in the additive, the acid resistance and heat resistance of the strains can be improved. According to the present invention, Lactobacillus food which can satisfy consumers can be provided by improving the survival rate of Lactobacillus strains in food. COPYRIGHT KIPO 2018 (AA) Survival rate versus OH (%) (BB) Concentration (%, maltodextrin: gentio oligosaccharide) ...

인체기능의 활성화 및 구강용해성이 탁월한 분말식초의 제조방법

... 본 발명은 인체기능의 활성화 및 구강용해성을 지닌 분말식초를 제조하는 방법에 있어서: (a) 현미분말 100g에 현미식초, 사과식초, 감식초, 복분자 식초, 한방식초, 흑초, 포도식초, 곡물식초 등의 어느 하나에서 선택되는 천연 양조식초를 100g 비율로 더 혼합하여 배합하고, 열풍건조의 경우에 20℃~60℃까지 가온(加溫)하여 수분함량을 3~15%로 유지하고, 냉동건조의 경우에 영하 40℃~영상 50℃까지 서서히 온도변화를 유발하여 기본원료를 생성하는 단계; (b) 자일리톨 25~30중량부, 올리고당 5~10중량부, 유산균 5~15중량부, 무수구연산 0.5~4중량부, 비타민C 1.5~5중량부를 50~350메쉬(mesh)로 분쇄한 다음 이를 배합하여 부가원료를 생성하는 단계; 및 (c) 상기 기본원료와 부가원료를 설정된 비율로 투입하고, 기본원료와 부가원료의 메쉬(mesh)에 대응하여 5~80rpm의 교반회전수와 3~30분의 교반시간을 차등적으로 적용하는 것을 특징으로 하는 것을 특징으로 한다.이에 따라, 액상의 천연 양조식초를 분말식초로 변환하여 양산하도록 함에 있어서, 현미를 기재로 하는 인체기능의 활성화 효능을 안정적으로 유지하면서도 분말 상태로 보존성의 최적화를 도모하여 구강용해성의 탁월함과 함께, 휴대성과 저장성 및 간편성을 크게 확보할 수 있는 효과가 있다.

METHOD FOR PRODUCING FRUIT SYRUP CONTAINING PERICARP AND PULP

The present invention relates to a method for producing fruit syrup containing pericarp and pulp. According to the present invention, when producing lemon syrup or grapefruit syrup by the production method, it is possible to prevent degradation in drinkability which is one of features of fruit syrup due to excessive sweetness, while ensuring adequately adjustable bitterness of lemon syrup or grapefruit syrup prepared by conventional production methods, thereby excellently satisfying preference of consumers. COPYRIGHT KIPO 2017 ...

Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof

Disclosed are nutritional compositions including human milk oligosaccharides in combination with long chain polyunsaturated fatty acids and/or carotenoids that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases.

NUTRITIONAL COMPOSITIONS COMPRISING HUMAN MILK OLIGOSACCHARIDES AND NUCLEOTIDES AND USES THEREOF FOR TREATING AND/OR PREVENTING ENTERIC VIRAL INFECTION

Disclosed are nutritional compositions including human milk oligosaccharides and nucleotides that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases. 120-. (canceled)21. A synthetic pediatric formula comprising from about 0.01 mg/mL to about 10 mg/mL of a human milk oligosaccharide and from about 40 mg/L to about 320 mg/L of a nucleotide.22. The synthetic pediatric formula of claim 21 , wherein the human milk oligosaccharide is selected from 3′-fucosyllactose claim 21 , lacto-N-neotetraose claim 21 , 6′-sialyllactose claim 21 , 3′-sialyllactose claim 21 , sialic acid claim 21 , and combinations thereof.23. The synthetic pediatric formula of claim 22 , wherein the human milk oligosaccharide is lacto-N-neotetraose.24. The synthetic pediatric formula of claim 22 , wherein the human milk oligosaccharide is 3′-fucosyllactose.25. The synthetic pediatric formula of claim 22 , wherein the human milk oligosaccharide is selected from the group consisting of 3′-sialyllactose claim 22 , 6′-sialyllactose claim 22 , sialic acid claim 22 , and combinations thereof.26. The synthetic pediatric formula of claim 25 , wherein the human milk oligosaccharide comprises about 40 wt % 6′-sialyllactose claim 25 , about 10 wt % 3′-sialyllactose claim 25 , and about 50 wt % sialic acid.27. The synthetic pediatric formula of claim 21 , wherein the nucleotide is selected from the group consisting of cytidine 5′-monophosphate claim 21 , uridine 5′-monophosphate claim 21 , adenosine 5′-monophosphate claim 21 , guanosine 5′-monophosphate claim 21 , and combinations thereof.28. The synthetic pediatric formula of claim 27 , wherein the nucleotide comprises about 43% cytidine 5′-monophosphate claim 27 , about 18.5% uridine 5′-monophosphate claim 27 , about 16.5% adenosine 5′-monophosphate claim 27 , and about 22% guanosine 5′-monophosphate.29. The synthetic pediatric formula of claim 28 , wherein the ...

OLIGOSACCHARIDE COMPOSITION, METHOD, AND USE THEREOF

The invention provides oligosaccharide compositions, wherein arabinoxylan is present in said composition in amounts of 40-70% (w/w) of dry solid con-tent (DS) and the oligosaccharides have a dispersity (D) of 10-17. The oligosaccharide compositions are useful as bulking agents and for increasing the mouthfeel of a food product. 1. An Oligosaccharide composition comprising:i) 40-70% (w/w) DS arabinoxylan; andii) oligosaccharides having a dispersity (Ð) of 10-17.2. The oligosaccharide composition according to claim 1 , wherein the arabinose:xylose ratio in said arabinoxylan is 0.5 or higher.3. The oligosaccharide composition according to claim 1 , wherein said oligosaccharides have a weight average molecular weight of 10 claim 1 ,000-100 claim 1 ,000 daltons.4. The oligosaccharide composition according to claim 1 , wherein the amount of monosaccharides is 10% (w/w) of the amount of dry solids or more claim 1 , such as within the range of 10-40% (w/w) of the amount of dry solids.5. The oligosaccharide composition claim 1 , according to claim 1 , wherein the oligosaccharide composition is a stable syrup having a dry solid content of 60% (w/w) or more.6. The oligosaccharide composition according to claim 1 , wherein the viscosity of said composition at 24° C. and 10% (w/w) DS ranges from 2.0-6.0 cps claim 1 , preferably 2.5-5.5 cps.7. The oligosaccharide composition according to claim 1 , wherein the composition has shear thinning behavior at 30% (w/w) DS or more claim 1 , such as 40% (w/w) DS or more.8. The oligosaccharide composition according to claim 1 , wherein said composition is characterized by a tribological profile comprising a Boundary Regime at a sliding speed of less than 1 mm/s and a Mixed Regime at a sliding speed from 1-200 mm/s when the friction factor (coefficient of friction) for the oligosaccharide composition is determined in a tribometer as a function of sliding speed claim 1 , using elastimer plate(s) as sliding surface(s).9. The oligosaccharide ...

NUTRITIONAL FORMULATIONS INCLUDING HUMAN MILK OLIGOSACCHARIDES AND ANTIOXIDANTS AND USES THEREOF

Disclosed are nutritional compositions including human milk oligosaccharides in combination with long chain polyunsaturated fatty acids and/or carotenoids that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases. 1. A synthetic pediatric formula in powder or liquid form wherein , when the formula is a liquid , the formula comprises:a human milk oligosaccharide component comprising a human milk oligosaccharide selected form the group consisting of 6′-sialyllactose, 3′-sialyllactose 2′-fucosyllactose, 3-fucosyllactose, lacto-N-tetraose, lacto-N-neotetraose, lacto-N-fucopentaose, and combinations thereof;from about 5 mg per 100 kcals to 23 mg per 100 kcals of a long chain polyunsaturated fatty acid component comprising docosahexaenoic acid and arachidonic acid;from about 0.001 μg/mL to about 5 μg/mL of a carotenoid component comprising lutein, lycopene, beta-carotene, or a combination thereof;from about 10 mg/L to about 200 mg/L of a monomeric monophosphate nucleotide component;wherein from about 7% to about 40% of total calories in the formula are derived from protein, from about 25% to about 50% of total calories in the formula are derived from fat, and from about 35% to about 55% of total calories in the formula are derived from carbohydrates; andwherein the synthetic pediatric formula is shelf stable for at least 3 months.2. The synthetic pediatric formula of comprising 0.01 mg/mL to about 5 mg/mL of the human milk oligosaccharide component comprising 2′-fucosyllactose and 6′-sialyllactose.3. The synthetic pediatric formula of claim 1 , wherein the human milk oligosaccharide component comprises 2′-fucosyllactose which is present in a concentration of from about 0.01 mg/mL to less than 2 mg/mL.4. The synthetic pediatric formula of claim 1 , wherein the docosahexaenoic acid is present at a concentration of from about 0.025 mg/mL to about 0.130 mg/mL and the arachidonic acid ...

COMPOSITION FOR USE IN THE PREVENTION AND/OR TREATMENT OF SKIN CONDITIONS AND SKIN DISEASES

The invention discloses a composition comprising oligosaccharide, for use in the prevention and/or treatmentof skin conditions and/or skin diseases by increasing SCFA, in particular colonic propionate and butyrate. Said skin disease is in particular atopic dermatitis. 1. A method for the prevention and/or treatment of skin conditions and/or skin diseases in an infant or young child by increasing SCFA production in such infant or young child comprising administering a composition comprising an oligosaccharide mixture to an infant or young child in need of same.2. A method according to claim 1 , wherein the oligosaccharide mixture comprises at least one N-acetylated oligosaccharide claim 1 , at least one galacto-oligosaccharide and at least one sialylated oligosaccharide.3. A method according to claim 1 , wherein the oligosaccharide mixture comprises from 0.1 to 4.0 wt % of N-acetylated oligosaccharide(s) claim 1 , from 92.0 to 99.5 wt % of the galacto-oligosaccharide(s) and from 0.2 to 4.0 wt % of the sialylated oligosaccharide(s).4. A method according to claim 1 , wherein the composition comprises at least 0.01 wt % of N-acetylated oligosaccharide(s) claim 1 , at least 2.0 wt % of galacto-oligosaccharide(s) and at least 0.02 wt % of sialylated oligosaccharide(s).5. A method according to claim 1 , wherein the composition comprises a prebiotic claim 1 , said the prebiotic being selected from the group consisting of human milk oligosaccharides claim 1 , fructo-oligosaccharide claim 1 , inulin claim 1 , xylooligosaccharides claim 1 , polydextrose and combinations thereof.6Lactobacillus acidophilus, Lactobacillus salivarius, Lactobacillus rhamnosus, Lactobacillus paracasei, Lactobacillus casei, Lactobacillus johnsonii, Lactobacillus plantarum, Lactobacillus fermentum, Lactobacillus lactis, Lactobacillus delbrueckii, Lactobacillus helveticus, Lactobacillus bulgari, Lactococcus lactis, Lactococcus diacetylactis, Lactococcus cremoris, Streptococcus salivarius, Streptococcus ...

HUMAN MILK OLIGOSACCHARIDES AGAINST LATER IN LIFE EXCESSIVE FAT MASS ACCUMULATION AND RELATED HEALTH DISORDERS

The present invention relates to a nutritional composition comprising at least one fucosylated oligosaccharide for use in an infant or a young child for reducing and/or preventing later in life excessive fat mass accumulation and/or a health disorder related to excessive fat mass accumulation, wherein said fucosylated oligosaccharide has at least one fucose group attached by an alpha 1,3 linkage, at least one fucose group attached by an alpha 1,4 linkage, or combinations thereof. The invention also relates to nutritional composition for use to promote healthy growth. 1. A method for reducing and/or avoiding in an infant or young child later in life excessive fat mass accumulation and/or a later in life health disorder related to excessive fat mass accumulation comprising administering a nutritional composition comprising at least one fucosylated oligosaccharide to an infant or young child wherein the fucosylated oligosaccharide has at least one fucose group attached by an alpha 1 ,3 linkage , at least one fucose group attached by an alpha 1 ,4 linkage , or combinations thereof.2. Method according to wherein the composition comprises at least one fucosylated oligosaccharide which is fucosylated by FUT3.3. Method according to claim 1 , wherein the at least one fucosylated oligosaccharide is selected from the group consisting of 3′ fucosylated lactose (3FL) claim 1 , DFL claim 1 , LNFP II claim 1 , LNFP III claim 1 , LNFP V claim 1 , and combinations thereof.4. Method according to wherein the at least one fucosylated oligosaccharide is selected from the group consisting of 3′ fucosylated lactose claim 1 , DFL and combinations thereof.5. Method according to wherein the health disorder related to excessive fat mass accumulation is selected from the group consisting of overweight claim 1 , obesity claim 1 , type 2 diabetes claim 1 , insulin resistance claim 1 , hypertension claim 1 , cardiovascular disease or metabolic syndrome and premature adiposity rebound.6. Method ...

Fiber-Containing Carbohydrate Composition

A food product comprises an oligosaccharide composition that is digestion resistant or slowly digestible. The oligosaccharide composition can be produced by a process that comprises producing an aqueous composition that comprises at least one oligosaccharide and at least one monosaccharide by saccharification of starch, membrane filtering the aqueous composition to form a monosaccharide-rich stream and an oligosaccharide-rich stream, and recovering the oligosaccharide-rich stream. Alternatively, the oligosaccharide composition can be produced by a process that comprises heating an aqueous feed composition that comprises at least one monosaccharide or linear saccharide oligomer, and that has a solids concentration of at least about 70% by weight, to a temperature of at least about 40° C., and contacting the feed composition with at least one catalyst that accelerates the rate of cleavage or formation of glucosyl bonds for a time sufficient to cause formation of non-linear saccharide oligomers, wherein a product composition is produced that contains a higher concentration of non-linear saccharide oligomers than linear saccharide oligomers. 1. A process for making a slowly-digestible or digestion-resistant carbohydrate composition , the process comprisingproviding an aqueous feed composition that comprises dextrose, the aqueous feed composition including at least 70% by weight on a dry solids basis of monosaccharides and oligosaccharides; andreacting the aqueous feed composition at a solids concentration of at least 90% by weight in the presence of at least one acid catalyst that accelerates the rate of cleavage or formation of glucosyl bonds at a pH of no more than 4 and a temperature of at least about 149° C. for a time in the range of 0.1-15 minutes sufficient to produce a product saccharide composition in which the concentration of non-linear saccharide oligomers is at least twice as high as the concentration of linear saccharide oligomers, and in which the ...

OLIGOSACCHARIDE SYRUP HAVING IMPROVED STABILITY

The present invention relates to a saccharide syrup composition comprising an organic acid or its salt and an oligosaccharide, and more specifically, the saccharide syrup composition comprises allulose. 1. A method for preventing oligosaccharide decomposition , by adding an organic acid or its salt of 0.001 to 1.0 wt % to a saccharide syrup composition comprising the oligosaccharide.2. The method according to claim 1 , wherein the organic acid is one or more selected from the group consisting of lactic acid claim 1 , citric acid and ascorbic acid.3. The method according to claim 1 , wherein the oligosaccharide content is 20 to 90 wt % claim 1 , based on 100 wt % of the saccharide syrup composition.4. The method according to claim 1 , wherein the oligosaccharide content is 20 to 90 wt % and the allulose content is 10 to 80 wt % claim 1 , based on 100 wt % of the saccharide syrup composition.5. The method according to claim 1 , wherein the oligosaccharide is one or more kinds selected from the group consisting of galacto-oligosaccharide claim 1 , malto-oligosaccharide claim 1 , isomalto-oligosaccharide claim 1 , fructo-oligosaccharide and soy oligosaccharide.6. The method according to claim 1 , wherein the saccharide syrup composition added by the organic acid or its salt has an electrical conductivity of 100 to 1000 μS/cm.7. The method according to claim 1 , wherein pH of the saccharide syrup composition is 5.0 to 8.0.8. The method according to claim 1 , wherein the color value of the saccharide syrup composition is 0.005 to 0.2.9. The method according to claim 1 , wherein the preventing oligosaccharide decomposition is to have a content of the oligosaccharide of 80% or more claim 1 , based on 100% of the initial content of the oligosaccharide claim 1 , under storage conditions of a temperature of 45° C. and 42 days.10. The method according to claim 1 , wherein the saccharide syrup composition further comprises allulose syrup.11. The method according to claim 1 , ...

Compositions with specific oligosaccharides to prevent later in life obesity or related comorbidities, by increasing colonic scfa production and/or by increasing glp-1 secretion

The present invention relates to a nutritional composition comprising an oligosaccharide mixture, said oligosaccharide mixture comprising at least one N-acetylated oligosaccharide, one galacto-oligosaccharide and one sialylated oligosaccharide for use in reducing and/or avoiding excessive fat mass accumulation and/or in preventing any related later in life health disorders in an infant or a young child such as later in life obesity and related comorbidities, by increasing colonic SCFA production and/or GLP-1 secretion/releasein said infant or young child.

NUTRITIONAL FORMULATIONS INCLUDING HUMAN MILK OLIGOSACCHARIDES AND ANTIOXIDANTS AND USES THEREOF

Disclosed are nutritional compositions including human milk oligosaccharides in combination with long chain polyunsaturated fatty acids and/or carotenoids that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases. 1. A synthetic pediatric formula comprising a human milk oligosaccharide and from about 0.025 mM to about 1 mM of a long chain polyunsaturated fatty acid.2. The synthetic pediatric formula of claim 1 , wherein the human milk oligosaccharide is selected from the group consisting of 6′-sialyllactose claim 1 , 3′-sialyllactose claim 1 , 2′-fucosyllactose claim 1 , 3-fucosyllactose claim 1 , lacto-N-tetraose claim 1 , lacto-N-neotetraose claim 1 , lacto-N-fucopentaose claim 1 , and combinations thereof.3. The synthetic pediatric formula of claim 1 , wherein the human milk oligosaccharide is present in an amount of from about 0.001 mg/mL to about 20 mg/mL and is selected from the group consisting of 6′-sialyllactose claim 1 , 3′-sialyllactose claim 1 , 2′-fucosyllactose claim 1 , lacto-N-neotetraose claim 1 , and combinations thereof.4. The synthetic pediatric formula of claim 1 , wherein the long chain polyunsaturated fatty acid is selected from the group consisting of linoleic acid claim 1 , linolenic acid claim 1 , arachidonic acid claim 1 , docosahexaenoic acid claim 1 , eicosapentaenoic acid claim 1 , docosapentaenoic acid claim 1 , and combinations thereof.5. The synthetic pediatric formula of claim 1 , wherein the long chain polyunsaturated fatty acid is arachidonic acid claim 1 , docosahexaenoic acid claim 1 , or a combination of both.6. The synthetic pediatric formula of claim 1 , wherein the human milk oligosaccharide is 6′-sialyllactose.7. The synthetic pediatric formula of claim 6 , wherein the 6′-sialyllactose is present in a concentration of from about 0.001 mg/mL to about 20 mg/mL.8. The synthetic pediatric formula of claim 1 , wherein the human milk ...

Composition Comprising Neoagarooligosaccharide As Active Ingredient, For Prevention or Treatment of Sepsis or Septic Shock

The present invention relates to a composition for prevention or treatment of sepsis or septic shock, in which the composition includes neoagarooligosaccharide as an active ingredient, and the neoagarooligosaccharide according to the present invention has an excellent effect in terms of immune enhancement by effectively suppressing inflammation, and also exhibits a good effect in preventing sepsis, and therefore can be effectively used in pharmaceuticals and functional foods for prevention or treatment of sepsis or septic shock and immune enhancement. 1. A pharmaceutical composition for prevention or treatment of sepsis or septic shock , the pharmaceutical composition comprising neoagarooligosaccharide , which is prepared from agar or agarose by a DagA enzyme reaction , as an active ingredient.2Streptomyces coelicolor.. The pharmaceutical composition of claim 1 , wherein the DagA enzyme is derived from3. The pharmaceutical composition of claim 2 , wherein the DagA enzyme is represented by amino acid sequences 31 to 309 of SEQ ID NO: 2.4. The pharmaceutical composition of claim 2 , wherein the DagA enzyme is encoded by a nucleotide sequence of SEQ ID NO: 1.5. The pharmaceutical composition of claim 1 , wherein the enzyme reaction is carried out at a temperature of 35° C. to 45° C. and pH of 6 to 8.6. The pharmaceutical composition of claim 1 , wherein the neoagarooligosaccharide is one or more kinds selected from the group consisting of neoagarobiose claim 1 , neoagarotetraose claim 1 , and neoagarohexaose.7. A food composition for prevention or ameliorating sepsis or septic shock claim 1 , the food composition comprising neoagarooligosaccharide prepared from agar or agarose by DagA enzyme reaction as an active ingredient.8. A pharmaceutical composition for reinforcement of immunization claim 1 , the pharmaceutical composition comprising neoagarooligosaccharide prepared from agar or agarose by a DagA enzyme reaction claim 1 , as an active ingredient.9. A functional ...

NUTRITIONAL FORMULATIONS INCLUDING HUMAN MILK OLIGOSACCHARIDES AND ANTIOXIDANTS AND USES THEREOF

Disclosed are nutritional compositions including human milk oligosaccharides in combination with long chain polyunsaturated fatty acids and/or carotenoids that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases. 1. A synthetic pediatric formula comprising:hydrolyzed protein;from about 0.01 mg/mL to about 10 mg/mL of at least one of 6′-sialyllactose, 3′-sialyllactose 2′-fucosyllactose, 3-fucosyllactose, lacto-N-tetraose, lacto-N-neotetraose, and lacto-N-fucopentaose;from about 0.080 mg/mL to about 0.250 mg/mL of arachidonic acid;from about 0.001 μg/mL to about 5 μg/mL of at least one of lutein, lycopene, and beta-carotene;from about 10 mg/L to about 200 mg/L of a monomeric monophosphate nucleotide component;wherein the synthetic pediatric formula is shelf stable for at least 3 months.2. The synthetic pediatric formula of comprising 0.01 mg/mL to about 5 mg/mL of at least one of 2′-fucosyllactose claim 1 , 3′-sialylactose claim 1 , and 6′-sialyllactose.3. The synthetic pediatric formula of claim 1 , wherein the human milk oligosaccharide component comprises 2′-fucosyllactose which is present in a concentration of from about 0.01 mg/mL to 5 mg/mL.4. The synthetic pediatric formula of claim 1 , wherein the monomeric monophosphate nucleotide component is present in a concentration of from about 42 mg/L to about 1025. The synthetic pediatric formula of claim 1 , wherein the monomeric monophosphate nucleotide component comprises cytidine 5′-monophosphate claim 1 , adenosine 5′-monophosphate claim 1 , guanosine 5′-monophosphate claim 1 , and uridine 5′-monophosphate.6. The synthetic pediatric formula of claim I claim 1 , wherein at least one monomeric monophosphate nucleotide is a free acid and at least one other monomeric monophosphate nucleotide is a salt.7. The synthetic pediatric formula of claim 1 , comprising a combination of lutein claim 1 , lycopene claim 1 , and beta- ...

A METHOD OF PRODUCING MICROPARTICLES OF THE TYPE HAVING A CROSSLINKED, AGGREGATED PROTEIN MATRIX BY SPRAY DRYING

A method of producing microparticles by spray drying comprises the steps of providing a spray-drying feedstock solution comprising water, a volatile divalent metal salt, weak acid, 5-15% dairy or vegetable protein (w/v) and 1-20% active agent (w/v). The feedstock solution is adjusted to have a pH at which the volatile divalent metal salt is substantially insoluble. The feedstock solution is then spray-dried at an elevated temperature to provide atomised droplets, whereby the volatile divalent metal salt disassociates at the elevated temperature to release divalent metal ions which crosslink and aggregate the protein in the atomised droplets to produce micro-particles having a crosslinked aggregated protein matrix and active agent dispersed throughout the matrix. 120-. (canceled)21. A spray-dried , food grade , microparticle having an active agent homogenously dispersed throughout a continuous dairy or vegetable protein matrix , in which the protein matrix comprises agglomerated and divalent metal ion crosslinked protein.22. A spray dried microparticle according to and comprising hydrocolloid claim 21 , in which the active agent is homogenously dispersed throughout a continuous protein-hydrocolloid matrix.23. A spray dried microparticle according to in which the hydrocolloid comprises or consists of FOS.24. A spray dried microparticle according to in which the hydrocolloid comprises or consists of citrus fibre.25. A spray dried microparticle according to in which the hydrocolloid comprises or consists of FOS and citrus fibre claim 23 , and in which the active agent is homogenously dispersed throughout a continuous protein-FOS-citrus fibre matrix.26. A spray dried microparticle according to having a dimension of 20-90 microns.27. A spray dried microparticle according to in which the active agent is a cell.28. A spray dried microparticle according to in which the active agent is a compound.29. A spray dried microparticle according to and comprising at least 50% active ...

Human milk permeate compositions and methods of making and using same

This disclosure features human milk permeates and compositions containing the same obtained from fractionated whole human milk. The oligosaccharide rich permeate and permeate compositions of the present invention are useful as nutritional supplements for pre-term and full term infants, for establishing or maintaining gut flora and for treating the symptoms of inflammatory bowel disease.

AGENT FOR INCREASING INTESTINAL BUTYRIC ACID AND PROLIFERATION AGENT FOR BUTYRIC ACID-PRODUCING BACTERIA

[Problem] 18-.9. A method for proliferating butyric acid-producing bacteria , comprising the step of adding 1-kestose to a medium containing butyric acid-producing bacteria to culture the butyric acid-producing bacteria.10. A method for treatment or prevention of intestinal inflammation , fatty liver , diabetes , colorectal cancer , or obesity , comprising the step of increasing the amount or the concentration of butyric acid or the number of butyric acid-producing bacteria in intestines in a human or an animal having or being at risk of having intestinal inflammation , fatty liver , diabetes , colorectal cancer , or obesity by letting take the human or the animal 1-kestose.11. A method for producing a pharmaceutical preparation or a health food for treatment or prevention of intestinal inflammation , fatty liver , diabetes , colorectal cancer , or obesity using 1-kestose. The present invention relates to an agent for increasing intestinal butyric acid, a food composition for increasing intestinal butyric acid, a proliferation agent for butyric acid-producing bacteria, a food composition for proliferating butyric acid-producing bacteria, a method for increasing intestinal butyric acid, a method for proliferating butyric acid-producing bacteria, and a method for treatment or prevention of intestinal inflammation, fatty liver, diabetes, colorectal cancer, or obesity and use of 1-kestose for producing a pharmaceutical preparation for treatment or prevention of these diseases.Butyric acid is a short chain fatty acid and produced by butyric acid-producing bacteria that reside in the intestines in human and animal bodies. Studies in recent years have reported that butyric acid has various physiological effects such as anti-inflammatory effects and colorectal cancer preventing effects and that butyric acid may prevent or ameliorate various diseases.Based on theses, attempts to use butyric acid have been made for prevention and treatment of diseases and health promotion. ...

NUTRITIONAL FORMULATIONS INCLUDING HUMAN MILK OLIGOSACCHARIDES AND ANTIOXIDANTS AND USES THEREOF

Disclosed are nutritional compositions including human milk oligosaccharides in combination with long chain polyunsaturated fatty acids and/or carotenoids that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases. 1. A nutritional composition comprising a human milk oligosaccharide selected from the group consisting of 6′-sialyllactose , 3′-sialyllactose , 2′-fucosyllactose , 3-fucosyllactose , lacto-N-tetraose , lacto-N-neotetraose , lacto-N-fucopentaose , and combinations thereof and from 0.001 mg/mL to 1 mg/mL of a polyunsaturated fatty acid , wherein the polyunsaturated fatty acid comprises 0.105 mg/mL to 0.38 mg/mL of a combination of docosahexaenoic acid and arachidonic acid , and wherein a ratio of docosahexaenoic acid to arachidonic acid is from 1:4 to 1:2.2. The nutritional composition of claim 1 , wherein the polyunsaturated fatty acid comprises from 0.025 mg/mL to 0.130 mg/mL of docosahexaenoic acid.3. The nutritional composition of claim 1 , wherein the human milk oligosaccharide is present in an amount of from 0.001 mg/mL to 20 mg/mL and is selected from the group consisting of 6′-sialyllactose claim 1 , 3′-sialyllactose claim 1 , 2′ -fucosyllactose claim 1 , lacto-N-neotetraose claim 1 , and combinations thereof.4. The nutritional composition of claim 1 , wherein the nutritional composition further comprises a long chain polyunsaturated fatty acid selected from the group consisting of linoleic acid claim 1 , linolenic acid claim 1 , eicosapentaenoic acid claim 1 , docosapentaenoic acid claim 1 , and combinations thereof.5. The nutritional composition of claim 1 , wherein the human milk oligosaccharide is derived from a fermentation process claim 1 , an enzymatic process claim 1 , a chemical process claim 1 , or a combination thereof.6. The nutritional composition of claim 1 , wherein the human milk oligosaccharide is 6′-sialyllactose.7. The nutritional ...

Goods protection insert and uses thereof

The present disclosure provides protection inserts comprising a discrete substrate-forming material holding a nutrient composition, the nutrient composition comprising a combination of nutrients for supporting selective growth of one or more bacteriocin-producing bacterium on said substrate and being essentially free of externally added microorganisms Also disclosed herein is a consumer goods package comprising goods to be protected and a protection insert disclosed herein as well as methods of protecting goods making use of the insert disclosed herein.

NUTRITIONAL FORMULATIONS INCLUDING HUMAN MILK OLIGOSACCHARIDES AND ANTIOXIDANTS AND USES THEREOF

Disclosed are nutritional compositions including human milk oligosaccharides in combination with long chain polyunsaturated fatty acids and/or carotenoids that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases. 1. A synthetic pediatric formula comprising a human milk oligosaccharide selected from the group consisting of 6′-sialyllactose , 3′-sialyllactose , 2′-fucosyllactose , 3-fucosyllactose , lacto-N-tetraose , lacto-N-neotetraose , lacto-N-fucopentaose , and combinations thereof and from about 0.001 g/L to about 1 g/L of a long chain polyunsaturated fatty acid.2. The synthetic pediatric formula of claim 1 , wherein the total amount of human milk oligosaccharide is present in an amount of from about 0.01 mg/mL to about 20 mg/mL and the human milk oligosaccharide is selected from the group consisting of 6′-sialyllactose claim 1 , 3′-sialyllactose claim 1 , 2′-fucosyllactose claim 1 , lacto-N-neotetraose claim 1 , and combinations thereof.3. The synthetic pediatric formula of claim 1 , wherein the long chain polyunsaturated fatty acid is selected from the group consisting of linoleic acid claim 1 , linolenic acid claim 1 , arachidonic acid claim 1 , docosahexaenoic acid claim 1 , eicosapentaenoic acid claim 1 , docosapentaenoic acid claim 1 , and combinations thereof.4. The synthetic pediatric formula of claim 1 , wherein the long chain polyunsaturated fatty acid comprises from 0.08 mg/mL to 0.25 mg/mL of arachidonic acid.5. The synthetic pediatric formula of claim 1 , wherein the human milk oligosaccharide is derived from a fermentation process claim 1 , an enzymatic process claim 1 , a chemical process claim 1 , or a combination thereof.6. The synthetic pediatric formula of claim 1 , wherein the human milk oligosaccharide is 6′-sialyllactose.7. The synthetic pediatric formula of claim 1 , wherein the synthetic pediatric formula is shelf stable from 12 to 18 months.8. ...

Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof

Disclosed are nutritional compositions including human milk oligosaccharides in combination with long chain polyunsaturated fatty acids and/or carotenoids that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases.

NUTRITIONAL FORMULATIONS INCLUDING HUMAN MILK OLIGOSACCHARIDES AND ANTIOXIDANTS AND USES THEREOF

Disclosed are nutritional compositions including human milk oligosaccharides in combination with long chain polyunsaturated fatty acids and/or carotenoids that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases. 1. A nutritional composition comprising a human milk oligosaccharide selected from the group consisting of 6′-sialyllactose , 3′-sialyllactose , 2′-fucosyllactose , 3-fucosyllactose , lacto-N-tetraose , lacto-N-neotetraose , lacto-N-fucopentaose , and combinations thereof , and from 5 mg per 100 kcals to 23 mg per 100 kcals of total long chain omega-3 fatty acids.2. The nutritional composition of claim 1 , wherein the long chain omega-3 fatty acid comprises docosahexaenoic acid.3. The nutritional composition of claim 2 , comprising both docosahexaenoic acid and arachidonic acid claim 2 , wherein a ratio of docosahexaenoic acid to arachidonic acid is 1:4 to 1:2.4. The nutritional composition of further comprising from 0.001 μg/mL to 5 μg/mL of a carotenoid.5. The nutritional composition of claim 2 , wherein the composition further includes long chain omega-6 fatty acids and a ratio of long chain omega-6 fatty acids to long chain omega-3 fatty acids is from about 2:1 to about 3:1.6. The nutritional composition of further comprising a nucleotide in an amount of from 10 mg/mL to 200 mg/mL.7. The nutritional composition of claim 1 , wherein the nutritional composition is a nutritional powder or ready-to-feed nutritional liquid.8. The nutritional composition of claim 7 , wherein the nutritional composition is a nutritional powder and the powder is a spray dried powder.9. The nutritional composition of claim 1 , wherein the human milk oligosaccharide is derived from a source selected from human claim 1 , bovine claim 1 , ovine claim 1 , porcine claim 1 , caprine claim 1 , or combinations thereof.10. The nutritional composition of claim 1 , wherein the human milk ...

PROCESSED STACHYOSE COMPOSITIONS

The invention describes stachyose compositions and methods to prepare such compositions with reduced or eliminated odor causing impurities, such as aldehydic impurities, contained within stachyose compositions that occur in nature or are caused during commercial processing.

USE OF OLIGOSACCHARIDE COMPOSITIONS TO ENHANCE WEIGHT GAIN

Provided herein are compositions and methods related to use of oligosaccharides, such as 2′-fucosyllactose, for increasing weight gain in a subject. In some aspects the compositions and methods are for use in infants, such as premature infants or infants having intestinal failure. 1. A method of increasing weight gain in a subject , the method comprising: administering to a subject in need thereof a synthetic composition comprising an oligosaccharide and/or a glycoconjugate containing the oligosaccharide , wherein the oligosaccharide is an α1 ,2 fucosylated oligosaccharide.2. The method of claim 1 , wherein the synthetic composition comprises the α1 claim 1 ,2 fucosylated oligosaccharide and/or the glycoconjugate containing the α1 claim 1 ,2 fucosylated oligosaccharide as its sole source of fucosylated oligosaccharides.3. The method of claim 1 , wherein the subject is selected from the group consisting of a premature human infant claim 1 , a human subject who has undergone a surgery claim 1 , and a human subject who is suffering from undernutrition.4. The method of claim 3 , wherein the subject is a premature human infant.5. The method of claim 4 , wherein the premature human infant has a gestational age of less than 37 weeks.6. The method of claim 5 , wherein the premature human infant has a gestational age of less than 34 weeks.7. The method of claim 6 , wherein the premature human infant has a gestational age of less than 29 weeks.8. The method of claim 4 , wherein the premature human infant has a weight-for-age Z-score of less than −2.0.9. The method of claim 3 , wherein the subject is a human patient who has undergone a surgery or is a human subject suffering from undernutrition.10. The method of claim 9 , wherein the subject is a human patient who has undergone a surgery claim 9 , which is an intestinal surgery or a bone marrow transplantation.11. The method of claim 10 , wherein the subject who has undergone an intestinal surgery has short bowel syndrome.12. ...

SYNERGISM OF GOS AND POLYFRUCTOSE

The present invention relates to the field of prebiotics. Provided are uses for compositions comprising synergistically effective amounts of polyfructose and galactooligosaccharides (GOS). 1. A method of treating eczema , the method consisting of administering to a mammal suffering from eczema a composition comprising galactooligosaccharide and polyfructose , wherein the weight ratio of galactooligosaccharide:polyfructose is 97:3 to 80:20 , wherein the composition does not comprise lactobacilli.2. The method according to claim 1 , wherein the weight ratio of galactooligosaccharide:polyfructose is 95:5 to 85:15.3. The method according to claim 1 , wherein the weight ratio of galactooligosaccharide:polyfructose is about 90:10.4. The method according to claim 1 , wherein the galactooligosaccharide is transgalacto-oligosaccharide.5. The method according to claim 1 , wherein the polyfructose is inulin.6. The method according to claim 1 , wherein the galactooligosaccharide is transgalacto-oligosaccharide and the polyfructose is inulin.7. The method according to claim 5 , wherein the inulin has an average degree of polymerization of 20 to 150.8. The method according to claim 6 , wherein the inulin has an average degree of polymerization of 20 to 150.9. The method according to claim 1 , wherein the composition is liquid.10. The method according to claim 1 , wherein the composition further does not comprise bifidobacteria.11. (canceled)12. The method according to claim 1 , wherein the mammal is a human child claim 1 , teenager or adult.13. The method according to claim 1 , wherein the mammal is a human infant.14. The method according to claim 13 , wherein the human infant is up to a 12 months old infant.15. A method of treating atopic disease claim 13 , the method consisting of administering to a mammal suffering from atopic disease a composition comprising galactooligosaccharide and polyfructose claim 13 , wherein the weight ratio of galactooligosaccharide:polyfructose is ...

NUTRITIONAL FORMULATIONS INCLUDING HUMAN MILK OLIGOSACCHARIDES AND ANTIOXIDANTS AND USES THEREOF

Disclosed are nutritional compositions including human milk oligosaccharides in combination with long chain polyunsaturated fatty acids and/or carotenoids that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases. 1. A synthetic pediatric formula in powder form comprising:from about 0.01 mg/mL to about 5 mg/mL of the human milk oligosaccharide 2′-fucosyllactose;from about 0.001 g/L to about 1 g/mL of a long chain polyunsaturated fatty acid component comprising docosahexaenoic acid and arachidonic acid, wherein the ratio of docosahexaenoic acid to arachidonic acid is from about 1:4 to about 1:2;from about 0.001 μg/mL to about 5 μg/mL of a carotenoid component comprising lutein, lycopene, and beta-carotene;from about 10 mg/L to about 200 mg/L of a monomeric monophosphate nucleotide component;wherein from about 7% to about 40% of total calories in the formula are derived from protein, from about 25% to about 50% of total calories in the formula are derived from fat, and from about 35% to about 55% of total calories in the formula are derived from carbohydrates; andwherein the synthetic pediatric formula is shelf stable from about 12 months to about 18 months.2. The synthetic pediatric formula of claim 1 , wherein the human milk oligosaccharide 2′-fucosyllactose is present in a concentration of from about 0.01 mg/mL to less than 2 mg/mL.3. The synthetic pediatric formula of claim 1 , wherein the arachidonic acid is derived from fungal oil.4. The synthetic pediatric formula of claim 1 , wherein the docosahexaenoic acid is derived from plant oil.5. The synthetic pediatric formula of claim 1 , wherein the docosahexaenoic acid is present at a concentration of from about 0.025 mg/mL to about 0.130 mg/mL and the arachidonic acid is present at a concentration of from about 0.080 mg/mL to about 0.250 mg/mL.6. The synthetic pediatric formula of claim 1 , wherein the monomeric ...

Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof

Disclosed are nutritional compositions including human milk oligosaccharides in combination with long chain polyunsaturated fatty acids and/or carotenoids that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases.

NUTRITIONAL FORMULATIONS INCLUDING HUMAN MILK OLIGOSACCHARIDES AND ANTIOXIDANTS AND USES THEREOF

Disclosed are nutritional compositions including human milk oligosaccharides in combination with long chain polyunsaturated fatty acids and/or carotenoids that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases. 1. A synthetic pediatric formula in powder form comprising:from about 0.01 mg/mL to about 5 mg/mL of the human milk oligosaccharide 2′-fucosyllactose;from about 100 mg/L to about 425 mg/L of a long chain omega-6 fatty acid;from about 40 mg/L to about 185 mg/L of a long chain omega-3 fatty acid;from about 0.001 μg/mL to about 5 μg/mL of a carotenoid component comprising lutein, lycopene, beta-carotene, or a combination thereof;from about 10 mg/L to about 200 mg/L of a monomeric monophosphate nucleotide component;wherein the ratio of long chain omega-6 fatty acids to long chain omega-3 fatty acids is from about 2:1 to about 3:1;wherein from about 7% to about 40% of total calories in the formula are derived from protein, from about 25% to about 50% of total calories in the formula are derived from fat, and from about 35% to about 55% of total calories in the formula are derived from carbohydrates; andwherein the human milk oligosaccharide is produced using microbial fermentation.2. The synthetic pediatric formula of claim 1 , wherein the human milk oligosaccharide 2′-fucosyllactose is present in a concentration of from about 0.01 mg/mL to less than 2 mg/mL.3. The synthetic pediatric formula of claim 1 , wherein the long chain omega-6 fatty acid is arachidonic acid and the long chain omega-3 fatty acid is docosahexaenoic acid.4. The synthetic pediatric formula of claim 1 , wherein the carotenoid component comprises the combination of lutein claim 1 , lycopene claim 1 , and beta-carotene.5. The synthetic pediatric formula of claim 1 , wherein the monomeric monophosphate nucleotide component comprises cytidine 5′-monophosphate claim 1 , adenosine 5′-monophosphate claim 1 ...

NUTRITIONAL FORMULATIONS INCLUDING HUMAN MILK OLIGOSACCHARIDES AND ANTIOXIDANTS AND USES THEREOF

Disclosed are nutritional compositions including human milk oligosaccharides in combination with long chain polyunsaturated fatty acids and/or carotenoids that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases.

Fermented infant formula

A fermented infant formula or follow on formula for promoting a growth trajectory more similar to the growth trajectory in breast-fed infants. A fermented infant formula or follow on formula for i) promoting a balanced growth trajectory or body development in an infant and/or ii) preventing or reducing the risk of an unbalanced growth trajectory or body development in an infant. Saud formula comprises 3 to 7 g lipid/100 kcal, 1.25 to 5 g protein/100 kcal and 6 to 18 g digestible carbohydrate/100 kcal and wherein the nutritional composition comprises an ingredient fermented by lactic acid producing bacteria, and 0.05 to 1.5 wt % lactic acid based on dry weight.

NUTRITIONAL FORMULATIONS INCLUDING HUMAN MILK OLIGOSACCHARIDES AND ANTIOXIDANTS AND USES THEREOF

Disclosed are nutritional compositions including human milk oligosaccharides in combination with long chain polyunsaturated fatty acids and/or carotenoids that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases. 1. A nutritional powder comprising a human milk oligosaccharide selected from the group consisting of 6′-sialyllactose , 3′-sialyllactose , 2′-fucosyllactose , 3-fucosyllactose , lacto-N-tetraose , lacto-N-neotetraose , lacto-N-fucopentaose , and combinations thereof and docosahexaenoic acid in an amount of about 3 mg per 100 kcals to about 16 mg per 100 kcals.2. The nutritional powder of claim 1 , wherein the nutritional powder further comprises arachidonic acid in an amount of about 10 mg per 100 kcals to about 31 mg per 100 kcals.3. The nutritional powder of claim 1 , wherein the human milk oligosaccharide is present in an amount of from about 0.01 mg/mL to about 20 mg/mL and is selected from the group consisting of 6′-sialyllactose claim 1 , 3′-sialyllactose claim 1 , 2′-fucosyllactose claim 1 , lacto-N-neotetraose claim 1 , and combinations thereof.4. The nutritional powder of claim 1 , wherein the nutritional powder further comprises a long chain polyunsaturated fatty acid selected from the group consisting of linoleic acid claim 1 , linolenic acid claim 1 , arachidonic acid claim 1 , eicosapentaenoic acid claim 1 , docosapentaenoic acid claim 1 , and combinations thereof.5. The nutritional powder of claim 1 , wherein the human milk oligosaccharide is derived from a fermentation process claim 1 , an enzymatic process claim 1 , a chemical process claim 1 , or a combination thereof.6. The nutritional powder of claim 1 , wherein the human milk oligosaccharide is 6′-sialyllactose.7. The nutritional powder of claim 1 , wherein the human milk oligosaccharide is 2′-fucosyllactose.8. The nutritional powder of claim 7 , wherein the 2′-fucosyllactose is present in a ...

NUTRITIONAL COMPOSITIONS AND INFANT FORMULAS COMPRISING A MIX OF OLIGOSACCHARIDES AND OPTIONALLY BIFIDOBACTERIUM LACTIS FOR PREVENTING, TREATING OR REDUCING THE SEVERITY OF NON-ROTAVIRUS-ASSOCIATED DIARRHOEA

The invention relates to a nutritional composition comprising at least one N-acetylated oligosaccharide, and at least one galacto-oligosaccharide, and at least one sialylated oligosaccharide. The composition optionally comprises a spp. probiotic, preferably CNCM-I-3446 probiotic. The composition treat ro reduces the risk, the severity and/or the occurrence of non-rotavirus associated diarrhoea. The composition also promotes a healthy intestinal flora and has beneficial long and short terms effects. The composition is in particular intended for infants between 0 and 12 months of age fed predominantly with infant formula. 1. A method for preventing and/or treating and/or reducing the severity and/or risk and/or occurrence of non-rotavirus-associated diarrhea in infants or young children between 0 and 36 months comprising administering a nutritional composition for to infants or young children , the composition comprising at least one N-acetylated oligosaccharide , at least one galacto-oligosaccharide , and at least one sialylated oligosaccharide.2Bifidobacterium animalislactis. The method of wherein the composition comprises a spp. probiotic claim 1 , in an amount of between 10and 10cfu per gram of composition.3. The method of for promoting or inducing a gut microbiota that is closer to the microbiota of infants fed exclusively with human breast milk claim 1 , in comparison to the microbiota of infants fed predominantly with a conventional nutritional composition not comprising said probiotic claim 1 , in infants or young children between 0 and 36 months claim 1 , optionally between 0 and 12 months of age.4. The method of wherein the infants are born with a fragile or unbalanced microbiota or dysbiosis of microbiota.5. The method of wherein the composition comprises oligofructose.6. The method of wherein the composition comprising fat and at least 8% claim 1 , preferably at least 9.6% of the fat is sn2 palmitate.7. The method of wherein the composition comprises ...

NUTRITIONAL FORMULATIONS INCLUDING HUMAN MILK OLIGOSACCHARIDES AND ANTIOXIDANTS AND USES THEREOF

Disclosed are nutritional compositions including human milk oligosaccharides in combination with long chain polyunsaturated fatty acids and/or carotenoids that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases. 1. A synthetic pediatric formula in powder or liquid form wherein , when the formula is a liquid , the formula comprises:a human milk oligosaccharide component comprising a human milk oligosaccharide selected form the group consisting of 6′-sialyllactose, 3′-sialyllactose 2′-fucosyllactose, 3-fucosyllactose, lacto-N-tetraose, lacto-N-neotetraose, lacto-N-fucopentaose, and combinations thereof;from about 5 mg per 100 kcals to 23 mg per 100 kcals of a long chain polyunsaturated fatty acid component comprising docosahexaenoic acid and arachidonic acid;from about 0.001 μg/mL to about 5 μg/mL of a carotenoid component comprising lutein, lycopene, beta-carotene, or a combination thereof;from about 10 mg/L to about 200 mg/L of a monomeric monophosphate nucleotide component;wherein from about 7% to about 40% of total calories in the formula are derived from protein, from about 25% to about 50% of total calories in the formula are derived from fat, and from about 35% to about 55% of total calories in the formula are derived from carbohydrates; andwherein the synthetic pediatric formula is shelf stable for at least 3 months.2. The synthetic pediatric formula of comprising 0.01 mg/mL to about 5 mg/mL of the human milk oligosaccharide component comprising 2′-fucosyllactose and 6′-sialyllactose.3. The synthetic pediatric formula of claim 1 , wherein the human milk oligosaccharide component comprises 2′-fucosyllactose which is present in a concentration of from about 0.01 mg/mL to less than 2 mg/mL.4. The synthetic pediatric formula of claim 1 , wherein the docosahexaenoic acid is present at a concentration of from about 0.025 mg/mL to about 0.130 mg/mL and the arachidonic acid ...

NUTRITIONAL COMPOSITIONS AND INFANT FORMULAS COMPRISING BIFIDOBACTERIUM ANIMALIS SSP. LACTIS AND OPTIONALLY A MIX OF OLIGOSACCHARIDES FOR INDUCING A GUT MICROBIOTA CLOSE TO THE ONE OF BREAST FED INFANTS

The invention relates to a nutrition composition with promoting or inducing a gut microbiota that is closer to infants fed exclusively with human breast milk, in comparison to infant fed with conventional nutritional composition. The composition is in particular intended for infants between 0 and 12 months of age fed predominantly with infant formula. The infants can be fed during 2, 4, or 6 months and the composition can be an infant formula. The composition promotes a healthy intestinal flora and has beneficial long and short terms effects. 1Bifidobacterium animalislactis. A method for promoting or inducing a gut microbiota that is closer to the microbiota of infants fed exclusively with human breast milk , in comparison to the microbiota of infants fed predominantly with a conventional nutritional composition not comprising the probiotic , in infants or young children between 0 and 36 months comprising administering a nutritional composition to such infants or young children comprising a spp. probiotic.2. The method of wherein the composition comprises at least one component selected from the group consisting of N-acetylated oligosaccharide claim 1 , galacto-oligosaccharide claim 1 , and sialylated oligosaccharide.3. The method of wherein the infants are born with a fragile or unbalanced microbiota or dysbiosis of microbiota.4. The method of wherein the infants are 0 to 6 months old.5. The method of wherein the composition comprises oligofructose.6. The method of wherein the composition comprising fat and at least 8% of the fat is sn2 palmitate.7. The method of wherein the composition comprises triglycerides having more than 33% of the palmitic acid in sn2 position.8. The method of wherein the composition is an infant formula or a follow-on formula.9. The method of wherein the composition comprises alpha-lactalbumin proteins in an amount of at least 0.3 g/100 kcal of composition.10B. animalisBifidobacterium,B. LongumLactobacillus,CoprobacillusStreptococcus.. The ...

Glycerin-based gummy candy and foam candy products with probiotic bacteria

The present invention relates to a glycerin-based candy product comprising probiotic bacteria, said product having a moisture content less than 9% and a water activity (a w ) less than 0.5 and comprising a) glycerin in an amount of 10% to 40% (w/w), b) 40% to 75% (w/w) of at least one saccharide or at least one polyol which is not glycerin, or a mixture thereof, c) at least one hydrocolloid, and d) at least one species of a probiotic bacterium. Further, the invention relates to methods for producing a glycerin-based candy product comprising probiotic bacteria.

Nutritional Compositions Containing Structured Fat Globules And Uses Thereof

The present disclosure relates to a lipid source for nutritional compositions, comprising an enriched lipid fraction which comprises structured fat globules. The enriched lipid fraction provides fat globules having a desired size and fatty acid composition and may be stabilized by components such as phospholipids, cholesterol, milk-fat globule membrane protein and combinations thereof. Additionally, the disclosure relates to methods of supporting lipid digestion in a pediatric subject by providing a nutritional composition comprising an enriched lipid fraction having structured fat globules that are more accessible to lipases. The chemical composition, size and structure of the fat globules may improve digestion. The disclosed nutritional compositions may provide additive and or/synergistic beneficial health effects. 1. An nutritional composition comprising:a carbohydrate source,a protein source, anda lipid source comprising milk fat globules formed from an enriched lipid fraction derived from milk.2. The nutritional composition of claim 1 , wherein the average diameter of the milk fat globules range is at least about 2 μm.3. The nutritional composition of claim 2 , wherein the average diameter of the milk fat globules range is in the range of about 2 μm to about 13 μm.4. The nutritional composition of claim 3 , wherein the average diameter of the milk fat globules range is in the range of about 3 μm to about 6 μm.5. The nutritional composition of claim 1 , wherein the specific surface area of the milk fat globules range is in the range of about 0.9 m/g to about 3 m/g.6. The nutritional composition of claim 1 , wherein the milk fat globules comprise trans-fatty acids at a level of from about 0.2 g/100 kcal to about 5.2 g/100 kcal; OBCFAs at a level of from about 0.3 g/100 kcal to about 6.1 g/100 kcal; BCFAs at a level of from about 0.2 g/100 kcal to about 5.4 g/100 kcal; CLA at a level of from about 0.4 g/100 kcal to about 0.8 g/100 kcal; and cholesterol at a level ...

NUTRITIONAL FORMULATIONS USING HUMAN MILK OLIGOSACCHARIDES FOR MODULATING INFLAMMATION

Disclosed is a nutritional composition for use in modulating or reducing inflammation in an adult or elderly individual in need thereof. In some aspects, the nutritional composition comprises a neutral human milk oligosaccharide. 114.-. (canceled)15. A nutritional composition for reducing inflammation in an adult or elderly individual in need thereof , the nutritional composition comprising at least one neutral human milk oligosaccharide in a concentration of from 0.001 mg/mL to 25 mg/mL , that reduces platelet-neutrophil complex formation.16. The nutritional composition according to claim 15 , wherein the at least one neutral human milk oligosaccharide is selected from the group consisting of 2′-fucosyllactose and lacto-N-neotetraose (LNnT) and combinations thereof.17. The nutritional composition according to claim 15 , wherein the at least one neutral human milk oligosaccharide is 2′-fucosyllactose claim 15 , and wherein 2′-fucosyllactose is present in the nutritional composition in a concentration of from 0.001 mg/mL to 15 mg/mL.18. The nutritional composition according to claim 15 , wherein the at least one neutral human milk oligosaccharide is 2′-fucosyllactose claim 15 , and wherein 2′-fucosyllactose is present in the nutritional composition in a concentration of from 0.050 mg/mL to 10 mg/mL.19. The nutritional composition according to claim 15 , wherein the at least one neutral human milk oligosaccharide is 2′-fucosyllactose claim 15 , and wherein 2′-fucosyllactose is present in the nutritional composition in a concentration of from 0.1 mg/mL to 10 mg/mL.20. The nutritional composition according to claim 15 , wherein the at least one neutral human milk oligosaccharide is lacto-N-neotetraose (LNnT) claim 15 , and wherein LNnT is present in the nutritional composition in a concentration of from 0.1 mg/mL to 5 mg/mL.21. The nutritional composition according to claim 15 , wherein the nutritional composition additionally comprises 3-fucosyllactose claim 15 , which ...

USE OF TRI-AND TETRA-SACCHARIDES AS TASTE MODULATORS

Tri- and tetra-saccharides are used in foods, beverages and other consumable products to mask or reduce the unpleasant taste of certain components also present in such products, such as the bitter taste of certain high intensity sweeteners. The organoleptic qualities of the products are thereby improved. In particular, melezitose, maltotriose and maltotetraose effectively reduce the bitterness of consumable products containing steviol glycosides such as rebaudioside A. 1. A composition for oral ingestion comprising an edible ingredient and at least one tri- and/or tetra-saccharide , wherein the edible ingredient has an unpleasant taste sensation when orally ingested in the absence of the at least one tri- and/or tetra-saccharide and wherein tri- and/or tetra-saccharide is present in the composition in a concentration effective to reduce or mask the unpleasant taste sensation.2. The composition of claim 1 , wherein the at least one tri- and/or tetra-saccharide includes at least one of melezitose claim 1 , maltotriose claim 1 , maltotetraose or a combination thereof.3. The composition of claim 1 , wherein the at least one tri- and/or tetra-saccharide consists essentially of at least one of melezitose claim 1 , maltotriose claim 1 , maltotetraose or a combination thereof.4. The composition of claim 1 , wherein the at least one tri- and/or tetra-saccharide comprises at least 60% by weight in total of at least one of melezitose claim 1 , maltotriose claim 1 , maltotetraose or a combination thereof.5. The composition of claim 1 , wherein the unpleasant taste sensation is one or more of an unpleasant off-taste claim 1 , an unpleasant aftertaste claim 1 , lingering sweetness or bitterness.6. The composition of claim 1 , wherein the unpleasant taste sensation is a bitter taste sensation.7. The composition of claim 1 , wherein the edible ingredient is a high intensity sweetener.8. The composition of claim 1 , wherein the edible ingredient is a high intensity sweetener ...

OLIGOSACCHARIDE SYRUP HAVING IMPROVED STABILITY

The present invention relates to a saccharide syrup composition comprising an organic acid or its salt and an oligosaccharide, and more specifically, the saccharide syrup composition comprises allulose. 1. A saccharide syrup composition for preventing oligosaccharide decomposition , comprising an oligosaccharide; and an organic acid or its salt.2. The saccharide syrup composition according to claim 1 , wherein the saccharide syrup has an electrical conductivity of 100 to 1000 μS/cm.3. The saccharide syrup composition according to claim 1 , wherein pH is 5.0 to 8.0.4. The saccharide syrup composition according to claim 1 , wherein the color value of the saccharide syrup composition is 0.005 to 0.2.5. The saccharide syrup composition according to claim 1 , wherein the preventing oligosaccharide decomposition is to have a content of the oligosaccharide of 80% or more claim 1 , based on 100% of the initial content of the oligosaccharide claim 1 , under storage conditions of a temperature of 45° C. and 42 days.6. The saccharide syrup composition according to claim 1 , wherein the organic acid is one or more selected from the group consisting of lactic acid claim 1 , citric acid and ascorbic acid.7. The saccharide syrup composition according to claim 1 , wherein the organic acid or its salt is contained in an amount of 0.001 to 1.0 wt %.8. The saccharide syrup composition according to claim 1 , wherein the oligosaccharide content is 20 to 90 wt % claim 1 , based on 100 wt % of the saccharide syrup composition.9. The saccharide syrup composition according to claim 1 , wherein the saccharide syrup composition further comprises allulose.10. The saccharide syrup composition according to claim 9 , wherein the oligosaccharide content is 20 to 90 wt % and the allulose content is 10 to 80 wt % claim 9 , based on 100 wt % of the saccharide syrup composition.11. The saccharide syrup composition according to claim 1 , wherein the oligosaccharide is one or more selected from the ...

INTESTINAL HEALTH PROMOTING COMPOSITIONS

Compositions for promoting intestinal health are disclosed and described. In one example, the composition can include a combination of cyanidins and delphinidins, in an amount sufficient to treat intestinal hyperpermeability. In a further example, the composition can further comprise a prebiotic blend and fructooligosaccharides. Further presented herein, is a method of treating a condition or disorder related to gastrointestinal health in a subject. In one example, the method can include maximizing tight junction integrity in epithelial cells of gastrointestinal tract of the subject. 1. An intestinal health promoting composition , comprising a combination of cyanidins and delphinidins , in an amount sufficient to treat intestinal hyperpermeability.2. The composition of claim 1 , wherein the cyanidins and the delphinidins are collectively present in an amount that maintains intestinal permeability.3. The composition of claim 1 , wherein the cyanidins and the delphinidins are collectively present in an amount that reduces intestinal hyperpermeability.4. The composition of claim 1 , wherein a source of at least one of the cyanidins and the delphinidins are derived from a black rice component claim 1 , a blueberry component claim 1 , a black current component claim 1 , a crowberry component claim 1 , a bilberry component claim 1 , black chokeberry component claim 1 , or a combination thereof.5. The composition of claim 4 , wherein the source of the cyanidins and the delphinidins are derived from the black rice component claim 4 , the blueberry component claim 4 , and the black current component.6. The composition of claim 4 , wherein the composition comprises the black rice component and the black rice component is derived from a member selected from the group consisting of black rice kernels claim 4 , black rice concentrate claim 4 , black rice extract claim 4 , black rice powder claim 4 , or a combination thereof.7. The composition of claim 6 , wherein the black rice ...

COMPOSITION COMPRISING FUT2-DEPENDENT OLIGOSACCHARIDES AND LACTO-N-NEOTETRAOSE FOR USE IN PROMOTING BRAIN DEVELOPMENT AND COGNITION

A nutritional composition contains Fut2-dependent oligosaccharides for promoting brain growth and development in infants in the very early postnatal period. The nutritional composition contains Fut2-dependent oligosaccharides and Lacto-N-neotetraose and is specifically for use in promoting brain catch-up growth in preterm infants or infants with low-birth weight. A kit can include at least two of these nutritional compositions. 1: A method for promoting brain growth and development in an infant between 0 and 4 months of age in need of brain catch-up growth , the method comprising administering a nutritional composition comprising Lacto-N-Neotetraose (LNnT) and an effective amount of 2′Fucosyllactose (2′FL) to the infant , the nutritional composition does not contain probiotics.2: The method according to claim 1 , wherein the infant is between 0 and 2 months of age.3: The method according to claim 1 , wherein the nutritional composition is administered to the infant in an amount effective for achieving a characteristic selected from the group consisting of: head circumference growth rate in infants claim 1 , brain catch-up growth in infants claim 1 , cognitive function in infants claim 1 , psychomotor development in infants claim 1 , and any combination thereof.4: The method according to claim 1 , wherein the nutritional composition provides nutrition to the infant.5: The method according to claim 1 , wherein the nutritional composition is administered to the infant in addition to breast feeding.6: The method according to claim 1 , wherein the Lacto-N-Neotetraose (LNnT) is 0.1 to 0.6 g/L of the nutritional composition.7: The method according to claim 1 , wherein the nutritional composition further comprises at least one additional Fucosyltransferase 2 (Fut2)-dependent oligosaccharide selected from the group consisting of di-Fucosyllactose (diFL) and Lacto-N-fucopentaose I (LNFP I).8: The method according to claim 1 , wherein the nutritional composition is in a form ...

NUTRITIONAL COMPOSITION FOR IMPROVING CELL MEMBRANES

An early in life nutritional intervention with a lipid component having both large lipid globules with phospholipids and an increased amount of palmitic acid in the sn-2 position in triglycerides were found to improve the fatty acid composition of cell membranes, in particular brain membranes. 1. A method for improving the fatty acid composition of cell membranes in a human subject , the method comprising administering to the subject a nutritional composition comprising lipid in the form of lipid globules , wherein the lipid comprises(i) at least 0.5 wt. % alpha-linolenic acid based on total fatty acids,(ii) at least 5 wt. % linoleic acid based on total fatty acids,(iii) at least 10 wt. % palmitic acid based on total fatty acids, wherein at least 15 wt. % of the palmitic acid, based on total palmitic acid, is located at the sn-2 position of a triglyceride, and(v) at least 0.5 wt. % phospholipid based on total lipid, wherein a part of the phospholipid is in the coating of the lipid globule,wherein the lipid globules have a mode diameter based on volume of at least 1 μm and/or at least 45 vol. % have a diameter of 2-12 μm,wherein the nutritional composition is not human milk or comprises vegetable lipid, andwherein the cell membranes are brain cell membranes or red blood cell membranes.2. The method according to claim 1 , wherein the improvement of cell membranes is selected from the group consisting of increasing membrane fluidity claim 1 , increasing PUFA claim 1 , increasing LC-PUFA claim 1 , increasing n3 PUFA claim 1 , increasing n3 LC-PUFA claim 1 , increasing DHA claim 1 , increasing ARA claim 1 , decreasing weight ratio of n6/n3 PUFA claim 1 , and decreasing weight ratio of n6/n3 LC PUFA.3. The method according to claim 1 , wherein at least 25 wt. % of palmitic acid claim 1 , based on total palmitic acid claim 1 , is located at the sn-2 position of a triglyceride.4. The method according to claim 1 , wherein the phospholipids comprise at least 5 wt. % ...

COMPOSITION COMPRISING NEOAGAROOLIGOSACCHARIDE AS ACTIVE INGREDIENT, FOR PREVENTION OR TREATMENT OF SEPSIS OR SEPTIC SHOCK

The present invention relates to a composition for prevention or treatment of sepsis or septic shock, in which the composition includes neoagarooligosaccharide as an active ingredient, and the neoagarooligosaccharide according to the present invention has an excellent effect in terms of immune enhancement by effectively suppressing inflammation, and also exhibits a good effect in preventing sepsis, and therefore can be effectively used in pharmaceuticals and functional foods for prevention or treatment of sepsis or septic shock and immune enhancement. 19-. (canceled)10. A method for preventing or treating sepsis or septic shock in a subject , the method comprising administering to the subject a neoagarooligosaccharide , wherein the neoagarooligosaccharide is prepared from agar or agarose by an agarase gene (DagA) enzyme reaction.11Streptomyces coelicolor.. The method of claim 10 , wherein the DagA enzyme is derived from12. The method of claim 11 , wherein the DagA enzyme is represented by amino acid sequence 31 to 309 of SEQ ID NO: 2.13. The method of claim 11 , wherein the DagA enzyme is encoded by a nucleotide sequence of SEQ ID NO: 1.14. The method of claim 10 , wherein the neoagarooligosaccharide is selected from the group consisting of neoagarobiose claim 10 , neoagarotetraose claim 10 , neoagarohexaose claim 10 , and any combination thereof.15. The method of claim 10 , wherein the neoagarooligosaccharide is administered at about 0.001 mg/kg to about 1000 mg/kg per day.16. The method of claim 10 , wherein the neoagarooligosaccharide is administered orally claim 10 , rectally claim 10 , intravenously claim 10 , intramuscularly claim 10 , subcutaneously claim 10 , or intracerebrally.17. The method of claim 10 , wherein the neoagarooligosaccharide is administered in the form of an injection. The present invention relates to a composition for prevention or treatment of sepsis or septic shock, in which the composition includes neoagarooligosaccharide as an active ...

Ferment collagen drink and the method of preparing the same

The present invention disclosed a ferment collagen drink and the method of preparing the same, the ferment collagen drink includes the following raw materials: collagen tripeptide, collagen peptide, blueberry juice concentrate, cherry juice concentrate, apple juice concentrate, dark plum juice concentrate, grape juice concentrate, and lemon juice concentrate, fruit and vegetable ferment powder, fructo-oligosaccharide, konjaku flour, extract, sea buckthorn fruit powder, donkey-hide gelatin, citric acid, guar gum, Aspartame, vitamin C, and water.

PROBIOTIC COMPOSITIONS INCLUDING IMMUNE MODULATORS

A digestive product includes a probiotic component and an immune modulator, such as transfer factor and/or a nanofraction immune modulator. The digestive product may also contain a prebiotic component, such as one or more of galactooligosaccharides, xylooligosaccharides, and fructooligosaccharides. The probiotic component may be encapsulated, such as probiotic micro beadlets. 1. A composition comprising:an immune modulating component; anda probiotic component.2. The composition of claim 1 , wherein the immune modulating component comprises a fraction of at least one of colostrum and eggs lacking transfer factor claim 1 , the fraction capable of moderating metabolic activity of T-cells.3. The composition of claim 2 , wherein the fraction comprises bovine colostrum claim 2 , egg yolk claim 2 , and bovine colostrum extract.4. The composition of claim 3 , wherein the fraction has an upper molecular weight cutoff of 3 claim 3 ,000 Da.5. The composition of claim 3 , wherein the immune modulating component comprises a weight ratio of about 68:30:2 of bovine colostrum:egg yolk:bovine colostrum extract.6. The composition of claim 5 , wherein the one or more prebiotics of the immune modulating component comprises one or more of 3′-sialyllactose claim 5 , 6′-sialyllactose claim 5 , and 6′ sialyl-N-acetyllactosamine.7. The composition of claim 1 , further comprises a prebiotic component.8. The composition of claim 6 , wherein the prebiotic component comprises at least one of xylooligosaccharides claim 6 , galactooligosaccharides claim 6 , and fructooligosaccharides.9. The composition of claim 8 , wherein the prebiotic component has a weight ratio of about 2:1:2 of xylooligosaccharides to galactooligosaccharides to fructooligosaccharides.10. The composition of claim 1 , wherein the probiotic component comprises a probiotic contained within a microcapsule.11. The composition of claim 7 , wherein the composition further comprises additives claim 7 , and wherein the composition ...

Fiber-Containing Carbohydrate Composition

A food product comprises an oligosaccharide composition that is digestion resistant or slowly digestible. The oligosaccharide composition can be produced by a process that comprises producing an aqueous composition that comprises at least one oligosaccharide and at least one monosaccharide by saccharification of starch, membrane filtering the aqueous composition to form a monosaccharide-rich stream and an oligosaccharide-rich stream, and recovering the oligosaccharide-rich stream. Alternatively, the oligosaccharide composition can be produced by a process that comprises heating an aqueous feed composition that comprises at least one monosaccharide or linear saccharide oligomer, and that has a solids concentration of at least about 70% by weight, to a temperature of at least about 40° C., and contacting the feed composition with at least one catalyst that accelerates the rate of cleavage or formation of glucosyl bonds for a time sufficient to cause formation of non-linear saccharide oligomers, wherein a product composition is produced that contains a higher concentration of non-linear saccharide oligomers than linear saccharide oligomers. 1. A process for making a slowly-digestible or digestion-resistant carbohydrate composition , the process comprisingproviding an aqueous feed composition that comprises dextrose and at least one linear dextrose oligomer, the aqueous feed composition including at least 70% by weight on a dry solids basis of dextrose and dextrose oligomers, the aqueous feed composition having a dextrose equivalence of 26-95; andreacting the aqueous feed composition at a total solids concentration of at least about 90% by weight in the presence of at least one acid catalyst that accelerates the rate of cleavage or formation of glucosyl bonds at a pH of no more than 4 and a temperature of at least about 149° C. for a time of 0.1-15 minutes to produce a product composition in which the concentration of non-linear saccharide oligomers is at least twice as ...

Duplicated Dry lavers Adhered with Foods to the Inner Part of Its and Manufacturing Method Thereof

본 발명은 김의 사이에 식품류를 부착시켜 구성된 이중 김 및 그 제조방법에 관한 것이다. 보다 상세하게는 하부의 김(bottom) 내면에 접착성 식품조성물을 도포하여 건조과일류, 건조씨앗류, 건조육포류, 건조어포류 등을 부착시키고 그 상부에 김(top)을 접합하여 구성된 것이다. The present invention relates to a double laver formed by attaching foods between the laver and a manufacturing method thereof. More specifically, by applying an adhesive food composition on the bottom inner seam (bottom) by attaching dried fruits, dried seeds, dried beef jerky, dried fish and the like, and is configured by bonding a seaweed (top) on the top. 전통적으로 김은 굽거나 참기름을 발라서 밥과 함께 반찬으로 하거나, 김부각을 만들어 간식으로 하거나, 김밥에 사용하는 것이 보편적이다. Traditionally, laver is used as a side dish with grilled or sesame oil and served as a side dish, or as a snack made with gimbapak, or used in gimbap. 본 발명은 1매당 3g(건조 중량) 이상된 김을 원료로 하여 180-250℃로 전기히터로 구이하고 올리고당, 덱스트린, 설탕, 솔비톨 등을 혼합한 접착성 식품조성물을 하부 김의 내면에 도포한 후 건조과일류로 바나나, 살구, 곶감, 사과 등을, 건조씨앗류로 호박씨, 해바라기씨, 참깨, 땅콩, 편강 등을, 건조육포류로 쇠고기, 오징어, 명태 등을 부착시켜 김으로 덧씌우기한 후 40-60℃의 열풍으로 10시간 이상 건조하여 일정한 크기로 절단하고 포장하여 이중김을 제조한다. In the present invention, a laver having a weight of 3 g (dry weight) or more is used as a raw material, roasted with an electric heater at 180-250 ° C., and an adhesive food composition containing oligosaccharides, dextrin, sugar, sorbitol, and the like is coated on the inner surface of the lower laver. After attaching dried fruits, bananas, apricots, dried persimmons, apples, dried seeds, pumpkin seeds, sunflower seeds, sesame seeds, peanuts, flakes, etc. Dry over 10 hours with hot air at 60 ℃ to cut and package to a constant size to produce a double laver. 본 발명은 김의 용도를 다양화하기 위하여 김이 가지고 있는 우수한 영양분과 맛을 식품과 결합시켜 김을 반찬용 이외의 간이식품으로 개발하여 김의 가공도와 부가가치를 높이는 데 그 목적이 있다. The purpose of the present invention is to improve the processing and added value of seaweed by developing seaweed as a simple food other than the side dish by combining the excellent nutrients and taste of seaweed with food to diversify the use of seaweed.

Vinegar beberage using jujube and fruit juice

본 발명은 대추와 과즙을 이용한 식초 음료 제조 방법 및 이 방법에 의해 제조된 대추와 과즙을 이용한 식초 음료에 관한 것으로, 식초의 효능을 전달할 수 있고 식초의 신맛을 부드럽게 하면서 각종 과일의 맛을 느낄 수 있도록 하여 섭취시 거부감을 없애고 식초와 모든 재료의 영양소가 파괴 및 변형되지 않도록 함으로써 건강식품으로서의 신뢰성을 향상함을 목적으로 한다. 본 발명에 의한 대추와 과즙을 이용한 식초 음료 제조 방법은, 식초 베이스, 대추 농축액, 석류와 블루베리와 사과 중 하나 이상의 과즙 농축액, 정제수, 식이섬유와 액상 과당과 올리고당과 비타민 C를 포함하는 기능성 원료를 준비하는 제1단계와; 상기 제1단계를 통해 준비된 재료 중에서 식초 베이스, 대추 농축액, 과즙 농축액을 혼합하여 교반하는 제2단계와; 상기 제2단계를 통해 혼합된 혼합물을 초산 발효시키는 제3단계와; 상기 제3단계를 거쳐 초산 발효된 식초음료 원액을 숙성시키는 제4단계와; 상기 제4단계를 통해 제조된 식초음료 원액에 상기 제1단계에서 준비한 정제수를 가하여 pH를 조절함과 아울러 고형분을 여과하여 식초 음료를 제조하는 제5단계와; 상기 제5단계를 통해 제조된 식초 음료를 포장하는 제6단계를 포함한다. The present invention relates to a method for producing vinegar drink using jujube and juice, and a vinegar drink using jujube and juice prepared by the method, and can transmit the efficacy of vinegar and feel the taste of various fruits while softening sourness of vinegar So as to eliminate the feeling of rejection when consumed and prevent the nutrients of vinegar and all materials from being destroyed and deformed, thereby improving the reliability as a health food. A method for producing a vinegar drink using jujube and juice according to the present invention is characterized in that a vinegar base, a jujube concentrate, a functional concentrate containing at least one juice concentrate of pomegranate, blueberry and apple, purified water, dietary fiber, liquid fructose, oligosaccharide and vitamin C The method comprising: A second step of mixing and stirring the vinegar base, the jujube concentrate, and the juice concentrate in the materials prepared through the first step; A third step of acetic acid fermenting the mixed mixture through the second step; A fourth step of aging the acetic acid fermented vinegar beverage stock solution through the third step; Adding the purified water prepared in the first step to the vinegar beverage stock solution prepared in the fourth step to adjust the pH and filtering the solid content to produce a vinegar beverage; And a ...

Method of making sweetner containing of galeato-oligo-saccharide and stevioside

(a) adding stevioside into a lactose soln.; (b) administering beta-galactosidase which obtd. from microorganism into the soln.; and (c) reacting it at 30-70 deg.C. The anzyme is free protein enzyme, enzyme containing microorganism or immobilized enzyme. The stevioside is used in the ratio of 0.5-20 wt.% to the galactose.

Preparation Method for a Persimmon Leaf Juice as a Chief Element of Persimmon Leaf

본 발명은 감잎 추출물을 주성분으로 하여 씀바귀 추출물, 옥수수 추출물, 과당, 감식초, 매실 농축액 등을 혼합한 감잎음료의 제조방법에 관한 것이다. 감잎에는 탄닌을 포함한 훼놀성 화합물이 다양하게 함유되어 있어 생리적 작용과 함께 탄닌 성분중 갈레이트(gallate)가 혈압상승억제 효과가 있다는 것이 확인되어 오래 전부터 한방약으로 사용되어 왔다. The present invention relates to a method for producing a persimmon leaf drink containing a persimmon leaf extract as a main ingredient, and extracts such as moth extract, corn extract, fructose, persimmon vinegar, plum concentrate. Persimmon leaves contain a variety of phenolic compounds, including tannins have been used as a herbal medicine for a long time has been confirmed that gallate (gallate) of the tannin component along with the physiological action has the effect of inhibiting blood pressure rise. 본 발명은 감잎을 수확하여 수세, 절단, 마쇄하여 물로 추출한 감잎 추출물에 산사가 함유된 매실 농축액, 이소말토올리고 당(30% 이상)을, 과당, 비타민 C, 호박산, 구연산 등의 첨가물과 씀바귀, 멸라초, 감초, 옥수수차, 치커리 등의 추출물 음료를 제조한 후 감(Persimmon)향 또는 땅콩(peanut)향을 사용하여 각각의 단계별로 관능검사를 통해 첨가된 성분별로 기호성이 우수한 조합을 선정하여 최종적으로 감잎 추출물에 씀바귀 추출물, 옥수수 추출물, 과당, 감식초, 매실 농축액을 혼합하여 기호성과 저장성이 우수한 감잎음료를 제조하는 데 있다. The present invention is harvested persimmon leaves, washed, cut, crushed and extracted persimmon leaf extract extracted with water, plum concentrate, isomaltooligosaccharides (30% or more), fructose, vitamin C, succinic acid, citric acid and other additives and bitter, After extract extracts of perilla, licorice, corn tea, chicory, etc., persimmon (peanut) fragrance (Persimmon) or peanut (peanut) fragrance through each sensory test by selecting the combination of excellent palatability by ingredients added Finally, persimmon leaf extract is mixed with persimmon extract, corn extract, fructose, persimmon vinegar and plum concentrate to produce persimmon leaf beverage with excellent palatability and shelf life. 본 발명의 감잎은 개화 시기인 5월 중순부터 6월 초순에 수확한 원료로서 비타민 및 페놀성 함량이 높아 0.1∼5.8%에 이르며 뚜렷한 항산화성 특징과 함께 항돌연변이성이 확인되었고 수퍼옥사이드 디스뮤테이스(superoxide dismutase) 활성에도 관여하는 등 건강음료가 될 수 있을 것으로 기대된다. Persimmon leaf of the present invention is a raw material harvested from the middle ...

Yogurt containing fermented red bean and method for preparing the same

Fermented red bean yogurt and a method for producing the same are disclosed. The fermented red bean yogurt produced according to the present invention has an excellent inhibitory effect on myutanic kraase activity, an antioxidative effect, an effect of stimulating tyrosinase activity, and an effect of suppressing maltase activity of human small intestine.

A process for preparing beverage containing flower, inner skin and pulp of a chestnut and a beverage thereof

본 발명은 밤 꽃 또는 밤 꿀, 밤 속껍질 및 밤 과실을 이용하여 밤 음료를 제조하는 방법 및 그로부터 얻어지는 밤 음료에 관한 것으로, 구체적으로는 밤 꽃 및 속 껍질을 엑기스로 제조한 원액을 이용하고 이를 밤 과실 죽인 밤 죽과 혼합함으로써 음용이 용이하고 밤의 성분을 모두 이용함으로써 건강에 유익한 음료를 생산할 수 있으며 단순히 버려지던 밤 꽃과 밤 속껍질을 활용함으로써 밤이 가지고 있는 영양성분을 최대한 섭취하면서도 저렴한 비용으로 음료를 제조할 수 있는 장점이 있다. The present invention relates to a method for producing a chestnut drink using chestnut flower or chestnut honey, chestnut skin and chestnut fruit, and to a chestnut beverage obtained therefrom. It is easy to drink by mixing with chestnut porridge which killed chestnut fruit, and it is possible to produce a healthful drink by using all the ingredients of chestnuts. There is an advantage to prepare a drink.

Manufacturing method of stir-fried ssamjang using anti-bacterial plant compound red pepper paste

본 발명은 복합발효액 고추장를 이용한 볶음 쌈장에 관한 것으로서, 더욱 상세하게는 항균식물 복합발효액을 첨가한 복음고추장 70중량%와 볶음된장 30중량%로 혼합하여 볶음쌈장을 제조하는 것으로서 녹차, 매실, 질경이, 어성초, 자소엽의 항균식물로 이루어진 복합발효액을 이용하여 전통 발효식품인 고추장을 제조하고 이를 볶아 복합발효액 볶음 고추장과 볶음된장을 혼합하여로 볶음쌈장을 제조함으로 쌈장 섭취시에 항균식물 복합발효액의 효능을 함께 이용할 수 있도록 하기 위한 항균식물 복합발효액 고추장을 이용한 볶음쌈장 제조방법에 관한 것이다. The present invention relates to a stir-fried ssamjang using a complex fermentation solution Gochujang, and more particularly, to prepare a stir-fried ssamjang by mixing 70% by weight of Gochujang pepper paste added with an antibacterial plant complex fermentation solution and 30% by weight of stir-fried soybean paste, green tea, plum, plantain, Efficacy of antibacterial plant complex fermentation solution when ingesting ssamjang by making red pepper paste, a traditional fermented food, using a complex fermentation solution composed of antibacterial plants of Eoseongcho and perilla leaf, and stir-frying it to make fried ssamjang by mixing red pepper paste and stir-fried soybean paste. It relates to a method for preparing stir-fried ssamjang using an antibacterial plant complex fermentation solution for using together with red pepper paste.

VITAMINIZED NUTRITION COMPOSITIONS BASED ON MILK

1. Питательная композиция на основе молока, содержащая:a) примерно до 5,5 г/100 ккал источника жира или липида;b) примерно до 6 г/100 ккал источника белка; иc) источник углеводов, так, чтобы питательная композиция содержала примерно до 18 г/100 ккал всех углеводов, где по меньшей мере 60% всех углеводов составляет фруктоза, лактоза или их сочетание.2. Питательная композиция по п. 1, где все углеводы содержат по меньшей мере примерно 10% по массе фруктозы.3. Питательная композиция по п. 1, где все углеводы содержат по меньшей мере примерно 60% по массе лактозы.4. Питательная композиция по п. 1, где объединенное количество фруктозы и лактозы, присутствующее во всех углеводах, составляет по меньшей мере примерно 70% по массе.5. Питательная композиция по п. 1, где вся лактоза в питательной композиции составляет примерно от 6,0 г/100 ккал примерно до 11,7 г/100 ккал.6. Питательная композиция по п. 5, где добавленная лактоза составляет примерно от 0,8 г/100 ккал примерно до 5,4 г/100 ккал.7. Питательная композиция по п. 5, где фруктоза, присутствующая в питательной композиции, составляет примерно 3,6 г/100 ккал.8. Питательная композиция по п. 1, которая содержит примерно от 11,5 г/100 ккал примерно до 16 г/100 ккал всех углеводов, и дополнительно, где лактоза присутствует в питательной композиции на уровне примерно от 6,5 г/100 ккал примерно до 11,2 г/100 ккал, а фруктоза присутствует в питательной композиции на уровне примерно от 1,4 г/100 ккал примерно до 3,2 г/100 ккал.9. Питательная композиция по п. 1, где питательная композиция не содержит добавленной сахарозы.10. Питательная композиция по п. 1, где питательная композиция представляет собой молочную смесь для детей 1-3 лет.11. Питательная компо� РОССИЙСКАЯ ФЕДЕРАЦИЯ (19) RU (11) (13) 2013 148 072 A (51) МПК A23L 1/29 (2006.01) ФЕДЕРАЛЬНАЯ СЛУЖБА ПО ИНТЕЛЛЕКТУАЛЬНОЙ СОБСТВЕННОСТИ (12) ЗАЯВКА НА ИЗОБРЕТЕНИЕ (21)(22) Заявка: 2013148072/13, 26.03.2012 (71) Заявитель(и): ЭмДжейЭн Ю.Эс. Холдингс ЛЛК (US) Приоритет(ы): (30) ...

Composition of Fruits and Vegetables Beverage Containing Fig and the Method Thereof

본 발명은 조성물 총 중량에 대하여, 무화과 농축액 1 ~ 5 중량%, 과당 5 ~ 15 중량%, 올리고당 0.5 ~ 5 중량%, 구연산 0.01 ~ 0.2 중량%, 비타민C 0.01 ~ 0.1 중량%, SY-RED 색소 0.005 ~ 0.05 중량%, 칼라믹스 알에스-엘 색소 0.005 ~ 0.05 중량%, 무화과향 0.005 ~ 0.15 중량% 및 정제수 74.45 ~ 93.465 중량%를 포함하는 과채 음료 조성물 및 상기 과채 음료 조성물의 제조방법에 관한 것이다. The present invention is based on the total weight of the composition, 1 to 5% by weight of the fig concentrate, 5 to 15% by weight fructose, 0.5 to 5% by weight oligosaccharide, 0.01 to 0.2% by weight citric acid, 0.01 to 0.1% by weight vitamin C, SY-RED pigment It relates to a vegetable beverage composition comprising 0.005 to 0.05% by weight, color mix RS-L pigment 0.005 to 0.05% by weight, figs 0.005 to 0.15% by weight and purified water 74.45 to 93.465% by weight and a method for producing the vegetable beverage composition .

Soybean-curd babaroa and soybean milk pudding with oligosaccharide and without off-flavor and manufacturing method thereof

본 발명은 콩 이취감이 없고 올리고당을 함유한 두부 바바로와 또는 두유 푸딩 및 그 제조방법에 관한 것으로, 더욱 구체적으로 콩 이취감이 없고 올리고당을 함유한 두부 바바로와는 두유, 두부, 코코아, 또는 올리고당을 포함하여 응고된 형태로 형성된 콩 이취감이 없고 올리고당을 함유한 두부 바바로와이다. 또한, 콩 이취감이 없고 올리고당을 함유한 두유 푸딩은 두유, 인삼, 또는 올리고당을 포함하여 응고된 형태로 형성된 콩 이취감이 없고 올리고당을 함유한 두유 푸딩이다. 본 발명의 콩 이취감이 없고 올리고당을 함유한 두부 바바로와 또는 두유 푸딩은 코코아, 또는 인삼을 함유하여 콩 비린맛을 없애고, 대장기능을 활성화하는 올리고당과 소화흡수되기에 적합한 다른 구성 성분들을 바바로와 또는 푸딩의 형태로 형성한 것으로, 섭취시 위에 무리가 없으면서도, 대장기능을 활성화하고, 영양이 풍부하고, 콩에 대한 거부감 없이, 미감과 맛이 있어, 반복 섭취 가능하다. 또한, 본 발명의 콩 이취감이 없고 올리고당을 함유한 두부 바바로와 또는 두유 푸딩은 적은 비용으로, 간단하게 제조되어, 성장식, 식사대용식, 환자식, 회복식, 기능식, 다이어트식, 간식, 또는 노인식으로 사용될 수 있다. The present invention relates to tofu Barbarossa containing soybean odor and oligosaccharides and soy milk pudding, and to a method for producing the same. More specifically, tofu Barbarossa containing soybean odor and containing oligosaccharides, soy milk, tofu, cocoa, Or tofu Barbarowa, which contains no oligosaccharide and has no oligosaccharides in a coagulated form, including oligosaccharides. In addition, soymilk pudding without soybean odor and containing oligosaccharides is soymilk pudding without soybean odor and formed in a coagulated form including soymilk, ginseng, or oligosaccharide. Tofu Bavaro and soy milk pudding containing no oligosaccharides and oligosaccharides of the present invention contains cocoa or ginseng to eliminate soybean fishy taste, and oligosaccharides that activate colon function and other components suitable for digestion and absorption. Formed in the form of baro or pudding, without ingestion in the stomach without ingestion, activate the colon function, rich in nutrition, without a sense of rejection, soybeans, taste and taste, can be repeated intake. In addition, tofu Barbarowa or soy milk pudding containing no oligosaccharide and oligosaccharides of the present invention is produced at a low cost, simply, growth, meal replacement, patient, recovery, functional, diet, snack , Or can be used as a senior citizen. 바바로와, 푸딩, 콩, 코코아, 한천, ...

Soybean-curd babaroa and soybean milk pudding with oligosaccharide and without off-flavor and manufacturing method thereof

본 발명은 콩 이취감이 없고 올리고당을 함유한 두부 바바로와 또는 두유 푸딩 및 그 제조방법에 관한 것으로, 더욱 구체적으로 콩 이취감이 없고 올리고당을 함유한 두부 바바로와는 두유, 두부, 코코아, 또는 올리고당을 포함하여 응고된 형태로 형성된 콩 이취감이 없고 올리고당을 함유한 두부 바바로와이다. 또한, 콩 이취감이 없고 올리고당을 함유한 두유 푸딩은 두유, 인삼, 또는 올리고당을 포함하여 응고된 형태로 형성된 콩 이취감이 없고 올리고당을 함유한 두유 푸딩이다. 본 발명의 콩 이취감이 없고 올리고당을 함유한 두부 바바로와 또는 두유 푸딩은 코코아, 또는 인삼을 함유하여 콩 비린맛을 없애고, 대장기능을 활성화하는 올리고당과 소화흡수되기에 적합한 다른 구성 성분들을 바바로와 또는 푸딩의 형태로 형성한 것으로, 섭취시 위에 무리가 없으면서도, 대장기능을 활성화하고, 영양이 풍부하고, 콩에 대한 거부감 없이, 미감과 맛이 있어, 반복 섭취 가능하다. 또한, 본 발명의 콩 이취감이 없고 올리고당을 함유한 두부 바바로와 또는 두유 푸딩은 적은 비용으로, 간단하게 제조되어, 성장식, 식사대용식, 환자식, 회복식, 기능식, 다이어트식, 간식, 또는 노인식으로 사용될 수 있다. 바바로와, 푸딩, 콩, 코코아, 한천, 젤라틴, 인삼, 두유, 두부, 간식, 곡물

Food and beverage composition containing extract of black waxy rice with giant embryo

본 발명은 흑찰거대배아미 추출물을 유효성분으로 함유하는 항산화 활성 증진용 식음료 조성물, 상기 식음료 조성물의 제조방법 및 상기 식음료 조성물을 함유한 식품에 관한 것이다. The present invention relates to a food and beverage composition for enhancing antioxidant activity, a method for preparing the food and beverage composition, and a food containing the food and beverage composition.

Microorganism inhibition solution for fresh meat

본 발명은 육류의 선도보존제에 관한 것으로, 더욱 구체적으로는 키토올리고당 을 용해한 유기산 수용액이 인체에 영향을 주지 않으면서, 육류의 조직을 손상시키지 않고 미생물의 생육을 억제시켜 육류의 저장성을 향상시킬 수 있으므로, 이를 선도보존제로 사용하는 것에 관한 것이다. The present invention relates to a freshness preservative of meat, and more particularly, an organic acid solution in which chitooligosaccharides are dissolved can improve the shelf life of meat by inhibiting the growth of microorganisms without damaging meat tissues without affecting the human body. Thus, it relates to using it as a preservative.

Traditional wellbeing beverage using various herbs

본 발명은 인지기능개선효과를 발휘하는 한약재를 이용한 웰빙한방음료에 관한 것으로, 더욱 상세하게는 당귀의 열수추출물 85~88중량%; 당류 10.66~14.12중량%; 폴리덱스트로즈 0.8~1.2중량%; 및, 유기산 0.08~0.14중량%; 를 포함하여 제조되는 것을 특징으로 하는 웰빙한방음료에 대한 것이다. The present invention relates to a well-being herbal beverage using a herbal medicine that exhibits an effect of improving cognitive function, more specifically, 85 to 88% by weight of hot water extract of Angelica vulgaris; 10.66-14.12 weight% of saccharides; 0.8-1.2% polydextrose; And 0.08 to 0.14% by weight of organic acid; It is for a well-being herbal drink characterized in that it is prepared to include. 본 발명의 웰빙한방음료는 천연재료의 이용으로 부작용의 위험이 없으며, 한약재의 쓴맛을 보완하였기 때문에 다양한 연령층에게 친숙한 음료로 이용될 수 있을 것으로 기대된다. The well-being herbal beverage of the present invention has no risk of side effects by using natural ingredients, and is expected to be used as a beverage familiar to various age groups because it supplements the bitter taste of herbal medicines. 한방음료, 인지, 한약재, 당귀 Herbal Beverage, Cognition, Herbal Medicine, Dongguk

substitute Food and a method of manufacturing

본 발명은 알파화한 통곡물 한끼 대용식품의 제조에 관한 것으로 알파화한 통곡물을 곡물 혼합분말과 섞어서 한끼 식사의 대용식품으로 포만감을 가질 수 있는 통곡물 한끼 대용식품의 제조방법에 관한 것이다. 본 발명은 곡물 혼합분말에 알파화시킨 통곡물현미, 통곡물수수, 참깨알곡 및 검은깨알곡을 혼합하고 올리고당분말 및 결정과당을 첨가하여 제조한다. 상기 알파화한 통곡물 한끼 대용식품에 혼합되는 원료는 곡물 혼합분말 100중량부에 통곡물현미 20~40중량부, 통곡물 수수 10~20중량부, 참깨알곡 5~15중량부, 검정깨알곡 5~15중량부의 비율로 혼합하여 제조하고, 상기 곡물 혼합분말은 보리가루 100중량부에 현미가루 70~90중량부, 검정콩가루 50~60중량부를 혼합하되, 현미찹쌀40~55중량부, 백태 30~50중량부, 흑미 30~40중량부, 수수 30~40중량부, 율무 15~25중량부 및 아마란스 5~15중량부를 가루형태로 혼합하여 제조한다. The present invention relates to the production of a substitute whole grain whole grain food, and a method for preparing a whole grain substitute food having a fullness as a substitute food for a single meal by mixing an alphalized whole grain with a grain mixed powder. The present invention is produced by mixing whole grain rice, whole grain cereals, sesame seeds and black sesame seeds which have been alpha-digested with grain powder, and adding oligosaccharide powder and crystalline fructose. The raw material to be mixed with the above-mentioned alpha-whole grain substitute food is a mixture of 20 to 40 parts by weight of whole grain brown rice, 10 to 20 parts by weight of whole grain rice, 5 to 15 parts by weight of sesame seeds, And 50 to 60 parts by weight of black soybean flour are mixed in 100 parts by weight of the grain flour, wherein 40 to 55 parts by weight of brown rice glutinous rice, 40 to 55 parts by weight of brown rice flour, 30 to 50 parts by weight of black rice, 30 to 40 parts by weight of black rice, 30 to 40 parts by weight of corn, 15 to 25 parts by weight of yulmu and 5 to 15 parts by weight of amaranthin in powder form.

Oligosaccharides obtained from polysaccharides-derived from Formitella fracinea and method for preparing the same

본 발명은 항보체 활성을 갖는 장수버섯 자실체 유래의 다당체로부터 얻은 올리고당 및 이의 제조방법에 관한 것이다. 보다 구체적으로 장수버섯 자실체에서 분리한 보체활성화 다당체를 글루코시다제로 처리하여 얻은 올리고당 및 이의 제조방법에 의한 것이다. The present invention relates to oligosaccharides obtained from polysaccharides derived from long-lived mushroom fruiting bodies having anti-complement activity and a method for producing the same. More specifically, the oligosaccharides obtained by treating the complement-activating polysaccharide isolated from longevity mushroom fruiting body with glucosidase and a method for producing the oligosaccharide.

Beverage and its preparation

본 발명은 음료 조성물과 그 제조방법에 관한 것으로서, 더욱 상세하게는 미싯가루, 클로렐라 추출물, 당, 호료 및 음용수를 첨가하여 통상의 음료 제조방법으로 제조하고, 호화한 후 순간살균하면서 충전하여 멸균시키고 냉각시킴으로써 뭉침이나 엉김이 없고 대량생산이 용이하며 어린이의 성장발육을 도모할 수 있는 미싯가루와 클로렐라 추출물 함유 음료의 제조방법에 관한 것이다. The present invention relates to a beverage composition and a method for preparing the same, more specifically, powdered, chlorella extract, sugar, flavors and drinking water is added to prepare a conventional beverage production method, and after sterilization by filling with instant sterilization The present invention relates to a method for preparing a beverage containing minced powder and chlorella extract, which is free of clumps or tangles, facilitates mass production, and enables children to grow and grow.

Hard candy containing malto oligosaccharides

본 발명은 하드 캔디 제조용 조성물 및 이를 이용하여 제조된 하드캔드에 관한 것으로서, 더욱 자세하게는 말토올리고당과 설탕을 포함하는 하드 캔디 제조용 조성물, 이를 이용하여 제조되며 흡습성이 낮고 경도가 높으며 칼로리가 낮은 하드 캔디에 관한 것이다. The present invention relates to a composition for preparing hard candy and a hard can prepared using the same, and more specifically, a composition for preparing hard candy containing malto-oligosaccharide and sugar, manufactured using the same, and having low hygroscopicity, high hardness, and low calorie. It is about.

Beverages containing onion concentrate and preparation method thereof

본 발명은 최적 추출조건을 이용하여 양파 농축액을 제조하고, 제조된 양파 농축액에 복분자 농축액, 말로덱스트린, 자몽종자 추출액, 프락토올리고당, 스테비텐 플러스, 비타민 C, 구연산, CMC(Carboxy methyl cellulose), 드링크 향으로 구성된 첨가제 및 정제수를 혼합하여 제조된 음료용 조성물 및 그의 제조방법에 관한 것으로, 본 발명에 따른 양파 음료는 최적의 추출조건으로 제조된 양파 농축액을 기본 원료로 사용하고, 복분자 농축액을 비롯한 각종의 재료를 가장 적합 비율로 배합함으로서 양파의 매운 맛과 냄새는 줄이면서 특유의 향미 및 건강기능성분은 유지된 건강기능성 음료로서 우수한 효과가 있다. The present invention is to prepare an onion concentrate using the optimal extraction conditions, bokbunja concentrate, malodextrin, grapefruit seed extract, fructooligosaccharide, stebitene plus, vitamin C, citric acid, CMC (Carboxy methyl cellulose), The present invention relates to a beverage composition prepared by mixing additives and purified water, and a preparation method thereof. The onion beverage according to the present invention uses an onion concentrate prepared under optimum extraction conditions as a basic raw material, By combining various ingredients in the most suitable ratio, while reducing the pungent taste and smell of onions, the unique flavor and health functional ingredients are excellent as a health functional beverage maintained. 양파, 양파음료, 양파 농축액 Onion, Onion Beverage, Onion Concentrate

Vegan caremel composition

본 발명은 비건용 캐러멜 조성물에 관한 것으로, 더욱 상세하게는 두유, 아몬드유, 감미료, 볶은 콩가루, 펙틴 및 현미유로 이루어진다. 상기의 성분으로 이루어지는 캐러멜 조성물은 맛과 식감이 우수할 뿐만 아니라, 지방의 함량이 낮아 취식자의 건강을 증진시키며, 우유와 같은 동물성 단백질 대신 두유와 아몬드유가 함유되어 비건(vegan)과 같은 채식주의자도 섭취가 가능하다.

Method for producing kale beverage and kale beverage produced by same method

본 발명은 (a) 건조한 케일에 물을 첨가한 후 추출하고 여과하여 케일 추출액을 제조하는 단계; (b) 건조한 감초에 물을 첨가한 후 추출하고 여과한 후 농축하여 감초 농축액을 제조하는 단계; (c) 건조한 복령에 물을 첨가한 후 추출하고 여과하여 복령 추출액을 제조하는 단계: (d) 착즙한 사과 착즙액을 여과한 후 농축하여 사과 농축액을 제조하는 단계; 및 (e) 상기 (a)단계의 제조한 케일 추출액, 상기 (b)단계의 제조한 감초 농축액, 상기 (c)단계의 제조한 복령 추출액, 상기 (d)단계의 제조한 사과 농축액과 비타민 C, 구연산, 폴리덱스트로스, 프락토올리고당, 액상과당 및 물을 혼합하는 단계를 포함하여 제조하는 것을 특징으로 하는 케일 음료의 제조방법 및 상기 방법으로 제조된 케일 음료에 관한 것이다. (A) preparing a kale extract by adding water to a dry kale followed by extraction and filtration; (b) adding water to the dried licorice, extracting, filtering and concentrating to prepare a licorice concentrate; (c) adding water to the dried bamboo shoot and extracting and filtering the bamboo shoot to prepare a bamboo shoot extract; (d) filtering the juice of the apple juice and concentrating it to prepare an apple concentrate; And (e) extracting the kale extract prepared in step (a), the licorice concentrate prepared in step (b), the extract obtained in step (c), the apple concentrate prepared in step (d) , Citric acid, polydextrose, fructooligosaccharide, liquid fructose and water, and a cale beverage prepared by the method.

Functional drink for immune- enhancing and Manufacturing method thereof

본 발명은 면역증강용 기능성 음료에 관한 것이다. 보다 상세하게는 홍삼농축액, 산삼배양근농축액, 한약재농축액 및 키토산을 주성분으로 하는 음료로서 홍삼농축액 0.8~1.5중량%, 산삼배양근농축액 0.01~0.05중량%와, 한약재는 대추농축액 0.7~1.5(v/v)%, 산사자, 당귀, 구기자, 감초의 농축액을 각각 0.1~0.7중량%, 키토산 0.016~0.064중량%, 키토올리고당 0.2~0.7중량% 및 효모추출분말 0.05~0.15중량%에 비타민, 구연산, 아미노산, 올리고당을 적당량 혼합하여 구성된다.      The present invention relates to a functional beverage for immune boosting. More specifically, red ginseng concentrate, wild ginseng cultured root concentrate, herbal medicine concentrate and chitosan as main ingredients, red ginseng concentrate 0.8-1.5% by weight, wild ginseng cultured root concentrate 0.01-0.05% by weight, and herbal medicine 0.7-1.5 (v / v) ), 0.1 ~ 0.7% by weight, hawthorn, Angelica, goji berry and licorice concentrate, vitamins, citric acid, amino acid, amino acid, amino acid, amino acid, amino acid, amino acid, It consists of mixing an appropriate amount of oligosaccharide. 본 발명의 기능성음료는 세포주와 실험동물의 임상실험( in vitro, in vivo )을 통하여 특이적으로 면역력 증강 효과를 나타낸다. The functional beverage of the present invention specifically exhibits an immune enhancing effect through cell lines and clinical experiments of animals ( in vitro, in vivo ). 홍삼, 산삼 배양근, 키토산, 비장지표 Red ginseng, wild ginseng culture root, chitosan, spleen index

A method of producing microparticles of the type having a crosslinked, aggregated protein matrix by spray drying

Rice having useful ingredients for body and producing method thereof

본 발명은 기능성 쌀 및 그 제조방법에 관한 것으로써, 보다 구체적으로는 현미, 싹틔운 현미 및 백미에 마늘 효소액을 침투시켜서 마늘의 성분을 함유토록 하고, 한천용액에 원하는 기능성 성분을 혼합하여 코팅용 한천용액을 제조한 다음, 상기 마늘 효소액이 흡수된 쌀을 상기 코팅용 한천용액에 침지하여 코팅함으로써 제조되는 기능성 쌀 및 그 제조방법에 관한 것이다.         The present invention relates to a functional rice and a method of manufacturing the same, and more specifically, to penetrate the garlic enzyme solution into brown rice, sprouted brown rice and white rice to contain the components of garlic, mixing the desired functional components in agar solution for coating After preparing an agar solution, and relates to a functional rice produced by immersing and coating the rice absorbed by the garlic enzyme solution in the coating agar solution.

Beverage composition and manufacturing method thereof

본 밞병은 음료 조성물과 그 제조방법에 관한 것으로서, 더욱 상세하게는 미싯가루, 클로렐라 추출물, 당, 호료 및 음용수를 첨가하여 통상의 음료 제조방법으로 제조하고, 호화한 후 순간멸균하면서 충전하여 멸균시키고 냉각시킴으로써 뭉침이나 엉김이 없고 대량생산이 용이하여 어린이의 성장발육을 도모할 수 있는 미싯가루와 클로렐라 추출물 함유 음료의 제조방법에 관한 것이다.

Composition containing fut2-dependent oligosaccharides and lacto-n-neotetraose, for use in order to activate cerebral development and cognitive ability

FIELD: food industry. SUBSTANCE: invention relates to a nutritional composition containing fucosyltransferase 2 (Fut2)-dependent oligosaccharides and lacto-N-neotetraose (LNnT). Fucosyltransferase 2 (Fut2)-dependent oligosaccharides are 2'-fucosyllactose (2'FL). Infants were born from mothers with low activity Fut2, where said low activity Fut2 is characterized by concentration of 2'-fucosyllactose in breast milk of these mothers less than 0.2 g/l. EFFECT: application of nutritional composition containing fucosyltransferase 2 (Fut2)-dependent oligosaccharides and lacto-N-neotetraose (LNnT), in order to activate head growth rate, cerebral growth and psychomotor development in infants aged 0 to 1 month. 8 cl, 5 dwg, 3 tbl, 6 ex РОССИЙСКАЯ ФЕДЕРАЦИЯ (19) RU (11) (13) 2 720 933 C2 (51) МПК A23L 33/21 (2016.01) ФЕДЕРАЛЬНАЯ СЛУЖБА ПО ИНТЕЛЛЕКТУАЛЬНОЙ СОБСТВЕННОСТИ (12) ОПИСАНИЕ ИЗОБРЕТЕНИЯ К ПАТЕНТУ (52) СПК A23L 33/21 (2019.02); A23L 33/40 (2019.02) (21)(22) Заявка: 2017118533, 29.10.2015 (24) Дата начала отсчета срока действия патента: Дата регистрации: (73) Патентообладатель(и): СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А. (CH) 14.05.2020 31.10.2014 EP 14191277.4 (43) Дата публикации заявки: 03.12.2018 Бюл. № 34 (45) Опубликовано: 14.05.2020 Бюл. № 14 (56) Список документов, цитированных в отчете о поиске: WO 2013057049 A1, 25.04.2013. WO 2013025104 A1, 21.02.2013. US 20120172319 A1, 05.07.2012. EP 2767173 A1, 20.08.2014. US 20120219526 A1, 30.08.2012. (85) Дата начала рассмотрения заявки PCT на национальной фазе: 31.05.2017 2 7 2 0 9 3 3 Приоритет(ы): (30) Конвенционный приоритет: R U 29.10.2015 (72) Автор(ы): ДЕ КАСТРО Карлос Антонио (CH), ШПРЕНГЕР Норберт (CH), ТХАККАР Сагар (CH) EP 2015/075088 (29.10.2015) C 2 C 2 (86) Заявка PCT: (87) Публикация заявки PCT: R U 2 7 2 0 9 3 3 WO 2016/066735 (06.05.2016) Адрес для переписки: 101000, Москва, ул. Мясницкая, д. 13, стр. 5, ООО "Союзпатент" (54) КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ FUT2-ЗАВИСИМЫЕ ОЛИГОСАХАРИДЫ И ЛАКТО-NНЕОТЕТРАОЗУ, ДЛЯ ...

Nutritional composition for plasma membrane improvement

FIELD: nutrition. SUBSTANCE: invention relates to the field of nutrition affecting brain development. Proposed is a use of lipid in the production of a nutritional composition for improving fatty acid content in human cell membranes. The lipid is in form of lipid globules, wherein the lipid contains at least 0.5% wt. alpha-linolenic acid, at least 5% wt. linolenic acid and at least 10% wt. palmitic acid per total amount of fatty acids, wherein at least 15% wt. of palmitic acid per total amount of palmitic acid is at the sn-2 position of the triglyceride; wherein the lipid globules have a mode diameter per volume of at least 1 mcm and/or at least 45% vol. have a diameter of 2 to 12 mcm, and the lipid also contains at least 0.5% wt. phospholipids per total amount of lipids, wherein part of the phospholipid is in the lipid globule surface layer; wherein either the nutritional composition is not human milk or the nutritional composition is comprised of a plant lipid, wherein the cell membranes are brain cell membranes or erythrocyte membranes. EFFECT: by improving the composition of fatty acids in cell membranes of the human brain the lipids allow to improve cognitive functions and/or development and/or prevention of cognitive impairment, to improve behavioral characteristics and/or behavioral development, vision acuity and/or fine motor skills. 18 cl, 3 tbl, 2 ex РОССИЙСКАЯ ФЕДЕРАЦИЯ (19) RU (11) (13) 2 748 025 C2 (51) МПК A23D 9/013 (2006.01) A23L 33/12 (2016.01) ФЕДЕРАЛЬНАЯ СЛУЖБА ПО ИНТЕЛЛЕКТУАЛЬНОЙ СОБСТВЕННОСТИ (12) ОПИСАНИЕ ИЗОБРЕТЕНИЯ К ПАТЕНТУ (52) СПК A23D 9/013 (2021.01); A23L 33/12 (2021.01) (21)(22) Заявка: 2019121258, 08.12.2017 (24) Дата начала отсчета срока действия патента: Дата регистрации: 19.05.2021 09.12.2016 EP 16203280.9; 30.03.2017 EP 17163858.8 (43) Дата публикации заявки: 11.01.2021 Бюл. № 2 (56) Список документов, цитированных в отчете о поиске: WO 2011115476 A1, 22.09.2011. WO 2016010664 A1, 21.01.2016. WO 2015014967 A1, 05.02.2015. EA 21330 ...

NUTRITIONAL COMPOSITIONS AND BABY MIXTURES, INCLUDING BIFIDOBACTERIUM ANIMALIS OF THE SPECIES LACTIS AND OPTIONAL MIXTURE OF OLIGOSACCHARIDES, FOR THE INTRODUCTION OF INTESTINAL CHEMISTRY SIMPLY APPEARANCE.

РОССИЙСКАЯ ФЕДЕРАЦИЯ (19) RU (11) (13) 2018 107 612 A (51) МПК A23L 33/135 (2016.01) ФЕДЕРАЛЬНАЯ СЛУЖБА ПО ИНТЕЛЛЕКТУАЛЬНОЙ СОБСТВЕННОСТИ (12) ЗАЯВКА НА ИЗОБРЕТЕНИЕ (21)(22) Заявка: 2018107612, 04.08.2016 (71) Заявитель(и): НЕСТЕК С.А. (CH) Приоритет(ы): (30) Конвенционный приоритет: 04.08.2015 EP 15179741.2 (85) Дата начала рассмотрения заявки PCT на национальной фазе: 05.03.2018 R U (43) Дата публикации заявки: 05.09.2019 Бюл. № 25 (72) Автор(ы): ГАРСИА-РОДЕНАС, Клара Люсия (CH), БЕРГЕР, Бернард (CH), РЕЦЦОНИКО, Энеа (CH) (86) Заявка PCT: (87) Публикация заявки PCT: WO 2017/021479 (09.02.2017) R U (54) ПИТАТЕЛЬНЫЕ КОМПОЗИЦИИ И ДЕТСКИЕ СМЕСИ, ВКЛЮЧАЮЩИЕ BIFIDOBACTERIUM ANIMALIS ПОДВИДА LACTIS И НЕОБЯЗАТЕЛЬНО СМЕСЬ ОЛИГОСАХАРИДОВ, ДЛЯ ИНДУКЦИИ КИШЕЧНОЙ МИКРОБИОТЫ, КОТОРАЯ ПОХОЖА НА МИКРОБИОТУ МЛАДЕНЦЕВ, НАХОДЯЩИХСЯ НА ГРУДНОМ ВСКАРМЛИВАНИИ (57) Формула изобретения 1. Питательная композиция для младенцев или детей младшего возраста, включающая пробиотик Bifidobacterium animalis вида lactis, для стимуляции или индукции кишечной микробиоты, которая похожа на микробиоту младенцев, вскармливаемых исключительно человеческим грудным молоком, по сравнению с микробиотой младенцев, вскармливаемых преимущественно традиционной питательной композицией, не включающей указанного пробиотика, у младенцев или детей младшего возраста от 0 до 36 месяцев, необязательно от 0 до 12 месяцев. 2. Композиция по любому из предшествующих пунктов, отличающаяся тем, что указанная композиция включает в себя по меньшей мере один N-ацетилированный олигосахарид, и/или по меньшей мере один галактоолигосахарид, и/или по меньшей мере один сиалилированный олигосахарид, необязательно в следующем количестве: - N-ацетилированные олигосахариды: от 0,001 до 1 мас.%, предпочтительно от 0,003 мас.% до 0,3 мас.%; - галактоолигосахариды: от 1 до 10 мас.%, предпочтительно от 3 до 6 мас.%; - сиалилированные олигосахариды: от 0,005 до 1 мас.%, предпочтительно от 0,01 до 0,4 мас.%; все расчеты приведены в % от массы ...

Hard candy composition (versions)

FIELD: food industry. SUBSTANCE: present invention relates to improved solid are containing volume sweeteners and therapeutic substance. Disclosed is a composition of hard candy, including volume sweetener representing isomaltulose and trehalose, erythrite or their combination, and therapeutic substance representing inulin, undigestible dextrin, sukromalt and polydextrose or their combination, weight ratio of bulk sweetener to therapeutic substance is in wt% in terms of dry substances from 70/30 to 40/60. EFFECT: invention ensures production of candies acceptable transparency, fluidity in cold condition and stability of stickiness when producing, which are less than cariogenic and do not cause pathologic deviations in gastrointestinal tract. 18 cl, 16 tbl РОССИЙСКАЯ ФЕДЕРАЦИЯ (19) RU (11) (51) МПК A23G 3/34 (13) 2 581 221 C2 (2006.01) ФЕДЕРАЛЬНАЯ СЛУЖБА ПО ИНТЕЛЛЕКТУАЛЬНОЙ СОБСТВЕННОСТИ (12) ОПИСАНИЕ (21)(22) Заявка: ИЗОБРЕТЕНИЯ К ПАТЕНТУ 2013132153/13, 27.12.2011 (24) Дата начала отсчета срока действия патента: 27.12.2011 Приоритет(ы): (30) Конвенционный приоритет: (72) Автор(ы): ХСУ Чиа-Хуа (US), БАРКАЛОУ Дэвид Джи. (US), СТОСКИ Барбара (US) 30.12.2010 US 61/428,303 (43) Дата публикации заявки: 10.02.2015 Бюл. № 4 R U (73) Патентообладатель(и): ВМ. РИГЛИ ДЖ. КОМПАНИ (US) (45) Опубликовано: 20.04.2016 Бюл. № 11 (85) Дата начала рассмотрения заявки PCT на национальной фазе: 30.07.2013 (86) Заявка PCT: 2 5 8 1 2 2 1 (56) Список документов, цитированных в отчете о поиске: US 2010267658 A1, 21.10.2010. EP 0720819 A2, 10.07.1996. WO 2010031527 A1, 25.03.2010. 2 5 8 1 2 2 1 R U (87) Публикация заявки PCT: WO 2012/092255 (05.07.2012) Адрес для переписки: 119019, Москва, Гоголевский бульвар, 11, этаж 3, "Гоулингз Интернэшнл Инк.", В.А. Клюкину (54) СОСТАВ ТВЕРДОГО ЛЕДЕНЦА (ВАРИАНТЫ) (57) Реферат: Настоящее изобретение относится к весовое отношение объемного подсластителя к усовершенствованным твердым леденцам, лечебному веществу составляет в вес.% в расчете содержащим ...

COMPOSITION CONTAINING FUT2-DEPENDENT OLIGOSACCHARIDES AND LACTO-N-NEOTETRAOSIS, FOR USE IN ORDER TO ACTIVATE THE BRAIN DEVELOPMENT AND COGNITIVE ABILITY

РОССИЙСКАЯ ФЕДЕРАЦИЯ (19) RU (11) (13) 2017 118 533 A (51) МПК A23L 33/00 (2016.01) ФЕДЕРАЛЬНАЯ СЛУЖБА ПО ИНТЕЛЛЕКТУАЛЬНОЙ СОБСТВЕННОСТИ (12) ЗАЯВКА НА ИЗОБРЕТЕНИЕ (21)(22) Заявка: 2017118533, 29.10.2015 (71) Заявитель(и): НЕСТЕК С.А. (CH) Приоритет(ы): (30) Конвенционный приоритет: 31.10.2014 EP 14191277.4 34 (85) Дата начала рассмотрения заявки PCT на национальной фазе: 31.05.2017 EP 2015/075088 (29.10.2015) (87) Публикация заявки PCT: WO 2016/066735 (06.05.2016) R U (54) КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ FUT2-ЗАВИСИМЫЕ ОЛИГОСАХАРИДЫ И ЛАКТО-NНЕОТЕТРАОЗУ, ДЛЯ ПРИМЕНЕНИЯ С ЦЕЛЬЮ АКТИВАЦИИ РАЗВИТИЯ ГОЛОВНОГО МОЗГА И ПОЗНАВАТЕЛЬНОЙ СПОСОБНОСТИ (57) Формула изобретения 1. Питательная композиция, содержащая фукозилтрансфераза 2 (Fut2)-зависимые олигосахариды и лакто-N-неотетраозу (LNnT), для применения с целью активации роста и развития головного мозга у младенцев в возрасте от 0 до 4 месяцев. 2. Питательная композиция по п. 1 для применения с целью активации роста и развития головного мозга у младенцев в возрасте от 0 до 2 месяцев и предпочтительно в возрасте от 0 до 1 месяца. 3. Питательная композиция по п. 1 или 2 для применения по п. 1 или 2 для применения с целью активации любого одного из темпа роста окружности головы у младенцев, догоняющего роста головного мозга у младенцев, когнитивной функции у младенцев, психомоторного развития у младенцев или любой их комбинации, при этом возраст младенцев составляет предпочтительно от 0 до 4 месяцев, более предпочтительно от 0 до 2 месяцев, а наиболее предпочтительно от 0 до 1 месяца. 4. Питательная композиция по любому одному из предшествующих пунктов для применения с целью обеспечения питанием младенцев в возрасте от 0 до 4 месяцев, предпочтительно младенцев в возрасте от 0 до 2 месяцев, а более предпочтительно младенцев в возрасте от 0 до 1 месяца. 5. Питательная композиция по любому одному из предшествующих пунктов для Стр.: 1 A 2 0 1 7 1 1 8 5 3 3 A Адрес для переписки: 109012, 109012, Москва, ул. Ильинка, 5/2, ООО "Союзпатент" ...

Allulose syrup including oligosaccharide and method of preparing the same

The present invention relates to an oligosaccharide-containing allulose syrup product and a preparation method thereof. According to an embodiment of the present invention, a sugar syrup composition for preventing the oligosaccharide decomposition includes raw sugar syrup containing allulose syrup and oligosaccharides and 0.001 to 1.0 wt% of an organic acid or salt thereof. The present invention can prevent the decomposition of the oligosaccharides in the syrup and maintain the oligosaccharide content at a predetermined level, thereby extending the storage period of the oligosaccharides while maintaining the content of the oligosaccharides and physical properties of the sugar syrup.

Mixture of oligosaccharides and food product containing said mixture, in particular nutritional mixture for infant feeding

FIELD: food industry. SUBSTANCE: invention relates to a mixture of oligosaccharides, food product containing a mixture of oligosaccharides and to use of a food product. Mixture of oligosaccharides contains lacto-N-neotetraose, 6′sialyllactose and 2′fucosyllactose in equal parts and is used as a prebiotic. Food product is a mixture for infant feeding. Food product is used as synthetic food composition for preventing and reducing hazard, and/or reducing intensity, and/or reducing a rate of manifestation of food allergy and associated with food allergy consequences for health. EFFECT: food product is used as synthetic food composition for increasing oral tolerance to allergens. 20 cl, 4 dwg, 1 tbl, 1 ex РОССИЙСКАЯ ФЕДЕРАЦИЯ (19) RU (11) (13) 2 581 731 C2 (51) МПК A23L 29/30 (2016.01) A61K 31/702 (2006.01) A23L 33/00 (2016.01) ФЕДЕРАЛЬНАЯ СЛУЖБА ПО ИНТЕЛЛЕКТУАЛЬНОЙ СОБСТВЕННОСТИ (12) ОПИСАНИЕ (21)(22) Заявка: ИЗОБРЕТЕНИЯ К ПАТЕНТУ 2013128595/13, 21.11.2011 (24) Дата начала отсчета срока действия патента: 21.11.2011 (72) Автор(ы): ШПРЕНГЕР Норберт (CH), НЕЕЗЕР Жан-Ришар (CH) (73) Патентообладатель(и): НЕСТЕК С.А. (CH) Приоритет(ы): (30) Конвенционный приоритет: (43) Дата публикации заявки: 27.12.2014 Бюл. № 36 R U 23.11.2010 EP 10192231.8 (45) Опубликовано: 20.04.2016 Бюл. № 11 (85) Дата начала рассмотрения заявки PCT на национальной фазе: 24.06.2013 (86) Заявка PCT: 2 5 8 1 7 3 1 (56) Список документов, цитированных в отчете о поиске: US 6946451 B2, 20.09.2005. WO 2009/ 151315 A1, 17.12.2009. US 2010/0105615 А1, 29.04.2010. 2 5 8 1 7 3 1 R U (87) Публикация заявки PCT: C 2 C 2 EP 2011/070566 (21.11.2011) WO 2012/069416 (31.05.2012) Адрес для переписки: 109012, Москва, ул. Ильинка, 5/2, ООО "Союзпатент" (54) СМЕСЬ ОЛИГОСАХАРИДОВ И ПРОДУКТ ПИТАНИЯ, СОДЕРЖАЩИЙ ЭТУ СМЕСЬ, В ЧАСТНОСТИ ПИТАТЕЛЬНАЯ СМЕСЬ ДЛЯ КОРМЛЕНИЯ МЛАДЕНЦЕВ (57) Реферат: Изобретение относится к пищевой качестве синтетической пищевой композиции для промышленности, а именно к смеси предупреждения и снижения ...

Composition for improving hangover and method for manufacturing the same

다시마, 귤피, 칡꽃, 헛개나무, 대추, 구기자뿌리, 녹차어린잎, 사철쑥, 사인, 국화, 침향, 이소말토올리고당, D-l 멘톨, 유산균, 글루코만난 및 정제수를 혼합한 생약재혼합물을 포함하여 숙취 개선 효과를 갖도록 한 숙취 개선용 조성물 및 그 제조방법에 관한 것이다. Contains herbal medicine mixture containing kelp, tangerine peel, arrowroot flower, honeysuckle, jujube, goji root, green tea young leaf, wormwood, sage, chrysanthemum, aloes root, isomaltooligosaccharide, D-l menthol, lactic acid bacteria, glucomannan and purified water. It relates to a composition for improving a hangover and a method for manufacturing the same.

Macromolecular complex of bacterial origin and use thereof for preventing or treating rheumatoid arthritis

Предложен бактериальный макромолекулярный комплекс для профилактики или лечения воспалительного ревматизма и остеоартрита. Комплекс продуцирован штаммом бактерий Bifidobacterium longum CNCM I-3994. Комплекс состоит из цепей, объединяющих липопротеин и олигосахарид. При этом липопротеин имеет молекулярную массу в интервале от 30 кДа до 60 кДа, а олигосахарид - меньше чем 15 кДа и предпочтительно меньше чем 10 кДа. Липопротеиновая компонента, состоящая из всех липопротеинов каждой цепи, составляет от 75 до 99%, предпочтительно от 80 до 98%, более предпочтительно от 85 до 95% по массе от общей массы комплекса, и олигосахаридная компонента, состоящая из всех олигосахаридов, объединенных с каждой из цепей, составляет от 1 до 25%, предпочтительно от 2 до 20% и более предпочтительно от 5 до 15% от общей массы комплекса. Аминокислотная последовательность липопротеина является SEQ ID 2. Сахариды, образующие олигосахаридную компоненту комплекса, выбраны из галактозы (Gal), N-ацетилгалактозамина (Gal Nac), глюкозы (Glc), N-ацетилглюкозамина (Glc Nac), рамнозы (Rham) и маннозы (Man) и смесей вышеперечисленного. Средняя массовая доля Gal составляет 5-20 мкг/мг комплекса, Man 1-10 мкг/мг комплекса, Glc 10-50 мкг/мг комплекса, Gal Nac 2-10 мкг/мг комплекса, Glc Nac 1-5 мкг/мг комплекса, Rham 1-5 мкг/мг комплекса. Липиды, составляющие липопротеиновую компоненту комплекса, выбраны из группы, состоящей из насыщенных жирных кислот длиной C14:0, C16:0 и C18:0 и их смесей. Предложены также фармацевтическая, пищевая и нутрицевтическая композиции на основе указанного комплекса. 5 н. и 7 з.п. ф-лы, 9 ил., 5 табл., 9 пр. РОССИЙСКАЯ ФЕДЕРАЦИЯ (19) RU (11) (51) МПК C12N 1/20 C12P 1/04 C12P 19/04 C07K 14/195 A23L 33/135 A23L 33/195 ФЕДЕРАЛЬНАЯ СЛУЖБА A61K 35/745 ПО ИНТЕЛЛЕКТУАЛЬНОЙ СОБСТВЕННОСТИ A61K 38/16 A61P 19/00 C12R 1/01 (12) ОПИСАНИЕ (21)(22) Заявка: (13) 2 599 422 C2 (2006.01) (2006.01) (2006.01) (2006.01) (2016.01) (2016.01) (2015.01) (2006.01) (2006.01) (2006.01) ИЗОБРЕТЕНИЯ К ...

Spice sauce adding isomaltooligo saccharide, and processing method of it

The spiced sauce added with isomaltooligo saccharide comprises hot pepper paste 24w%, soy 13%, starch syrup 16%, sugar 9%, onion 7%, garlic 8%, red pepper 4%, ginger 2%, salt 2%, pepper 0.5%, isomaltooligo saccharide 0.5-32% and/or sesame oil 4%. The color of the sauce is not changed longer by the action of the saccharide to inhibit the Malliard reaction.

COMPOSITION CONTAINING 2FL AND LNnT TO CONTROL FOOD CONSUMPTION AND GROWTH IN INFANTS OR YOUNG CHILDREN

FIELD: food industry.SUBSTANCE: invention relates to a nutritional composition for an infant or a young child. Disclosed is use of nutritional composition containing at least one fucosylated oligosaccharide and at least one N-acetylated oligosaccharide, to reduce food intake in an infant or young child. Alternatively, said nutritional composition is used to control food intake in an infant or young child.EFFECT: invention allows preventing excessive accumulation of adipose tissue mass and providing prevention of related health disorders, for example similar to obesity, in further life.20 cl, 8 dwg, 4 tbl, 5 ex РОССИЙСКАЯ ФЕДЕРАЦИЯ (19) RU (11) (13) 2 735 250 C2 (51) МПК A23L 33/21 (2016.01) ФЕДЕРАЛЬНАЯ СЛУЖБА ПО ИНТЕЛЛЕКТУАЛЬНОЙ СОБСТВЕННОСТИ (12) ОПИСАНИЕ ИЗОБРЕТЕНИЯ К ПАТЕНТУ (52) СПК A23L 33/21 (2020.02); A23L 33/40 (2020.02) (21)(22) Заявка: 2018130494, 26.01.2017 (24) Дата начала отсчета срока действия патента: Дата регистрации: 29.10.2020 26.01.2016 EP 16152741.1 (43) Дата публикации заявки: 27.02.2020 Бюл. № 6 (45) Опубликовано: 29.10.2020 Бюл. № 31 (85) Дата начала рассмотрения заявки PCT на национальной фазе: 27.08.2018 (56) Список документов, цитированных в отчете о поиске: EP 2745705 A1, 25.06.2014. WO 2015071402 A1, 21.05.2015. WO 2015085557 A1, 18.06.2015. WO 2013057049 A1, 25.04.2013. EP 2510811 A2, 17.10.2012. WO 2009082214 A1, 02.07.2009. 2 7 3 5 2 5 0 (73) Патентообладатель(и): СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А. (CH) Приоритет(ы): (30) Конвенционный приоритет: R U 26.01.2017 (72) Автор(ы): БИНИА, Аристеа (CH), РАМОС НЬЕВЕС, Хосе Мануэль (CH), НЕМБРИНИ, Кьяра (CH), ШПРЕНГЕР, Норберт (CH), ФАВР, Лоран (CH) EP 2017/051585 (26.01.2017) C 2 C 2 (86) Заявка PCT: (87) Публикация заявки PCT: R U 2 7 3 5 2 5 0 WO 2017/129645 (03.08.2017) Адрес для переписки: 101000, Москва, ул. Мясницкая, д. 13, стр. 5, ООО "Союзпатент" (54) КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ 2FL И LNnT, ДЛЯ КОНТРОЛЯ ПОТРЕБЛЕНИЯ ПИЩИ И РОСТА У МЛАДЕНЦЕВ ИЛИ ДЕТЕЙ МЛАДШЕГО ВОЗРАСТА (57) Реферат: Изобретение ...

Patent RU2018130494A3

`”ВУ“” 2018130494`” АЗ Дата публикации: 13.05.2020 Форма № 18 ИЗИМ-2011 Федеральная служба по интеллектуальной собственности Федеральное государственное бюджетное учреждение ж 5 «Федеральный институт промышленной собственности» (ФИПС) ОТЧЕТ О ПОИСКЕ 1. . ИДЕНТИФИКАЦИЯ ЗАЯВКИ Регистрационный номер Дата подачи 2018130494/10(049521) 26.01.2017 РСТ/ЕР2017/051585 26.01.2017 Приоритет установлен по дате: [ ] подачи заявки [ ] поступления дополнительных материалов от к ранее поданной заявке № [ ] приоритета по первоначальной заявке № из которой данная заявка выделена [ ] подачи первоначальной заявки № из которой данная заявка выделена [ ] подачи ранее поданной заявки № [Х] подачи первой(ых) заявки(ок) в государстве-участнике Парижской конвенции (31) Номер первой(ых) заявки(ок) (32) Дата подачи первой(ых) заявки(ок) (33) Код страны 1. 16152741.1 26.01.2016 ЕР Название изобретения (полезной модели): [Х] - как заявлено; [ ] - уточненное (см. Примечания) КОМПОЗИЦИИ, СОДЕРЖАЩИЕ 2ЕГ И Е№Т, ДЛЯ КОНТРОЛЯ ПОТРЕБЛЕНИЯ ПИЩИ И РОСТА У МЛАДЕНЦЕВ ИЛИ ДЕТЕИ МЛАДШЕГО ВОЗРАСТА Заявитель: СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А., СН 2. ЕДИНСТВО ИЗОБРЕТЕНИЯ [Х] соблюдено [ ] не соблюдено. Пояснения: см. Примечания 3. ФОРМУЛА ИЗОБРЕТЕНИЯ: [Х] приняты во внимание все пункты (см. Примечания) [ ] приняты во внимание следующие пункты: [ ] принята во внимание измененная формула изобретения (см. Примечания) 4. КЛАССИФИКАЦИЯ ОБЪЕКТА ИЗОБРЕТЕНИЯ (ПОЛЕЗНОЙ МОДЕЛИ) (Указываются индексы МПК и индикатор текущей версии) А23Г, 33/21 (2016.01) 5. ОБЛАСТЬ ПОИСКА 5.1 Проверенный минимум документации РСТ (указывается индексами МПК) А23Т, 33/21 5.2 Другая проверенная документация в той мере, в какой она включена в поисковые подборки: 5.3 Электронные базы данных, использованные при поиске (название базы, и если, возможно, поисковые термины): СМГРА, РЕРАТБЗ пе, РУУРТ, ЕАРАТТУ, Езрасепеё боозе, ]-Р]а( Ра, КТРВГ, РАТЕМТЗСОРЕ, Ра еагсп, РибБМеа, 5СОРОЦ5, зслепсе Оиесе, ОЗРТО, \у/\.спзББ.га 6. ДОКУМЕНТЫ, ОТНОСЯЩИЕСЯ К ...

The manufacturing method of tomato vinegar drink having anti-obesity functional

본 발명은 항비만 효능을 가진 토마토 식초 음료의 제조방법에 관한 것으로, 분쇄된 토마토에 당도가 13°brix가 되도록 당을 첨가하는 당첨가단계(제1단계)와, 상기 제1단계에서 당이 첨가된 토마토에 주모를 접종하고 25~35℃에서 4~8일 동안 발효하는 알코올발효단계(제2단계)와, 상기 제2단계에서 알코올발효된 알코올발효액을 살균하고 여과하는 1차 살균 및 여과단계(제3단계)와, 상기 제3단계에서 1차 살균 및 여과된 토마토 여과액에 종초를 접종하고 25~35℃에서 200~300rpm으로 교반하여 10~15일 동안 발효하는 초산발효단계(제4단계)와, 상기 제4단계에서 초산발효된 초산발효액을 65~80℃에서 5~20분 동안 살균하고 여과하는 2차 살균 및 여과단계(제5단계)와, 상기 제5단계에서 2차 살균 및 여과된 토마토 발효원액에 부형제를 혼합하는 부형제 혼합단계(제6단계)와, 상기 제6단계에서 부형제가 혼합된 혼합액을 여과하여 살균하고 포장하는 살균 및 포장단계(제7단계)로 이루어진 것이다. 상기의 방법으로 제조된 항비만 효능을 가진 토마토 식초 음료는 과잉 토마토 산물을 이용하여 2단계 발효를 진행하고, 부형제를 혼합하여 토마토 식초 음료를 제조함으로써, 단기간에 대량생산이 가능하고 실온에서 2년 이상 저장 가능하며, 토마토의 다양한 생리활성 물질들을 함유하고 있으며, 항비만 효과 또한 우수하여 기능성 식품소재로 활용가능하다. The present invention relates to a method for preparing a tomato vinegar drink having an anti-obesity effect, comprising the step of adding a sugar to the ground tomato so as to have a sugar content of 13 ° brix (first step) (Step 2) of fermenting the fermented alcohol fermented at 25 to 35 DEG C for 4 to 8 days (step 2), and sterilizing and filtering the alcohol fermented alcohol fermented in the second step (Step 3), inoculating a primary herbicide to the primary sterilized and filtered tomato filtrate in the third step, agitating the mixture at 25 to 35 ° C at 200 to 300 rpm and fermenting the mixture for 10 to 15 days (Step 5) for sterilizing and filtering the acetic acid fermentation broth fermented by acetic acid at 65 to 80 ° C for 5 to 20 minutes and filtering the same at the fifth step, And an excipient mixing step of mixing the excipient into the filtered tomato fermentation stock solution (step 6 ) And been made in the first step and the packaging step of sterile filtration sterilization and packaging by the excipients are mixed in a mixed solution 6 (the seventh step). The tomato vinegar beverage having the anti-obesity effect produced by the above method can be mass-produced in a short period of time by two-stage fermentation using an excess tomato product and ...

NUTRITIONAL COMPOSITION FOR IMPROVING CELL MEMBRANES

РОССИЙСКАЯ ФЕДЕРАЦИЯ (19) RU (11) (13) 2019 121 258 A (51) МПК A23D 9/013 (2006.01) ФЕДЕРАЛЬНАЯ СЛУЖБА ПО ИНТЕЛЛЕКТУАЛЬНОЙ СОБСТВЕННОСТИ (12) ЗАЯВКА НА ИЗОБРЕТЕНИЕ (21)(22) Заявка: 2019121258, 08.12.2017 (71) Заявитель(и): Н.В. НЮТРИСИА (NL) Приоритет(ы): (30) Конвенционный приоритет: 09.12.2016 EP 16203280.9; 30.03.2017 EP 17163858.8 (85) Дата начала рассмотрения заявки PCT на национальной фазе: 09.07.2019 EP 2017/081998 (08.12.2017) (87) Публикация заявки PCT: A WO 2018/104512 (14.06.2018) Адрес для переписки: 129090, Москва, ул. Б. Спасская, 25, стр. 3, ООО "Юридическая фирма Городисский и Партнеры" R U (57) Формула изобретения 1. Применение липида в производстве питательного состава для применения для улучшения состава жирных кислот в клеточных мембранах у человека, в котором липид находится в форме липидных глобул, где а. липид содержит по меньшей мере 0,5 мас.% альфа-линоленовой кислоты в расчете на общее количество жирных кислот и по меньшей мере 5 мас.% линолевой кислоты в расчете на общее количество жирных кислот, и b. липид содержит по меньшей мере 10 мас.% пальмитиновой кислоты в расчете на общее количество жирных кислот, и по меньшей мере 15 мас.% пальмитиновой кислоты в расчете на общее количество пальмитиновой кислоты находится в положении sn-2 триглицерида, и с. липидные глобулы имеют модовый диаметр в расчете на объем по меньшей мере 1 мкм, и/или по меньшей мере 45 об.% имеют диаметр 2-12 мкм, и d. липид содержит по меньшей мере 0,5 мас.% фосфолипидов в расчете на общее количество липидов, где часть фосфолипида находится в покрытии липидной глобулы, и причем либо питательный состав не является человеческим молоком, либо питательный состав содержит растительный липид, причем клеточные мембраны представляют собой клеточные мембраны головного мозга или мембраны эритроцитов. Стр.: 1 A 2 0 1 9 1 2 1 2 5 8 (54) ПИТАТЕЛЬНЫЙ СОСТАВ ДЛЯ УЛУЧШЕНИЯ КЛЕТОЧНЫХ МЕМБРАН 2 0 1 9 1 2 1 2 5 8 (86) Заявка PCT: R U (43) Дата публикации заявки: 11.01.2021 Бюл. № 2 (72) ...

Beverage composition containing persimmon vinegar

본 발명은 감식초, 감미제 및 식용 산미제를 함유하는 음용하기에 편리하며 식초의 건강기능성도 도모할 수 있는 음료조성물에 관한 것이다.

NUTRITIONAL COMPOSITIONS AND BABY MIXTURES CONTAINING A MIXTURE OF OLIGOSACCHARIDES AND OPTIONAL BIFIDOBACTERIUM LACTIS FOR PREVENTION, TREATMENT OR REDUCTION OF THE SEVERITY OF NON-RELATED DIARRHEA

РОССИЙСКАЯ ФЕДЕРАЦИЯ (19) RU (11) (13) 2019 105 764 A (51) МПК A23L 33/21 (2016.01) ФЕДЕРАЛЬНАЯ СЛУЖБА ПО ИНТЕЛЛЕКТУАЛЬНОЙ СОБСТВЕННОСТИ (12) ЗАЯВКА НА ИЗОБРЕТЕНИЕ (21)(22) Заявка: 2019105764, 06.07.2017 (71) Заявитель(и): СОСЬЕТЕ ДЕ ПРОДЮИ НЕСТЛЕ С.А. (CH) Приоритет(ы): (30) Конвенционный приоритет: 04.08.2016 EP 16182797.7 (85) Дата начала рассмотрения заявки PCT на национальной фазе: 04.03.2019 R U (43) Дата публикации заявки: 04.09.2020 Бюл. № 25 (72) Автор(ы): БЕРГЕР, Бернард (CH), БРЮССОВ, Гаральд (CH) (86) Заявка PCT: (87) Публикация заявки PCT: WO 2018/024440 (08.02.2018) R U (54) ПИТАТЕЛЬНЫЕ КОМПОЗИЦИИ И ДЕТСКИЕ СМЕСИ, СОДЕРЖАЩИЕ СМЕСЬ ОЛИГОСАХАРИДОВ И НЕОБЯЗАТЕЛЬНО BIFIDOBACTERIUM LACTIS ДЛЯ ПРОФИЛАКТИКИ, ЛЕЧЕНИЯ ИЛИ СНИЖЕНИЯ СТЕПЕНИ ТЯЖЕСТИ ДИАРЕИ, НЕ СВЯЗАННОЙ С РОТАВИРУСОМ (57) Формула изобретения 1. Питательная композиция для младенцев или детей младшего возраста, которая содержит по меньшей мере один N-ацетилированный олигосахарид, и по меньшей мере один галактоолигосахарид, и по меньшей мере один сиалилированный олигосахарид, необязательно в следующем количестве: N-ацетилированные олигосахариды от 0,001 до 1 мас.%, предпочтительно от 0,003 мас.% до 0,3 мас.%; галактоолигосахариды от 1 до 10 мас.%, предпочтительно от 3 до 6 мас.%; сиалилированные олигосахариды от 0,005 до 1 мас.%, предпочтительно от 0,01 до 0,4 мас.%; все расчеты приведены в мас.% композиции, для профилактики, и/или лечения, и/или снижения степени тяжести, и/или риска, и/ или распространенности диареи, не связанной с ротавирусом, у младенцев или детей младшего возраста в возрасте от 0 до 36 месяцев, необязательно от 0 до 12 месяцев или от 0 до 6 месяцев. 2. Питательная композиция по п. 1, содержащая пробиотик Bifidobacterium animalis вида lactis, необязательно CNCM-I-3446, необязательно в количестве от 105 до 1012 КОЕ/г композиции, предпочтительно от 106 до 108 КОЕ/г композиции. Стр.: 1 A 2 0 1 9 1 0 5 7 6 4 A Адрес для переписки: 109012, ул. Мясницкая, д. 13, стр. 5, Москва, 101000, ...

Method for manufacturing red pepper paste using water-soluble dietary fiber and red pepper paste manufactured by the same

Preparing and immersing meju in a saline solution of a certain salinity; A water-soluble dietary fiber mixing and meju-aging step (S320) for mixing and aging the water-soluble dietary fiber with the meju-immersed brine; Agglomerated meju separation and pulverization step (S330) for separating and aging the aged meju in the water soluble dietary fiber mixing and meju aging step (S320); In the aged meju separation and pulverization step (S330), the meju powder and the red pepper powder mixing step (S340) for mixing the powdered meju and the red pepper powder and aging to prepare the red pepper paste; and the red pepper paste aging step (S350) Including, In the water-soluble dietary fiber mixing and meju-aging step (S320), the water-soluble dietary fiber is prepared by mixing the water-soluble dietary fiber material and the thickening polysaccharide, The water-soluble dietary fiber material contains at least one of indigestible maltodextrin or polydextrose, and contains at least 50 mass% of dietary fiber. The water-soluble dietary fiber material contains at least 20 g of the dietary fiber dissolved in 20 ml of water at 20 ° C, Is an indigestible saccharide having a viscosity of less than 20 mPas, The thickening polysaccharide is a polysaccharide having a viscosity of 20 mPas or higher at a viscosity of 5 mass% aqueous solution at 20 캜, and at least one of alginate, propylene glycol alginate, carrageenan, guar gum, starch or starch derivative is used to produce a kochujang Wherein the water-soluble dietary fiber is a water-soluble dietary fiber. According to the above-mentioned constitution, the present invention provides a water-soluble dietary fiber which exerts a physiological effect such as inhibition of blood glucose level rise, rectal action, and improvement of lipid metabolism or excretes a carcinogenic substance to the outside of the body to exert excellent effects in prevention of adult diseases such as hyperlipidemia, diabetes, , It is possible to improve the ...

Manufacturing method of fermentation beverage

본 발명은 괭이밥과 엉겅퀴를 이용하여 스트레스 감소와 간기능 개선을 위한 발효음료 제조방법에 관한 것으로, 괭이밥과 엉겅퀴를 전초 채취한 후 절단하여 건조하여 준비하고, 정제수에 상기 괭이밥, 엉겅퀴 및 감초를 넣고 끓인 물에 고들밥과 엿기름을 혼합한 후 발효시켜 식혜를 만들었다. 우리의 산야에서 쉽게 구할 수 있는 괭이밥, 엉겅퀴 등의 맛과 향을 그대로 보존하면서 맛이 좋고 먹기에 편리하며, 이들이 갖고 있는 고유한 영양분 및 건강기능을 유지하고 있는 새로운 형태의 발효음료를 제공할 수 있다. The present invention relates to a method for producing a fermented beverage for reducing stress and improving liver function by using hoe rice and thistle, preparing chopped hoe rice and thistle after cutting and drying, putting the hoe rice, thistle and licorice into purified water. Boiled water was mixed with gorse rice and malt and fermented to make Sikhye. It is delicious and convenient to eat while preserving the taste and aroma of hoe rice, thistle, etc., which are easily available in our mountains, and can provide new types of fermented beverages that maintain their unique nutrients and health functions. have. 발효음료, 괭이밥, 엉겅퀴, 감초, 식혜 Fermented beverage, hoe rice, thistle, licorice, Sikhye

Composition with specific oligosaccharide is by increasing colon SCFA yield and/or by increasing GLP-1 secretions for preventing fat or relevant comorbidities in the future

本发明涉及营养组合物，该营养组合物包含低聚糖混合物，所述低聚糖混合物包含至少一种N‑乙酰化低聚糖、一种低聚半乳糖和一种唾液酸化低聚糖，该营养组合物通过增加婴儿或幼儿结肠SCFA产量和/或GLP‑1分泌/释放，用于降低和/或避免所述婴儿或幼儿脂肪量过度积聚和/或预防所述婴儿或幼儿的任何相关的日后的健康障碍诸如日后的肥胖和相关的并存病。

Producing process of cactus drink

PURPOSE: A method for producing a drink by using fruits and stems of Optia fiacus media having excellent pharmacological effects is provided, to serve the drink promoting physical health and make use of the Optia fiacus media as a substitute for import crops. CONSTITUTION: The method includes the following steps of: (i) chopping fruits of the Optia fiacus media and separating viscous materials and seeds from the crushed fruits; (ii) mixing the viscous materials with 2times of refined water and compressing the mixture with a French press; (iii) destructing viscous ingredients of the viscous material by homogenizing the squeezed solution and heating at 100deg.C for 25min before filtrating the heated fruit solution 3times; (iv) mixing the resulting fruit extract with stem extract of the Optia fiacus media in a ratio of 1:1; (v) mixing 30wt% of the fruit extract, the stem extract or mixed extract of the fruit and the stem with 15.0wt% of liquid high fructose, 0.06wt% of tartaric acid, 0.06wt% of citric acid, 0.06wt% of lactic acid, 0.5wt% of vitamin C, 0.25wt% of mixed fruit fragrance, 0.25wt% of benzoate, 0.02wt% of natural coloring agent and 54wt% of refined water; and (vi) filtrating and sterilizing the mixture at high temperature of 96deg.C for 15sec and filling the resulting mixture in a container before sterilizing at 82deg.C for 10min, cooling and packing the product.

Composition and method Manufacturing jelly collagen casing of Sugar-free

The present invention relates to a method for manufacturing a sugar-free jelly, and more particularly, to a method for manufacturing a sugar-free collagen casing jelly, which comprises the following steps: mixing raw materials; adding the raw materials in a stirring concentrator, a concentrate storage tank, a jelly concentrate molding machine, a collagen casing filling machine, a twisting machine, a conveyor transfer hanger, a movable rack storage rack, a steamer, and a cooling dryer in order; drum cutting and sterilizing the jelly; oil-coating the jelly on the surface thereof; and packaging the jelly. The present invention provides the sugar-free jelly, in which the jelly has a collagen casing to package the collagen on the surface thereof, and soft jellies are contained therein to exhibit a soft texture when the collagen casing bursts when a user chews the jelly, wherein the texture is similar to a texture of chewing grapes.

Seasoning season using isomaltooligosaccharide and its manufacturing method

본 발명은 양념장의 색태, 조직감, 향미등을 장시간 유지하며, 특히 양념장의 품질염화에 가장 큰 영향을 미치는 갈변을 장시간 억제할 수 있는 양념장 및 그 제조방법에 관한 것이다. 양념장 조성물 중 환원당의 급원이 될 수 있는 물엿과 설탕을 이소말토올리고당으로 대체함으로써 갈변의 속도를 장기간 억제할 수 있는 양념장을 만들 수 있다. 이소말토올리고당의 특징으로 갈락토올리고당, 프락토올리고당등의 올리고당이산과 열에 의해 조미과정중에 대부분 파괴되는 단점을 나타내지만 이소말토올리고당은 내산성과 내열성을 가지고 있어 제조과정 중에 대부분이 잔존하게 되어 그 기능을 나타내게 된다. 이소말토올리고당을 첨가한 양념장은 37℃ 저장과정 중 대조구(이소말토올리고당이 첨가되지 않은 양념장)에 비해 1-2개월정도 갈변억제 기능을 가진다. 즉 상온에서 4주-8주 정도 그 효과를 나타낸다. 그 첨가된 농도는 0.5wt%-2wt%이며, 이 이상의 함량증가는 정제수의 양을 감소시키는 결과로 인해 조직감 및 외관상의 광택이 문제가 되어 제품으로 적당하지 못하다.

Wild morning glory fermentation source manufacturing method

본 발명은 메꽃 발효 소스 제조방법을 제공하는 것을 목적으로 하는 것으로, 본 발명의 메꽃 발효 소스 제조방법의 구성은 메꽃의 꽃부분과 뿌리, 잎, 줄기 부분과 황설탕, 백설탕, 삼온당을 혼합하여 발효시켜서 메꽃 발효재료를 만드는 메꽃 발효 단계; 야관문의 잎과 줄기 부분과 황설탕, 백설탕, 삼온당을 혼합하여 발효시켜서 야관문 발효재료를 만드는 야관문 발효 단계; 삼지구엽초의 잎과 줄기 부분과 황설탕, 백설탕, 삼온당을 혼합하여 발효시켜서 삼지구엽초 발효재료를 만드는 삼지구엽초 발효 단계; 청미래의 잎과 열매와 줄기 부분과 토복령과 황설탕, 백설탕, 삼온당을 혼합하여 발효시켜서 청미래 발효재료를 만드는 청미래 발효 단계; 솔잎과 황설탕, 백설탕, 삼온당 및 토복령을 혼합하여 발효시켜서 솔잎 발효재료를 만드는 청미래 발효 단계; 상기 메꽃 발효재료, 야관문 발효재료, 삼지구엽초 발효재료, 청미래 발효재료 및 솔잎 발효재료를 모두 혼합하여 발효 혼합 재료를 만드는 발효 혼합 재료 형성 단계; 상기 발효 혼합 재료에 감초, 올리고당, 물을 혼합하여 발효 원액을 만든 다음 상기 발효 원액을 숙성시켜서 메꽃 발효 소스를 만드는 메꽃 발효 소스 형성 단계;를 포함하는 것을 특징으로 한다. An object of the present invention is to provide a method for producing a bindweed fermented sauce, and the composition of the method for producing a bindweed fermented sauce is by mixing the flower part of the bindweed flower part, the root, the leaf, the stem part, and brown sugar, white sugar, and triple sugar. A bindweed fermentation step of making a bindweed fermentation material by fermenting; A Yagwanmun fermentation step of mixing and fermenting the leaves and stems of Yagwanmun with brown sugar, white sugar, and three hot sugar to make a fermented material for Yagwanmun; Samjiguyeopcho fermentation step of mixing and fermenting the leaves and stems of Samguyeopcho with brown sugar, white sugar, and threeonsugar to make fermented ingredients for Samguyeopcho; A Qingmirae fermentation step of mixing and fermenting leaves, fruits, and stems of Qingmirae, earthenworms, brown sugar, white sugar, and three-on-one sugar to make a Qingmirae fermented material; Cheongmirae fermentation step of mixing and fermenting pine needles, brown sugar, white sugar, sorghum sugar, and Tobokryeong to make pine needle fermented material; A fermentation mixture material forming step of mixing all of the bindweed fermented material, the Yagwanmun fermented material, the fermented Samji leaf herb fermented material, the Qingmirae fermented material and the pine needle fermented ...

Tomato ketchup using isomaltooligosaccharide and its manufacturing method

본 발명은 토마토페이스트에 부원료를 혼합하여 색택, 조직감, 맛등을 장기간 유지하며, 특히 토마토케찹의 품질열화에 가장 큰 영향을 미치는 갈변을 장시간 억제할 수 있는 토마토케찹을 제조하는 방법에 관한 것이다. 토마토케찹 조성물 중 환원당의 급원이 될 수 있는 물엿과 설탕을 이소말토올리고당으로 대체함으로써 갈변의 속도를 장기간 억제할 수 있는 토마토케찹을 만들 수 있다. 이소말토올리고당의 특징은 갈락토올리고당, 프락토올리고당등의 올리고당이 산과 열에 약해 조미과정중에 대부분 파괴되는 단점을 나타내나, 이소말토올리고당은 내산성의 내열성을 가지고 있어 제조과정 중에 대부분 잔존하게되어 그 기능을 나타내게 된다. 이소말토올리고당을 첨가한 토마토케찹은 저장과정 중 대조구(이소말토올리고당이 첨가되지 않은 토마토케찹)에 비해 2~6개월정도 갈변억제 기능을 가진다. 그 첨가된 농도는 0.5wt%~50wt%이며 50wt%이상이 되면 외관중 조직감과 관능적인 측면에서 문제가 발생하게된다. 그러므로 갈변억제기능은 이 이상의 농도에서는 더욱 효과가 좋으나 관능적인 측면에서 그 함량을 0.5중량%~50중량%가 바람직하다.

Making method of low calorie kombucha using fermentated sugar

본 발명은 발효당을 이용한 저열량의 콤부차 제조방법에 관한 것이다. 구체적으로, 본 발명에 따른 제조방법으로 제조된 콤부차는 콤부차 원료인 천연 추출액의 기능 및 성분은 유지하면서도 시판되는 콤부차에 비해 낮은 열량을 제공하고, 올리고당이 풍부하여 프로바이오틱스로의 특성이 우수함으로써, 기능성 식품으로서 유용하게 사용될 수 있다. The present invention relates to a method for manufacturing low-calorie kombucha using fermented sugar. Specifically, kombucha prepared by the manufacturing method according to the present invention provides a lower calorific value compared to commercially available kombucha while maintaining the functions and components of a natural extract, which is a raw material for kombucha, and is rich in oligosaccharides, so it has excellent properties as probiotics. By doing so, it can be usefully used as a functional food.

Method for Producing Fermented Milk with Berries and Fermented Milk Thereby

The present invention relates to a process for producing milk, which comprises inoculating milk into a starter, kefir seed, oligosaccharide and xylitol instead of sugar, adding maltodextrin as a thickening agent, fermenting the yeast, preparing plain yogurt and then cranberry The present invention relates to a process for producing fermented milk containing berries enhanced in functionality by addition of powder of Straw Berry and Aronia and fermented milk prepared therefrom.

Method for producing red ginseng extract comprising medicinal herbs concentrate and plant extract

본 발명은 홍삼농축액, 한약재 농축액 및 식물혼합추출물 등을 이용하여 제조하는 것을 특징으로 하는 홍삼엑기스의 제조방법 및 상기 방법으로 제조된 홍삼엑기스에 관한 것으로, 홍삼과 한약재 및 식물성분 특유의 맛과 향이 어우러지고, 항산화, 면역증강, 혈행개선 등에 도움을 줄 수 있는 새로운 형태의 기능성 홍삼 엑기스를 제공한다.